Alabdan N, AlRuthia Y, Yates MED, Sales I, Finch CK, Hudson JQ. Predictors of adherence to a new erythropoiesis-stimulating agent inpatient ordering policy: A cross-sectional study. PLoS One. 2017;12(11):e0188390.

Alfadly SO, Wajid S, Abdulghani MA-MM, Anaam MS, Bajubair MS, Ba-Samad SM, Alarifi MN, Babelghaith SD, Sales I. Evaluation of the knowledge and practices of pregnant Yemeni women regarding teratogens. Trop J Pharm Res. 2017; 16(9):2281-8.
Allender JE, Reed BN, Foster JL, Moretz JD, Oliphant CS, Jennings DL, DiDomenico RJ, Coons JC. Pharmacologic considerations in the management of patients receiving left ventricular percutaneous mechanical circulatory support. Pharmacotherapy. 2017 Oct;37(10):1272-1283.

Alothman AF, Althaqafi AO, Matar MJ, Moghnieh R, Alenazi TH, Farahat FM, Corman S, et al. Burden and treatment patterns of invasive fungal infections in hospitalized patients in the Middle East: real-world data from Saudi Arabia and Lebanon. Infect Drug Resist. 2017;10:35-41. doi: 10.2147/IDR.S97413.

Alpert CM, Smith MA, Hummel SL, Hummel EK. Symptom burden in heart failure: assessment, impact on outcomes, and management. Heart Fail Rev. 2017;22(1):25-39.

Al-Ruthia YS, Balkhi B, AlGhadeer S, Mansy W, AlSanawi H, AlGasem R, AlMutairi L, Sales I. Relationship between health literacy and body mass index among Arab women with polycystic ovary syndrome. Saudi Pharm J. 2017;25(7):1015-1018.

Althaqafi AO, Matar MJ, Moghnieh R, Alothman AF, Alenazi TH, Farahat F, Corman S, et al. Burden of methicillin-resistant Staphylococcus aureus pneumonia among hospitalized patients in Lebanon and Saudi Arabia. Infect Drug Resist. 2017;10:49-55.

Atilano-Roque A, Joy MS. Characterization of simvastatin acid uptake by organic anion transporting polypeptide 3A1 (OATP3A1) and influence of drug-drug interaction. Toxicol In Vitro. 2017;45(Pt 1):158-165.

Ayers GT. Considerations for determining perceived benefits and challenges of student organizations at pharmacy school satellite campuses. Am J Pharm Educ. 2017;81(2):39.

Barnes MD, Winkler ML, Taracila MA, Page MG, Desarbre E, Kreiswirth BN, Shields RK, et al. Klebsiella pneumoniae carbapenemase-2 (KPC-2), substitutions at ambler position Asp179, and resistance to ceftazidime-avibactam: unique antibiotic-resistant phenotypes emerge from β-lactamase protein engineering. MBio. 2017;8(5). pii: e00528-17.

Benedict N, Smithburger P, Donihi AC, Empey P, Kobulinsky L, Seybert A, Waters T, Drab S, Lutz J, Farkas D, Meyer S. Blended simulation progress testing for assessment of practice readiness. Am J Pharm Educ. 2017;81(1):14.

Bhuiyan J, Jonkman L, Connor S, Giannetti V. Qualitative evaluation of perceptions of smoking cessation among clients at an alcohol and other drug treatment program. Res Social Adm Pharm. 2017;13(6):1082-1089.

Bowers R, Tunney R, Kelly K, et al. Impact of standardized simulated patients on first-year pharmacy students' knowledge retention of insulin injection technique and counseling skills. Am J Pharm Educ. 2017;81(6):113.

Boyce RD, Jao J, Miller T, Kane-Gill SL. Automated screening of emergency department notes for drug-associated bleeding adverse events occurring in older adults. Appl Clin Inform. 2017;8(4):1022-1030.
Bremmer DN, Balada-Llasat JM, Goff DA, Bauer KA. Ceftriaxone Etest non-susceptible methicillin susceptible Staphylococcus aureus time-kill responses. Diagn Microbiol Infect Dis. 2017;88(2):192-194.

Bröckelmann PJ, Zagadailov EA, Corman SL, et al. Brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma who are Ineligible for autologous stem cell transplant: A Germany and United Kingdom retrospective study. Eur J Haematol. 2017;99(6):553-558.

Buehrle DJ, Shields RK, Shah N, Shoff C, Sheridan K. Risk factors associated with outpatient parenteral antibiotic therapy program failure among intravenous drug users. Open Forum Infect Dis. 2017;4(3):ofx102.

Bulik CC, Okusanya ÓO, Lakota EA, et al. Pharmacokinetic-pharmacodynamic evaluation of gepotidacin against Gram-positive organisms using data from murine infection models. Antimicrob Agents Chemother. 2017;61(2). pii: e00115-16.

Burcham PK, Rozycki AJ, Abel EE. Considerations for analgosedation and antithrombotic management during extracorporeal life support. Ann Transl Med. 2017;5(4):69.

Calabrese MJ, Cooke CE, Watson K, de Bittner MR. Emerging roles for pharmacists in performance-based risk-sharing arrangements. Am J Health Syst Pharm. 2017;74(13):1007-1012.

Casapao AM, Jacobs DM, Bowers DR, et al; REACH-ID Study Group. Early administration of adjuvant β-lactam therapy in combination with vancomycin among patients with methicillin-resistant Staphylococcus aureus bloodstream infection: a retrospective, multicenter analysis. Pharmacotherapy. 2017;37(11):1347-1356.

Castelli G, Petrone A, Xiang J, et al. Rates of nonsteroidal anti-inflammatory drug use in patients with established cardiovascular disease: a retrospective, cross-sectional study from NHANES 2009-2010. Am J Cardiovasc Drugs. 2017;17(3):243-249.

Cavallari LH, Lee CR, Beitelshees AL, Cooper-DeHoff RM, Duarte JD, Voora D, Kimmel SE, McDonough CW, Gong Y, Dave CV, Pratt VM, Alestock TD, Anderson RD, Alsip J, Ardati AK, Brott BC, Brown L, Chumnumwat S, Clare-Salzler MJ, Coons JC, et al; IGNITE Network. Multisite investigation of outcomes with implementation of CYP2C19 genotype-guided antiplatelet therapy after percutaneous coronary intervention. JACC Cardiovasc Interv. 2017 Oct 25. pii: S1936-8798(17)31499-1.

Chang C, Hu Y, Hogan SL, Mercke N, Gomez M, O'Bryant C, Bowles DW, George B, Wen X, Aleksunes LM, Joy MS. Pharmacogenomic variants may influence the urinary excretion of novel kidney injury biomarkers in patients receiving cisplatin. Int J Mol Sci. 2017;18(7). pii: E1333.

Cocanour CS, Chang P, Huston JM, Adams CA Jr, Diaz JJ, Wessel CB, Falcione BA, et al. Management and novel adjuncts of necrotizing soft tissue infections. Surg Infect (Larchmt). 2017;18(3):250-272.

 

Coons JC, Iasella CJ, Chanas T, et al. Comparative effectiveness and safety analysis of dual antiplatelet therapies within an integrated delivery system. Ann Pharmacother. 2017;51(8):649-655.

Copenhaver AM, Jarrett JB. Considerations in determining the ideal pharmacy residency candidate. Am J Pharm Educ. 2017;81(5):97.

Corman S, Elbasha EH, Michalopoulos SN, Nwankwo C. Cost-utility of elbasvir/grazoprevir in patients with chronic hepatitis C genotype 1 infection. Value Health. 2017;20(8):1110-1120. doi: 10.1016/j.jval.2017.05.003.

Custodio JM, Chuck SK, Chu H, Cao H, Ma G, Flaherty J, Ling J, Kearney BP. Lack of clinically important PK interaction between coformulated ledipasvir/sofosbuvir and rilpivirine/emtricitabine/tenofovir alafenamide. Pharmacol Res Perspect. 2017;5(5). doi: 10.1002/prp2.353.

Davis SJ, Hurtado J, Nguyen R, et al. Innovations in medication preparation safety and wastage reduction: use of a workflow management system in a pediatric hospital. Hosp Pharm. 2017;52(1):54-59.

Diwan TS, Lichvar AB, Leino AD, et al. Pharmacokinetic and pharmacogenetic analysis of immunosuppressive agents after laparoscopic sleeve gastrectomy. Clin Transplant. 2017;31(6). doi: 10.1111/ctr.12975.

Dobson EL, Klepser ME, Pogue JM, et al; SIDP Community Pharmacy Antimicrobial Stewardship Task Force. Outpatient antibiotic stewardship: Interventions and opportunities. J Am Pharm Assoc (2003). 2017;57(4):464-473.

Donihi AC. Practical recommendations for transitioning patients with type 2 diabetes from hospital to home. Curr Diab Rep. 2017;17(7):52.

Durham SH, Badowski ME, Liedtke MD, Rathbun RC, Pecora Fulco P. Acute care management of the HIV-infected patient: a report from the HIV Practice and Research Network of the American College of Clinical Pharmacy. Pharmacotherapy. 2017;37(5):611-629.

Durigan RC, Niedermier V. Umeclidinium (Incruse Ellipta) for COPD. Am Fam Physician. 2017;95(2):120-121.
Empey PE, Stevenson JM, Tuteja S, Weitzel KW, Angiolillo DJ, Beitelshees AL, Coons JC, et al; IGNITE Network. Multi-site investigation of strategies for the implementation of CYP2C19 genotype-guided antiplatelet therapy. Clin Pharmacol Ther. 2017 Dec 26. doi: 10.1002/cpt.1006. [Epub ahead of print]

Ensor CR, Rihtarchik LC, Morrell MR, Hayanga JW, Lichvar AB, et al. Rescue alemtuzumab for refractory acute cellular rejection and bronchiolitis obliterans syndrome after lung transplantation. Clin Transplant. 2017;31(4). doi: 10.1111/ctr.12899.

 

Fargo EL. Professional attire dress codes for PharmD programs should not be mandatory. Am J Pharm Educ. 2017;81(3):59.

Felton MA, Jarrett JB, Meyer SM. Geriatric care curriculum in US PharmD programs: What's happening? Curr Pharm Teach Learn. 2017;9(3):504-509.

Finch NA, Zasowski EJ, Murray KP, Mynatt RP, Zhao JJ, Yost R, Pogue JM, Rybak MJ. A quasi-experiment to study the impact of vancomycin area under the concentration-time curve-guided dosing on vancomycin-associated nephrotoxicity. Antimicrob Agents Chemother. 2017;61(12). pii: e01293-17.

Flannery K, Drea E, Hudspeth L, Corman S, et al. Budgetary impact of cabazitaxel use after docetaxel treatment for metastatic castration-resistant prostate cancer. J Manag Care Spec Pharm. 2017;23(4):416-426.

Franquiz MJ, Kalaria SN, Armahizer MJ, et al. Lacosamide pharmacokinetics in a critically ill patient receiving continuous venovenous hemofiltration. Pharmacotherapy. 2017 Nov 21. doi: 10.1002/phar.2063. [Epub ahead of print]

Gavini M, Faber ES, Birnbaum A, Sadovsky R. Who really manages our patients' medications? A study of inner city adults over 40 years of age. J Am Pharm Assoc (2003). 2017;57(2):188-192.

George B, Wen X, Mercke N, Gomez M, O'Bryant C, Bowles DW, Hu Y, Hogan SL, Joy MS, Aleksunes LM. Profiling of kidney injury biomarkers in patients receiving cisplatin: time-dependent changes in the absence of clinical nephrotoxicity. Clin Pharmacol Ther. 2017;101(4):510-518.

George B, You D, Joy MS, Aleksunes LM. Xenobiotic transporters and kidney injury. Adv Drug Deliv Rev. 2017;116:73-91.

George B, Joy MS, Aleksunes LM. Urinary protein biomarkers of kidney injury in patients receiving cisplatin chemotherapy. Exp Biol Med (Maywood). 2017:1535370217745302. [Epub ahead of print]

German P, Mathias A, Brainard DM, Song Q, Ling J, Kearney BP. A thorough QT study to evaluate the effects of supratherapeutic doses of ledipasvir on the QTc interval in healthy subjects. Clin Pharmacol Drug Dev. 2017 Oct 23. doi: 10.1002/cpdd.390. [Epub ahead of print]

Gernant SA, Zillich AJ, Snyder ME. Access to medical records' impact on community pharmacist-delivered medication therapy management: a pilot from the Medication Safety Research Network of Indiana (Rx-SafeNet). J Pharm Pract. 2017:897190017735422.

Gibson CM, Elrod S. Students' versus residency programs' perceptions of a high-quality PGY1 residency applicant. Curr Pharm Teach Learn. 2017 [Article in Press]

Granko RP, Thompson JM, Morton CS, Little JD. Elements of success for transitioning to the role of director of pharmacy. Am J Health Syst Pharm. 2017;74(8):557-561.

Grice GR, Gattas NM, Prosser T, Voorhees M, Kebodeaux C, Tiemeier A, Berry TM, Wilson AG, Mann J, Juang P. Design and validation of patient-centered communication tools (PaCT) to measure students' communication skills. Am J Pharm Educ. 2017;81(8):5927.

Haidar G, Clancy CJ, Chen L, Samanta P, Shields RK, Kreiswirth BN, Nguyen MH. Identifying spectra of activity and therapeutic niches for ceftazidime-avibactam and imipenem-relebactam against carbapenem-resistant Enterobacteriaceae. Antimicrob Agents Chemother. 2017;61(9). pii: e00642-17.

Haidar G, Clancy CJ, Shields RK, Hao B, Cheng S, Nguyen MH. Mutations in blaKPC-3 that confer ceftazidime-avibactam resistance encode novel KPC-3 variants that function as extended-spectrum β-lactamases. Antimicrob Agents Chemother. 2017;61(5). pii: e02534-16.

Haidar G, Philips NJ, Shields RK, et al. Ceftolozane-tazobactam for the treatment of multidrug-resistant Pseudomonas aeruginosa infections: clinical effectiveness and evolution of resistance. Clin Infect Dis. 2017;65(1):110-120.

Hale GM, Hassan SL, Hummel SL, Lewis C, Ratz D, Brenner M. Impact of a pharmacist-managed heart failure postdischarge (bridge) clinic for veterans. Ann Pharmacother. 2017;51(7):555-562.

Hale GM, Valdes J, Brenner M. The treatment of primary orthostatic hypotension. Ann Pharmacother. 2017;51(5):417-428.

Hammond DA, Rowe JM, Wong A, Wiley TL, Lee KC, Kane-Gill SL. Patient outcomes associated with phenobarbital use with or without benzodiazepines for alcohol withdrawal syndrome: a systematic review. Hosp Pharm. 2017;52(9):607-616.

Hammond DA, Oyler DR, Devlin JW, Painter JT, Bolesta S, Swanson JM, Bailey BJ, Branan T, Barletta JF, Dunn B, Haney JS, Juang P, Kane-Gill SL, Kiser TH, Shafeeq H, Skaar D, Smithburger P, Taylor J. Perceived motivating factors and barriers for the completion of postgraduate training among american pharmacy students prior to beginning advanced pharmacy practice experiences. Am J Pharm Educ. 2017;81(5):90.

Hampe HM, Graper L, Hayes-Leight K, Olszewski D, Moffa M, Bremmer DN. Accurate identification of infection source in burn trauma patients with central line infection to determine appropriate treatment option as well as proper public reporting. Crit Care Nurs Q. 2017;40(1):16-23.

Han JK, Hill LG, Koenig ME, Das N. Naloxone counseling for harm reduction and patient engagement. Fam Med. 2017;49(9):730-733.

Heisel RW, Sutton RR, Mascara GP, Winger DG, Weber DR, Lim SH, Oleksiuk LM. Vancomycin-resistant enterococci in acute myeloid leukemia and myelodysplastic syndrome patients undergoing induction chemotherapy with idarubicin and cytarabine. Leuk Lymphoma. 2017;58(11):2565-2572.

Hiensch R, Poeran J, Saunders-Hao P, et al. Impact of an electronic sepsis initiative on antibiotic use and health care facility-onset Clostridium difficile infection rates. Am J Infect Control. 2017;45(10):1091-1100.

Huang D, Yu B, Diep JK, Sharma R, Dudley M, Monteiro J, Kaye KS, Pogue JM, Abboud CS, Rao GG. In vitro assessment of combined polymyxin B and minocycline therapy against Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae. Antimicrob Agents Chemother. 2017;61(7). pii: e00073-17.

Human T, Cook AM, Anger B, Bledsoe K, Castle A, Deen D, et al. Treatment of hyponatremia in patients with acute neurological injury. Neurocrit Care. 2017;27(2):242-248.

Iasella CJ, Johnson HJ, Dunn MA. Adverse drug reactions: Type A (intrinsic) or Type B (idiosyncratic). Clin Liver Dis. 2017;21(1):73-87.

Ie K, Felton M, Springer S, Wilson SA, Albert SM. Physician factors associated with polypharmacy and potentially inappropriate medication use. J Am Board Fam Med. 2017;30(4):528-536.

Jacobs DM, Dilworth TJ, Beyda ND, Casapao AM, Bowers DR. Overtreatment of asymptomatic candiduria among hospitalized patients: a multi-institutional study. Antimicrob Agents Chemother. 2017;62(1). pii: e01464-17.

Johnson KL, Alsharif NZ, Rovers J, Connor S, White ND, Hogue MD. Recommendations for planning and managing international short-term pharmacy service trips. Am J Pharm Educ. 2017;81(2):23.

Jones LK, Greskovic G, Grassi DM, Graham J, Sun H, Gionfriddo MR, Murray MF, Manickam K, Nathanson DC, Wright EA, Evans MA. Medication therapy disease management: Geisinger's approach to population health management. Am J Health Syst Pharm. 2017;74(18):1422-1435.

Jordan RP, Bratberg J, Congdon HB, Cross LB, Hill LG, et al. The Report of the 2016-2017 Advocacy Standing Committee. Am J Pharm Educ. 2017;81(8):S10.

Joseph T, Hale GM, Eltaki SM, et al. Integration strategies of pharmacists in primary care-based accountable care organizations: a Report from the Accountable Care Organization Research Network, Services, and Education. J Manag Care Spec Pharm. 2017;23(5):541-548.

Kalluri HV, Sacha LM, Ingemi AI, Shullo MA, et al. Low vitamin D exposure is associated with higher risk of infection in renal transplant recipients. Clin Transplant. 2017;31(5).

Kane-Gill SL, Dasta JF, Buckley MS, Devabhakthuni S, et al. Clinical practice guideline: safe medication use in the ICU. Crit Care Med. 2017;45(9):e877-e915.

Kane-Gill SL, Dasta JF, Buckley MS, Devabhakthuni S, et al. Executive summary: clinical practice guideline: safe medication use in the ICU. Crit Care Med. 2017;45(9):1546-1551.

Kane-Gill SL, Smithburger PL, Kashani K, Kellum JA, Frazee E. Clinical relevance and predictive value of damage biomarkers of drug-induced kidney injury. Drug Saf. 2017;40(11):1049-1074.
Kapoor K, Verceles AC, Netzer G, Chaudhry A, Bolgiano M, Devabhakthuni S, et al. A collaborative cardiologist-intensivist management model improves cardiac intensive care unit outcomes. J Am Coll Cardiol. 2017 Sep 12;70(11):1422-1423.

Kerlin MP, Adhikari NK, Rose L, Wilcox ME, Bellamy CJ, et al; ATS Ad Hoc Committee on ICU Organization. An Official American Thoracic Society Systematic Review: the effect of nighttime intensivist staffing on mortality and length of stay among intensive care unit patients. Am J Respir Crit Care Med. 2017;195(3):383-393.

Khan I, Haymore J, Barnaba B, Armahizer M, et al. Esophageal cooling device versus other temperature modulation devices for therapeutic normothermia in subarachnoid and intracranial hemorrhage. Ther Hypothermia Temp Manag. 2017 Dec 13. doi: 10.1089/ther.2017.0033. [Epub ahead of print]

Klepser ME, Dobson EL, Pogue JM, et al; SIDP Community Pharmacy Antimicrobial Stewardship Task Force. A call to action for outpatient antibiotic stewardship. J Am Pharm Assoc (2003). 2017;57(4):457-463.

Kloet MA, Lohr BR, Smithburger PL, Seybert AL, Kane-Gill SL. Prospective assessment of inpatient boxed warning prescriber adherence. J Patient Saf. 2017;13(1):25-30.

Laliberte B, Reed BN, Devabhakthuni S, Watson K, Ivaturi V, Liu T, Gottlieb SS. Observation of patients transitioned to an oral loop diuretic before discharge and risk of readmission for acute decompensated heart failure. J Card Fail. 2017;23(10):746-752.

Laliberte B, Reed BN, Devabhakthuni S, Watson K, et al. Observation of patients transitioned to an oral loop diuretic before discharge and risk of readmission for acute decompensated heart failure. J Card Fail. 2017;23(10):746-752.

Lam SW, Russo-Alvarez G, Cristiani C, Rothberg MB. Development of an ambulatory clinical pharmacy prioritization prediction model for patients with diabetes.Ann Pharmacother. 2017;51(1):33-38.

Lashinsky JN, Henig O, Pogue JM, Kaye KS. Minocycline for the treatment of multidrug and extensively drug-resistant A. baumannii: a review. Infect Dis Ther. 2017;6(2):199-211.

Last AR, Ference JD, Menzel ER. Hyperlipidemia: drugs for cardiovascular risk reduction in adults. Am Fam Physician. 2017;95(2):78-87.

Lupu AM, Clinebell K, Gannon JM, Ellison JC, Chengappa KNR. Reducing anticholinergic medication burden in patients with psychotic or bipolar disorders. J Clin Psychiatry. 2017 Nov 21. pii: 16m11269. [Epub ahead of print]

Lyon KC, Likar E, Martello JL, Regier M. Retrospective cross-sectional pilot study of rifaximin dosing for the prevention of recurrent hepatic encephalopathy. J Gastroenterol Hepatol. 2017;32(9):1548-1552.

Maeng DD, Tom LA, Wright EA. Patient characteristics and healthcare utilization patterns associated with unused medications among Medicare patients. Res Social Adm Pharm. 2017;13(6):1090-1094.

Matar MJ, Moghnieh R, Alothman AF, Althaqafi AO, Alenazi TH, Farahat FM, Corman S, et al. Treatment patterns, resource utilization, and outcomes among hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections in Lebanon and Saudi Arabia. Infect Drug Resist. 2017;10:43-48.

McGrane I, VandenBerg A, Munjal R. Treatment of pseudobulbar affect with fluoxetine and dextromethorphan in a woman with multiple sclerosis. Ann Pharmacother. 2017;51(11):1035-1036.

McGrane IR, Loveland JG, de Leon J. Possible oxcarbazepine inductive effects on aripiprazole metabolism: a case report. J Pharm Pract. 2017 Jan 1:897190017710523.

Mehta U, Kalk E, Boulle A, et al. Pharmacovigilance: A public health priority for South Africa. S Afr Health Rev. 2017;2017:125-133.

Millisor VE, Roberts JK, Sun Y, et al. Derivation of new equations to estimate glomerular filtration rate in pediatric oncology patients. Pediatr Nephrol. 2017 Jun 2. doi: 10.1007/s00467-017-3693-5. [Epub ahead of print]

Mogalian E, German P, Kearney BP, et al. Preclinical pharmacokinetics and first-in-human pharmacokinetics, safety, and tolerability of velpatasvir, a pangenotypic hepatitis C virus NS5A inhibitor, in healthy subjects. Antimicrob Agents Chemother. 2017;61(5). pii: e02084-16.

Moghnieh R, Alothman AF, Althaqafi AO, Matar MJ, Alenazi TH, Farahat F, Corman SL, et al. Epidemiology and outcome of invasive fungal infections and methicillin-resistant Staphylococcus aureus (MRSA) pneumonia and complicated skin and soft tissue infections (cSSTI) in Lebanon and Saudi Arabia. J Infect Public Health. 2017;10(6):849-854.

Moore CA, Iasella CJ, Venkataramanan R, et al. Janus kinase inhibition for immunosuppression in solid organ transplantation: Is there a role in complex immunologic challenges? Hum Immunol. 2017;78(2):64-71.

Moore CA, Pilewski JM, Venkataramanan R, et al. Effect of aerosolized antipseudomonals on Pseudomonas positivity and bronchiolitis obliterans syndrome after lung transplantation. Transpl Infect Dis. 2017;19(3).

Nanji KC, Seger DL, Slight SP, Amato MG, Beeler PE, Her QL, Dalleur O, Eguale T, Wong A, et al. Medication-related clinical decision support alert overrides in inpatients. J Am Med Inform Assoc. 2017 Oct 27. doi: 10.1093/jamia/ocx115. [Epub ahead of print]

Navalkele B, Pogue JM, Karino S, et al. Risk of acute kidney injury in patients on concomitant vancomycin and piperacillin-tazobactam compared to those on vancomycin and cefepime. Clin Infect Dis. 2017;64(2):116-123.

Nguyen DC, Timmer TK, Davison BC, McGrane IR. Possible Garcinia cambogia-induced mania with psychosis: a case report. J Pharm Pract. 2017 Jan 1:897190017734728.

Nguyen TT, MacLasco A, Vitto MJ. Medication mismanagement using the rivaroxaban demonstration pack. Am J Health Syst Pharm. 2017;74(12):872-873.

Niedermier V, Ayers G, Springer S. Lixisenatide (Adlyxin) for type 2 diabetes mellitus. Am Fam Physician. 2017;96(4):257-258.

Nolt VD, Kibler AV, Wilkening GL, Fabian TJ. Second-generation antipsychotic utilization and metabolic parameter monitoring in an inpatient pediatric population: a retrospective analysis. Paediatr Drugs. 2017;19(2):139-146.

Omaki E, Castillo R, Eden K, Davis S, McDonald E, Murtaza U, Gielen A; My Healthy Choices Decision Aid Study Team. Using m-health tools to reduce the misuse of opioid pain relievers. Inj Prev. 2017 Apr 6. pii: injuryprev-2017-042319. [Epub ahead of print]

Onufrak NJ, Rao GG, Forrest A, Pogue JM, et al. Critical need for clarity in polymyxin B dosing. Antimicrob Agents Chemother. 2017;61(5). pii: e00208-17.

Pogue JM, Ortwine JK, Kaye KS. Clinical considerations for optimal use of the polymyxins: A focus on agent selection and dosing. Clin Microbiol Infect. 2017;23(4):229-233.

Ramanathan S, Di Paolo JA, Jin F, Shao L, Sharma S, Robeson M, Kearney BP. Pharmacokinetics, pharmacodynamics, and safety of entospletinib, a novel pSYK inhibitor, following single and multiple oral dosing in healthy volunteers. Clin Drug Investig. 2017;37(2):195-205.

Raub JN, Fiorvento A, Franckowiak TM, Wood T, Gortney JS. Implementing and sustaining a mentorship program at a college of pharmacy: The Keys to Successful Mentorship. Curr Pharm Teach Learn. 2017;9(2):296-301.  

Reed BN, Devabhakthuni S. Diuretic resistance in acute decompensated heart failure: a challenging clinical conundrum. Crit Care Nurs Q. 2017;40(4):363-373.
Riedy M, DePaula B, Puder M, Gura KM, Sztam KA. Higher doses of fish oil-based lipid emulsions used to treat inadequate weight gain and rising triene:tetraene ratio in a severely malnourished infant with intestinal failure-associated liver disease. JPEN J Parenter Enteral Nutr. 2017;41(4):667-671.

Rivosecchi RM, Clancy CJ, Shields RK, Ensor CR, Shullo MA, Falcione BA, Venkataramanan R, Nguyen MH. Effects of isavuconazole on the plasma concentrations of tacrolimus among solid-organ transplant patients. Antimicrob Agents Chemother. 2017;61(9). pii: e00970-17.

Rivosecchi RM, Clancy CJ, Shields RK, Ensor CR, Shullo MA, Falcione BA, Venkataramanan R, Nguyen MH. Effects of isavuconazole on the plasma concentrations of tacrolimus among solid-organ transplant patients. Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e00970-17.

Rivosecchi RM, Kane-Gill SL, Garavaglia J, MacLasco A, Johnson H. The effectiveness of intravenous vitamin K in correcting cirrhosis-associated coagulopathy. Int J Pharm Pract. 2017;25(6):463-465.

Rivosecchi RM, Samanta P, Demehin M, Nguyen MH. Pharmacokinetics of azole antifungals in cystic fibrosis. Mycopathologia. 2017 Aug 9. doi: 10.1007/s11046-017-0189-6. [Epub ahead of print]

Roberts KL, Micek ST, Juang P, Kollef MH. Controversies and advances in the management of ventilator associated pneumonia. Expert Rev Respir Med. 2017 Nov;11(11):875-884.

Roumelioti ME, Trietley G, Nolin TD, et al. Beta-2 microglobulin clearance in high-flux dialysis and convective dialysis modalities: a meta-analysis of published studies. Nephrol Dial Transplant. 2017 Nov 27. doi: 10.1093/ndt/gfx311. [Epub ahead of print]

Sales I, Aljadhey H, Albogami Y, Mahmoud MA. Public awareness and perception toward adverse drug reactions reporting in Riyadh, Saudi Arabia. Saudi Pharm J. 2017;25(6):868-872.

Schwier NC, Hale GM, Davies ML. Treatment of adults with idiopathic recurrent pericarditis: novel use of immunotherapy. Pharmacotherapy. 2017;37(3):305-318.

Self WH, Semler MW, Wanderer JP, Ehrenfeld JM, Byrne DW, Wang L, Atchison L, Felbinger M, et al. Saline versus balanced crystalloids for intravenous fluid therapy in the emergency department: study protocol for a cluster-randomized, multiple-crossover trial. Trials. 2017;18(1):178.

Sharma R, Patel S, Abboud C, Diep J, Ly NS, Pogue JM, Kaye KS, Li J, Rao GG. Polymyxin B in combination with meropenem against carbapenemase-producing Klebsiella pneumoniae: pharmacodynamics and morphological changes. Int J Antimicrob Agents. 2017;49(2):224-232.

Shelburne SA, Kim J, Munita JM, Sahasrabhojane P, Shields RK, et al. Whole-genome sequencing accurately identifies resistance to extended-spectrum β-lactams for major Gram-negative bacterial pathogens. Clin Infect Dis. 2017;65(5):738-745.

Shi Q, Jolly M, Mccord MG, Joy MS. Surface-engineered blood adsorption device for hyperphosphatemia treatment. ASAIO J. 2017 Aug 8. doi: 10.1097/MAT.0000000000000639. [Epub ahead of print]

Shields RK, Anand R, Clarke LG, Paronish JA, Weirich M, Perone H, Kieserman J, Freedy H, Andrzejewski C, Bonilla H. Defining the incidence and risk factors of colistin-induced acute kidney injury by KDIGO criteria. PLoS One. 2017;12(3):e0173286.

Shields RK, Chen L, Cheng S, et al. Emergence of ceftazidime-avibactam resistance due to plasmid-borne blaKPC-3 mutations during treatment of carbapenem-resistant Klebsiella pneumoniae infections. Antimicrob Agents Chemother. 2017;61(3). pii: e02097-16.

Shields RK, Clancy CJ, Pasculle AW, Press EG, Haidar G, Hao B, Chen L, Kreiswirth BN, Nguyen MH. Verification of ceftazidime-avibactam and ceftolozane-tazobactam susceptibility testing methods against carbapenem-resistant Enterobacteriaceae and Pseudomonas aeruginosa. J Clin Microbiol. 2017 Nov 22. pii: JCM.01093-17. [Epub ahead of print]

Shields RK, Nguyen MH, Chen L, Press EG, Potoski BA, Marini RV, Doi Y, Kreiswirth BN, Clancy CJ. Ceftazidime-avibactam is superior to other treatment regimens against carbapenem-resistant Klebsiella pneumoniae bacteremia. Antimicrob Agents Chemother. 2017;61(8). pii: e00883-17.

Shields RK, Nguyen MH, Chen L, Press EG, Potoski BA, Marini RV, et al. Ceftazidime-avibactam Is superior to other treatment regimens against carbapenem-resistant Klebsiella pneumoniae bacteremia. Antimicrob Agents Chemother. 2017;61(8). pii: e00883-17.

Shields RK, Nguyen MH, Press EG, et al. Emergence of ceftazidime-avibactam resistance and restoration of carbapenem susceptibility in Klebsiella pneumoniae carbapenemase-producing K pneumoniae: a case report and review of literature. Open Forum Infect Dis. 2017;4(3):ofx101.

Shields RK, Nguyen MH, Press EG, et al. In Vitro selection of meropenem resistance among ceftazidime-avibactam-resistant, meropenem-susceptible Klebsiella pneumoniae isolates with variant KPC-3 carbapenemases. Antimicrob Agents Chemother. 2017;61(5). pii: e00079-17.

Shord SS, Casey D, Zhao H, Demko S, Keegan P, Pazdur R. FDA approval summary: sonidegib-response. Clin Cancer Res. 2017;23(19):5994.

Shord SS. The role of clinical pharmacology in oncology dose selection: advances and opportunities in personalized medicine. J Clin Pharmacol. 2017;57 Suppl 10:S99-S104.

Shorr AF, Pogue JM, Mohr JF. Intravenous fosfomycin for the treatment of hospitalized patients with serious infections. Expert Rev Anti Infect Ther. 2017;15(10):935-945.

Shoulders BR, Smithburger PL, Tchen S, Buckley M, Lat I, Kane-Gill SL. Characterization of guideline evidence for off-label medication use in the intensive care unit. Ann Pharmacother. 2017;51(7):529-542.

Sieg AC, Moretz JD, Horn E, Jennings DL. Pharmacotherapeutic management of gastrointestinal bleeding in patients with continuous-flow left ventricular assist devices. Pharmacotherapy. 2017;37(11):1432-1448.

Singh-Franco D, Hale G, Jacobs RJ. Oral anticoagulation therapy upon discharge in hospitalized patients with nonvalvular atrial fibrillation: a retrospective cohort study. Hosp Pract (1995). 2017:1-8. doi: 10.1080/21548331.2018.1415621. [Epub ahead of print]

Smith MA, Waite LH. Utilization of a virtual patient for advanced assessment of student performance in pain management. Curr Pharm Teach Learn. 2017;9(5):893-897.

Smithburger PL, Korenoski AS, Alexander SA, Kane-Gill SL. Perceptions of families of intensive care unit patients regarding involvement in delirium-prevention activities: a qualitative study. Crit Care Nurse. 2017;37(6):e1-e9.

Smithburger PL, Korenoski AS, Kane-Gill SL, Alexander SA. Perceptions of family members, nurses, and physicians on involving patients' families in delirium prevention. Crit Care Nurse. 2017;37(6):48-57.

Sorbera MA, Friedman ML, Cope R. New and emerging evidence on the use of second-generation direct acting antivirals for the treatment of hepatitis C virus in renal impairment. J Pharm Pract. 2017;30(3):359-365.

Stanford MM, Oprinovich SM, Snyder ME. Beyond the PGY-1 community pharmacy residency: Characterizing career pathways of residency graduates. J Am Pharm Assoc (2003). 2017;57(3S):S191-S196.e2.

Steltenpohl EA, Barry BK, Coley KC, McGivney MS, Olenak JL, Berenbrok LA. Point-of-care testing in community pharmacies: keys to success From Pennsylvania pharmacists. J Pharm Pract. 2017 Jan 1:897190017735243.

Taylor DM, Yap CYL, Knott JC, Taylor SE, et al. Midazolam-droperidol, droperidol, or olanzapine for acute agitation: a randomized clinical trial. Ann Emerg Med. 2017;69(3):318-326.e1.

Torres HA, Shigle TL, Hammoudi N, et al. The oncologic burden of hepatitis C virus infection: A clinical perspective. CA Cancer J Clin. 2017;67(5):411-431.

Tran T, Hardidge A, Heland M, Taylor SE, et al. Slick scripts: impact on patient flow targets of pharmacists preparing discharge prescriptions in a hospital with an electronic prescribing system. J Eval Clin Pract. 2017;23(2):333-339.

Tran T, Taylor SE, Hardidge A, Findakly D, Aminian P, Elliott RA. Impact of pharmacists assisting with prescribing and undertaking medication review on oxycodone prescribing and supply for patients discharged from surgical wards. J Clin Pharm Ther. 2017;42(5):567-572.

Trietley G, Skef S. Albiglutide (Tanzeum) for diabetes mellitus. Am Fam Physician. 2017;95(8):521-522.

Trietley GS, Wilson SA, Chaudhri P, Payette N, Higbea A, Nashelsky J. Clinical inquiry: Do ACE inhibitors or ARBs help prevent kidney disease in patients with diabetes and normal BP? J Fam Pract. 2017;66(4):257-263.

Trinh LD, Roach EM, Vogan ED, Lam SW, Eggers GG. Impact of a quality-assessment dashboard on the comprehensive review of pharmacist performance. Am J Health Syst Pharm. 2017;74(17 Supplement 3):S75-S83.

Trupka T, Fisher K, Micek ST, Juang P, Kollef MH. Enhanced antimicrobial de-escalation for pneumonia in mechanically ventilated patients: a cross-over study. Crit Care. 2017;21(1):180.

Tunney RK Jr, Johnson DC, Wang L, Cox ZL. Impact of pharmacist intervention to increase compliance with guideline-directed statin therapy during an acute coronary syndrome hospitalization. Ann Pharmacother. 2017;51(5):394-400.

Van Arsdale S, Yost SE, Hsu CH, et al. Pyridoxine deficiency after solid organ transplant. Prog Transplant. 2017;27(3):251-256.

Verlinden NJ, Coons JC, Iasella CJ, Kane-Gill SL. Triple antithrombotic therapy with aspirin, P2Y12 inhibitor, and warfarin after percutaneous coronary intervention: an evaluation of prasugrel or ticagrelor versus clopidogrel. J Cardiovasc Pharmacol Ther. 2017;22(6):546-551.

Walsh TL, Bremmer DN, Moffa MA, et al. Effect of antimicrobial stewardship program guidance on the management of uncomplicated skin and soft tissue infections in hospitalized adults. Mayo Clin Proc Innov, Qual Outcomes. 2017;1(1):91-9.

Walsh TL, DiSilvio BE, Hammer C, Beg M, Vishwanathan S, Speredelozzi D, Moffa MA, Hu K, Abdulmassih R, Makadia JT, Sandhu R, Naddour M, Chan-Tompkins NH, Trienski TL, Watson C, Obringer TJ, Kuzyck J, Bremmer DN. Impact of procalcitonin guidance with an educational program on management of adults hospitalized with pneumonia. Am J Med. 2017 Sep 22. pii: S0002-9343(17)30940-3. doi: 10.1016/j.amjmed.2017.08.039. [Epub ahead of print]

Weaver CB, Kane-Gill SL, Gunn SR, Kirisci L, Smithburger PL. A retrospective analysis of the effectiveness of antipsychotics in the treatment of ICU delirium. J Crit Care. 2017;41:234-239.

Wen X, Joy MS, Aleksunes LM. In vitro transport activity and trafficking of MRP2/ABCC2 polymorphic variants. Pharm Res. 2017;34(8):1637-1647.

Westberg SM, Beatty SJ, Corona AR, Deines S, Gunning KM, Gurgle HE, Holtan HS, Marciniak MW, McConnell KJ, McGivney MAS, Patel RJ. Residency pathways to ambulatory care practice: Essential insights for students, residents, and educators. J Am Pharm Assoc (2003). 2017 Oct 5. pii: S1544-3191(17)30841-5.

Whitman-Purves E, Coons JC, Miller T, DiNella JV, Althouse A, Schmidhofer M, Smith RE. Performance of anti-factor Xa versus activated partial thromboplastin time for heparin monitoring using multiple nomograms. Clin Appl Thromb Hemost. 2017:1076029617741363.

Wilkening GL, Gannon JM, Ross C, Brennan JL, Fabian TJ, Marcsisin MJ, Benedict NJ. Evaluation of branched-narrative virtual patients for interprofessional education of psychiatry residents. Acad Psychiatry. 2017;41(1):71-75.

Witcher R, Dzierba AL, Kim C, Smithburger PL, Kane-Gill SL. Adverse drug reactions in therapeutic hypothermia after cardiac arrest. Ther Adv Drug Saf. 2017;8(3):101-111.

Wong A, Amato MG, Seger DL, et al. Evaluation of medication-related clinical decision support alert overrides in the intensive care unit. J Crit Care. 2017;39:156-161.

Wong A, Erdman M, Hammond DA, Holt T, Holzhausen JM, Horng M, Huang LL, Jarvis J, Kram B, Kram S, Lesch C, Mercer J, Rech MA, Rivosecchi R, et al. Major publications in the critical care pharmacotherapy literature in 2015. Am J Health Syst Pharm. 2017;74(5):295-311.

Wong A, Pickering AJ, Potoski BA. Dosing practices of intravenous acyclovir for herpes encephalitis in obesity: results of a pharmacist survey. J Pharm Pract. 2017;30(3):324-328.

Wright EA, Steinhubl SR, Jones JB, et al. Medication burden in patients with acute coronary syndromes. Am J Manag Care. 2017;23(4):e106-e112.

Yap CYL, Taylor DM, Knott JC, Taylor SE, et al. Intravenous midazolam-droperidol combination, droperidol or olanzapine monotherapy for methamphetamine-related acute agitation: subgroup analysis of a randomized controlled trial. Addiction. 2017;112(7):1262-1269.

Zagadailov EA, Corman S, Chirikov V, et al. Real-world effectiveness of brentuximab vedotin versus physicians' choice chemotherapy in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplantation in the United Kingdom and Germany. Leuk Lymphoma. 2017:1-7. doi: 10.1080/10428194.2017.1382698. [Epub ahead of print]

Zasowski EJ, Murray KP, Trinh TD, Finch NA, Pogue JM, Mynatt RP, Rybak MJ. Identification of vancomycin exposure-toxicity thresholds in hospitalized patients receiving intravenous vancomycin. Antimicrob Agents Chemother. 2017;62(1). pii: e01684-17.

Zasowski EJ, Trinh TD, Claeys KC, Casapao AM, et al. Multicenter observational study of ceftaroline fosamil for methicillin-resistant Staphylococcus aureus bloodstream infections. Antimicrob Agents Chemother. 2017;61(2). pii: e02015-16.

Abul-Husn NS, Manickam K, Jones LK, Wright EA, et al. Genetic identification of familial hypercholesterolemia within a single U.S. health care system. Science. 2016;354(6319). pii: aaf7000.

Adams SM, Anderson KB, Coons JC, Smith RB, Meyer SM, Parker LS, Empey PE. Advancing pharmacogenomics education in the core PharmD curriculum through student personal genomic testing. Am J Pharm Educ. 2016;80(1):3.

Alsharif NZ, Dakkuri A, Abrons JP, Williams D, Ombengi DN, Zheng H, Al-Dahir S, Tofade T, Gim S, et al. Current practices in global/international advanced pharmacy practice experiences: home/host country or site/institution considerations. Am J Pharm Educ. 2016;80(3):38.

American College of Clinical Pharmacy., Sorensen TD, Shapiro NL, Benedict N, et al. Recommendations for aligning PGY2 pharmacy residency training and pharmacy specialist board certification. Pharmacotherapy. 2016;36(5):e34-9.

Atilano-Roque A, Aleksunes LM, Joy MS. Bardoxolone methyl modulates efflux transporter and detoxifying enzyme expression in cisplatin-induced kidney cell injury. Toxicol Lett. 2016;259:52-9.

Atilano-Roque A, Roda G, Fogueri U, Kiser JJ, Joy MS. Effect of disease pathologies on transporter expression and function. J Clin Pharmacol. 2016;56(Suppl 7):S205-21.

Awdishu L, Joy MS. Role of pharmacogenomics in kidney disease and injury. Adv Chronic Kidney Dis. 2016;23(2):106-19.

Bacci JL, Akinwale TP, Adams AJ, McGivney MS. An analysis of community pharmacy shared faculty members' contributions to teaching, service, and scholarship. Am J Pharm Educ. 2016;80(7):115.

Bacci JL, Coley KC, McGrath K, Abraham O, Adams AJ, McGivney MS. Strategies to facilitate the implementation of collaborative practice agreements in chain community pharmacies. J Am Pharm Assoc (2003). 2016;56(3):257-265.e2.

Barrett TW, Wrenn KD, Slovis CM, Jones ID, Wright PW, Self WH, Russ S, Collins SP, Ward MJ, Felbinger M, et al. An outpatient management protocol for emergency department patients with a newly diagnosed lower extremity deep venous thrombosis. Crit Pathw Cardiol. 2016;15(3):75-6.

Baxi SM, Clemenzi-Allen A, Gahbauer A, et al. Vancomycin MIC does not predict 90-day mortality, readmission, or recurrence in a prospective cohort of adults with Staphylococcus aureus bacteremia. Antimicrob Agents Chemother. 2016;60(9):5276-84.

Bell HS, Dombrowski S, Gawronski KM, Reinhartz V. Expanding the possibilities for pharmacy-family medicine residency collaboration. Fam Med. 2016;48(8):656-7.

Benich JJ 3rd, Bragg SW, Freedy JR. Psychopharmacology in primary care settings. Prim Care. 2016;43(2):327-40.

Bhuiyan J, Jonkman L, Connor S, Giannetti V. Qualitative evaluation of perceptions of smoking cessation among clients at an alcohol and other drug treatment program. Res Social Adm Pharm. 2016 Nov 3. Epub ahead of print

Bombatch C, Pallotta A, Neuner EA, Taege AJ. Evaluation of herpes zoster vaccination in HIV-infected patients 50 years of age and older. Ann Pharmacother. 2016;50(4):326-7.

Bonafede M, Shi N, Barron R, Li X, Crittenden DB, Chandler D. Predicting imminent risk for fracture in patients aged 50 or older with osteoporosis using US claims data. Arch Osteoporos. 2016;11(1):26.

Borah BJ, Qiu Y, Shah ND, Gleason PP. Impact of provider mailings on medication adherence by Medicare Part D members. Healthc (Amst). 2016;4(3):207-16.

Bosso JA, Casapao AM, Edwards J, et al. Clinical pathway for moderate to severe acute bacterial skin and skin structure infections from a US perspective: a roundtable discussion. Hosp Pract (1995). 2016;44(4):183-189.

Bremmer DN, Bauer KA, Pouch SM, et al. Correlation of checkerboard synergy testing with time-kill analysis and clinical outcomes of extensively drug resistant Acinetobacter baumannii respiratory infections. Antimicrob Agents Chemother. 2016 Aug 15. Epub ahead of print

Bremmer DN, Nicolau DP, Burcham P, Chunduri A, Shidham G, Bauer KA. Ceftolozane/tazobactam pharmacokinetics in a critically ill adult receiving continuous renal replacement therapy. Pharmacotherapy. 2016;36(5):e30-e33.

Bremmer DN, Nicolau DP, Burcham P, et al. Ceftolozane/tazobactam pharmacokinetics in a critically ill adult receiving continuous renal replacement therapy. Pharmacotherapy. 2016;36(5):e30-e33.

Buehrle DJ, Shields RK, Chen L, et al. Evaluation of the in vitro activity of ceftazidime-avibactam and ceftolozane-tazobactam against meropenem-resistant Pseudomonas aeruginosa isolates. Antimicrob Agents Chemother. 2016;60(5):3227-31.

Buehrle DJ, Shields RK, Clarke LG, Potoski BA, Clancy CJ, Nguyen MH. Carbapenem-resistant Pseudomonas aeruginosa bacteremia: risk factors for mortality and microbiologic treatment failure. Antimicrob Agents Chemother. 2016 Nov 7. Epub ahead of print

Castelli G. Clinical pharmacists in family medicine residency programs: tackling the billing barrier. Fam Med. 2016;48(8):657-8.

Castelli G. DON'T QUIT ON YOUR SMOKERS. Persistence pays off when it comes to free nicotine replacement. W V Med J. 2016;112(2):13.

Claeys KC, Zasowski EJ, Casapao AM, et al. Daptomycin improves outcomes regardless of vancomycin MIC in a propensity-matched analysis of methicillin-resistant Staphylococcus aureus bloodstream infections. Antimicrob Agents Chemother. 2016;60(10):5841-8.

Cochran G, Bacci JL, Ylioja T, et al. Prescription opioid use: Patient characteristics and misuse in community pharmacy. J Am Pharm Assoc (2003). 2016;56(3):248-256.e6.

Cochran G, Hruschak V, Bacci JL, Hohmeier KC, Tarter R. Behavioral, mental, and physical health characteristics and opioid medication misuse among community pharmacy patients: A latent class analysis. Res Social Adm Pharm. 2017 Nov;13(6):1055-1061. doi: 10.1016/j.sapharm.2016.11.005. Epub 2016 Nov 15.

Coons JC, Miller T, Simon MA, Ishizawar DC, Mathier MA. Oral treprostinil for the treatment of pulmonary arterial hypertension in patients transitioned from parenteral or inhaled prostacyclins: case series and treatment protocol. Pulm Circ. 2016;6(1):132-5.

Cope R, Glowa T, Faulds S, McMahon D, Prasad R. Treating hepatitis C in a Ryan White-funded HIV clinic: has the treatment uptake improved in the interferon-free directly active antiviral era? AIDS Patient Care STDS. 2016;30(2):51-5.

Corbo JM, Delellis TM, Hill LG, Rindfuss SL, Nashelsky J. ACE inhibitors or ARBs to prevent CKD in patients with microalbuminuria. Am Fam Physician. 2016;94(8):652-653.

Custodio JM, Fordyce M, Garner W, Vimal M, Ling KH, Kearney BP, Ramanathan S. Pharmacokinetics and safety of tenofovir alafenamide in HIV-uninfected subjects with severe renal impairment. Antimicrob Agents Chemother. 2016;60(9):5135-40.

Davies ML, Pham DQ, Drab SR. GLP1-RA add-on therapy in patients with type 2 diabetes currently on a bolus containing insulin regimen. Pharmacotherapy. 2016;36(8):893-905.

Davis LE, Miller ML, Raub JN, Gortney JS. Constructive ways to prevent, identify, and remediate deficiencies of "challenging trainees" in experiential education. Am J Health Syst Pharm. 2016;73(13):996-1009.

Deal EN, Stranges PM, Maxwell WD, Bacci J, et al; American College of Clinical Pharmacy. The Importance of research and scholarly activity in pharmacy training. Pharmacotherapy. 2016;36(12):e200-e205.

Deutsch S, Koerner P, Miller RT, Craft Z, Fancher K. Utilization patterns for oral oncology medications in a specialty pharmacy cycle management program. J Oncol Pharm Pract. 2016;22(1):68-75.

Devabhakthuni S, Reed BN, Watson K. Interactive web-based regional journal club for postgraduate year 2 pharmacy residents in cardiology. Am J Health Syst Pharm. 2016;73(17):1300.

Devabhakthuni S, Yoon CH, Pincus KJ. Review of the target-specific oral anticoagulants in development for the treatment and prevention of venous thromboembolism. J Pharm Pract. 2016;29(4):392-405.

Devlin JW, Smithburger P, Kane JM, Fraser GL, Skrobik Y. Intended and unintended consequences of constraining clinician prescribing: the case of antipsychotics. Crit Care Med. 2016;44(10):1805-7.

Dixit D, Endicott J, Burry L, Ramos L, Yeung SYA, Devabhakthuni S, et al. Management of acute alcohol withdrawal syndrome in critically ill patients. Pharmacotherapy. 2016;36(7):797-822.

Dobesh PP, Varnado S, Doyle M. Antiplatelet agents in cardiology: a report on aspirin, clopidogrel, prasugrel, and ticagrelor. Curr Pharm Des. 2016;22(13):1918-32.

Dornblaser EK, Ratka A, Gleason SE, Ombengi DN, Tofade T, Wigle PR, Zapantis A, Ryan M, Connor S, Jonkman LJ, et al. Current practices in global/international advanced pharmacy practice experiences: preceptor and student considerations. Am J Pharm Educ. 2016;80(3):39.

Economides MP, Mahale P, Kyvernitakis A, Turturro F, Kantarjian H, Naing A, Hosry J, Shigle TL, et al. Concomitant use of direct-acting antivirals and chemotherapy in hepatitis C virus-infected patients with cancer. Aliment Pharmacol Ther. 2016;44(11-12):1235-1241.

Eisenhower C, Koronkowski M, Marcum Z. Implications of recent drug approvals for older adults. Ann Longterm Care. 2016;24(1):25-30.

Espinel-Ingroff A, Arendrup M, Cantón E, Cordoba S, Dannaoui E, García-Rodríguez J, Gonzalez GM, Govender NP, Martin-Mazuelos E, Lass-Flörl C, Lackner M, Linares Sicilia MJ, Rodriguez-Iglesias MA, Pelaez T, Shields RK, et al. A multi-center study of method-dependent epidemiological cutoff values (ECVs) for resistance detection in Candida spp. and Aspergillus spp. to amphotericin B and echinocandins for the Etest agar diffusion method. Antimicrob Agents Chemother. 2016 Oct 31. Epub ahead of print

Faber ES, Gavini M, Ramirez R, Sadovsky R. Rhabdomyolysis after coadministration of atorvastatin and sacubitril/valsartan (Entresto™) in a 63-year-old woman. Drug Saf Case Rep. 2016;3(1):14.

Felton M, Weinberg R, Pruskowski J. Olanzapine for nausea, delirium, anxiety, insomnia, and cachexia #315. J Palliat Med. 2016;19(11):1224-1225.

Friedman B, Bressler A, Cleveland K, Lat A, Helgeson M, Sherman C, Castaneda-Ruiz B. 686: Televancin observational use registry: preliminary results for bacteremia and endocarditis. Crit Care Med. 2016;44(12 Suppl 1):248.

German P, Mathias A, Brainard D, Kearney BP. Clinical pharmacokinetics and pharmacodynamics of ledipasvir/sofosbuvir, a fixed-dose combination tablet for the treatment of hepatitis C. Clin Pharmacokinet. 2016;55(11):1337-1351.

Gibson C, Elrod S. Student versus residency program perceptions of a high-quality PGY1 residency applicant. Pharmacotherapy. 2016;36(12):e221

Gibson G, Gowan M, Juang P, et al. 690: Discontinuation of micafungin therapy utilizing a validated clinical predication rule for candidemia. Crit Care Med. 2016;44(12 Suppl 1):249.

Gist KM, Goldstein SL, Joy MS, Vinks AA. Milrinone dosing issues in critically ill children with kidney injury: a review. J Cardiovasc Pharmacol. 2016;67(2):175-81.

Gortney JS, Raub JN, Patel P, et al. Alcohol withdrawal syndrome in medical patients. Cleve Clin J Med. 2016;83(1):67-79.

Grant PM, Kitch D, McComsey GA, Collier AC, Koletar SL, Erlandson KM, Yin MT, Bartali B, Ha B, Melbourne K, Brown TT. Long-term bone mineral density changes in antiretroviral-treated HIV-infected individuals. J Infect Dis. 2016;214(4):607-11.

Groetzinger LM, Rivosecchi RM, Kane-Gill SL, Donahoe MP. Association between train-of-four values and gas exchange indices in moderate to severe acute respiratory distress syndrome. Ann Pharmacother. 2016;50(12):1009-1015.

Haidar G, Alkroud A, Cheng S, Churilla TM, Churilla BM, Shields RK, et al. Association between the presence of aminoglycoside-modifying enzymes and in vitro activity of gentamicin, tobramycin, amikacin, and plazomicin against Klebsiella pneumoniae carbapenemase- and extended-spectrum-β-lactamase-producing Enterobacter species. Antimicrob Agents Chemother. 2016;60(9):5208-14.

Hale GM, Kane-Gill SL, Groetzinger L, Smithburger PL. An evaluation of adverse drug reactions associated with antipsychotic use for the treatment of delirium in the intensive care unit. J Pharm Pract. 2016;29(4):355-60.

Hall DL, Schonder KS, Pater KS, McGivney MS, Meyer SM. Using the pharmacist interaction tracking tool for capturing student-patient interactions in direct and simulated patient care activities. Am J Pharm Educ. 2016;80(6):105.

Harris JR, Hale GM, Dasari TW, Schwier NC. Pharmacotherapy of vasospastic angina. J Cardiovasc Pharmacol Ther. 2016;21(5):439-51.

Hasassri ME, Boyce TG, Norgan A, Cunningham SA, Jeraldo PR, Weissman S, Patel R, Banerjee R, Pogue JM, Kaye KS. An immunocompromised child with bloodstream infection caused by two Escherichia coli strains, one harboring NDM-5 and the other harboring OXA-48-like carbapenemase. Antimicrob Agents Chemother. 2016;60(6):3270-5. Erratum in: Antimicrob Agents Chemother. 2016;60(8):5108.

Hedges A, Coons JC, Saul M, Smith RE. Clinical effectiveness and safety outcomes associated with prothrombin complex concentrates. J Thromb Thrombolysis. 2016;42(1):6-10.

Hefner JL, Tripathi RS, Abel EE, et al. Quality improvement intervention to decrease prolonged mechanical ventilation after coronary artery bypass surgery. Am J Crit Care. 2016;25(5):423-30.

Hohner E, Ortmann M, Murtaza U, et al. Implementation of an emergency department-based clinical pharmacist transitions-of-care program. Am J Health Syst Pharm. 2016;73(15):1180-7.

Im A, Amjad A, Agha M, Raptis A, Hou JZ, Farah R, Lim S, Sehgal A, Dorritie KA, Redner RL, McLaughlin B, Shuai Y, Duggal S, Boyiadzis M. Mitoxantrone and etoposide for the treatment of acute myeloid leukemia patients in first relapse. Oncol Res. 2016;24(2):73-80.

Jennings DL, Horn ET, Lyster H, Panos AL, Teuteberg JJ, Lehmkuhl HB, Perez A, Shullo MA. Assessing anticoagulation practice patterns in patients on durable mechanical circulatory support devices: an international survey. ASAIO J. 2016;62(1):28-32.

Jin H, Wang T, Falcione BA, et al. Trough concentration of voriconazole and its relationship with efficacy and safety: a systematic review and meta-analysis. J Antimicrob Chemother. 2016;71(7):1772-85.

Joshi G, Gandhi K, Shah N, Gadsden J, Corman SL. Peripheral nerve blocks in the management of postoperative pain: challenges and opportunities. J Clin Anesth. 2016;35:524-529.

Kane-Gill SL, MacLasco AM, Saul MI, Politz Smith TR, Kloet MA, Kim C, Anthes AM, Smithburger PL, Seybert AL. Use of text searching for trigger words in medical records to identify adverse drug reactions within an intensive care unit discharge summary. Appl Clin Inform. 2016;7(3):660-71.

Karino S, Kaye KS, Navalkele B, Nishan B, Salim M, Solanki S, Pervaiz A, Tashtoush N, Shaikh H, Koppula S, Martin ET, Mynatt RP, Murray KP, Rybak MJ, Pogue JM. Epidemiology of acute kidney injury among patients receiving concomitant vancomycin and piperacillin-tazobactam: opportunities for antimicrobial stewardship. Antimicrob Agents Chemother. 2016;60(6):3743-50.

Karmarkar TD, Starner CI, Qiu Y, Tiberg K, Gleason PP. Sofosbuvir initial therapy abandonment and manufacturer coupons in a commercially insured population. Am J Manag Care. 2016;22(6 Spec No.):SP191-7.

Kaye KS, Pogue JM, Tran TB, Nation RL, Li J. Agents of last resort: polymyxin resistance. Infect Dis Clin North Am. 2016;30(2):391-414.

King AE, Strnad K. Probable interaction between warfarin and banana flakes supplement. Nutr Clin Pract. 2016;31(1):125-31.

Koronkowski M, Eisenhower C, Marcum Z. An update on geriatric medication safety and challenges specific to the care of older adults. Ann Longterm Care. 2016;24(3):37-40.

Kozak MA, Melton JR, Gernant SA, Snyder ME. A needs assessment of unused and expired medication disposal practices: A study from the Medication Safety Research Network of Indiana. Res Social Adm Pharm. 2016;12(2):336-40.

Krakower DS, Maloney KM, Grasso C, Melbourne K, Mayer KH. Primary care clinicians' experiences prescribing HIV pre-exposure prophylaxis at a specialized community health centre in Boston: lessons from early adopters. J Int AIDS Soc. 2016;19(1):21165. Erratum in: J Int AIDS Soc. 2016;19(1):21596.

Lagnf AM, Zasowski EJ, Claeys KC, Casapao AM, Rybak MJ. Comparison of clinical outcomes and risk factors in polymicrobial versus monomicrobial enterococcal bloodstream infections. Am J Infect Control. 2016;44(8):917-21.

Laliberte B, Reed BN, Ather A, Devabhakthuni S, Watson K, et al. Safe and effective use of pharmacologic and device therapy for peripartum cardiomyopathy. Pharmacotherapy. 2016;36(9):955-70.

Lam SW, Russo-Alvarez G, Cristiani C, Rothberg MB. Development of an ambulatory clinical pharmacy prioritization prediction model for patients with diabetes. Ann Pharmacother. 2016 Sep 1. Epub ahead of print

LeBlanc J, Smithburger P, Kram S, Kane-Gill S. 912: Determining causality for suspected adverse drug reaction-related ICU admissions. Crit Care Med. 2016;44(12 Suppl 1):304.

Li X, Luthra R, Morrow PK, Fisher MD, Reiner M, Barron RL, Langeberg WJ. Comorbidities among patients with cancer who do and do not develop febrile neutropenia during the first chemotherapy cycle. J Oncol Pharm Pract. 2016;22(5):679-89.

Lichvar AB, Hedges A, Benedict NJ, Donihi AC. Combination of a flipped classroom format and a virtual patient case to enhance active learning in a required therapeutics course. Am J Pharm Educ. 2016; 80 (10): Article 175.

Lichvar AB, Moore CA, Ensor CR, McDyer JF, Teuteberg JJ, Shullo MA. Evaluation of direct oral anticoagulation therapy in heart and lung transplant recipients. Prog Transplant. 2016;26(3):263-9.

Liput SA, Kane-Gill SL, Seybert AL, Smithburger PL. A review of the perceptions of healthcare providers and family members toward family involvement in active adult patient care in the ICU. Crit Care Med. 2016;44(6):1191-7.

Littmann AE, Shields RK. Whole body heat stress increases motor cortical excitability and skill acquisition in humans. Clin Neurophysiol. 2016;127(2):1521-9.

Lucas A, Massey L, Gill T, Burger G, Little JD. Enactment of mandatory pharmacy technician certification in Kansas. Am J Health Syst Pharm. 2016;73(3):133-6.

Maeng DD, Tom LA, Wright EA. Patient characteristics and healthcare utilization patterns associated with unused medications among Medicare patients. Res Social Adm Pharm. 2016 Nov 9. Epub ahead of print

Malani AN, Brennan BM, Collins CD, Finks J, Pogue JM, Kaye KS. Antimicrobial stewardship practices in Michigan long-term care facilities. Infect Control Hosp Epidemiol. 2016;37(2):236-7.

McCartney E, Bacci JL, Ossman KL, Richardson RM, DelPizzo D, DeJames J, McGivney MS. Mobile application features sought after by patients of a regional grocery store chain pharmacy. J Am Pharm Assoc (2003). 2016;56(1):62-66.e1.

McCrink KA, Brill A, Jafferjee M, Valero TR, Marrero C, Hale GM, Lymperopoulos A, Rodriguez MM. β1-adrenoceptor Arg389Gly polymorphism confers differential β-arrestin binding tropism in cardiac myocytes. Pharmacogenomics. 2016 Oct;17(15):1611-1620.

McGrane IR, Loveland JG, Zaluski HJ. Adjunctive amantadine treatment for aggressive behavior in children: a series of eight cases. J Child Adolesc Psychopharmacol. 2016 Aug 2. Epub ahead of print

McGrane IR, Loveland JG. Pharmacogenetics of cytochrome P450 enzymes in American Indian and Caucasian children admitted to a psychiatric hospital. J Child Adolesc Psychopharmacol. 2016;26(4):395-9.

McGrane IR, Stuhec M. Comment on An open trial of lurasidone as an acute and maintenance adjunctive treatment for outpatients with treatment-resistant bipolar disorder. J Clin Psychopharmacol. 2016;36(5):520-1.

Merkel A, Bellamy C, Negoianu D, Candeloro C. 1966: Amikacin pharmacokinetics during high dialysate flow on continuous venovenous hemodialysis. Crit Care Med. 2016;44(12 Suppl 1):566.

Michaelidis CI, Fine MJ, Lin CJ, Linder JA, Nowalk MP, Shields RK, et al. The hidden societal cost of antibiotic resistance per antibiotic prescribed in the United States: an exploratory analysis. BMC Infect Dis. 2016;16(1):655.

Mitchell S, Li X, Woods M, Garcia J, Hebard-Massey K, Barron R, Samuel M. Comparative effectiveness of granulocyte colony-stimulating factors to prevent febrile neutropenia and related complications in cancer patients in clinical practice: A systematic review. J Oncol Pharm Pract. 2016;22(5):702-16.

Mogalian E, German P, Kearney BP, et al. Use of multiple probes to assess transporter- and cytochrome P450-mediated drug-drug interaction potential of the pangenotypic HCV NS5A inhibitor velpatasvir. Clin Pharmacokinet. 2016;55(5):605-13.

Nagel JL, Kaye KS, LaPlante KL, Pogue JM. Antimicrobial stewardship for the infection control practitioner. Infect Dis Clin North Am. 2016;30(3):771-84.

Natale JJ, Spinelli T, Calcagnile S, Lanzarotti C, Rossi G, Cox D, Kashef K. Drug-drug interaction profile of components of a fixed combination of netupitant and palonosetron: Review of clinical data. J Oncol Pharm Pract. 2016 Jun;22(3):485-95.

Nguyen-Ha PT, Howrie D, Crowley K, Vetterly CG, McGhee W, Berry D, Ferguson E, Polischuk E, et al. A quality assessment of a collaborative model of a pediatric antimicrobial stewardship program. Pediatrics. 2016;137(5). pii: e20150316.

Nicasio AM, VanScoy BD, Mendes RE, Castanheira M, Bulik CC, Okusanya OO, et al. Pharmacokinetics-pharmacodynamics of tazobactam in combination with piperacillin in an in vitro infection model. Antimicrob Agents Chemother. 2016;60(4):2075-80.

Orr KK, Lemay VA, Wojtusik AP, Opydo-Rossoni M, Cohen LB. Availability and accuracy of information regarding nonprescription emergency contraception. J Pharm Pract. 2016;29(5):454-60.

Pajoumand M, Kufera JA, Bonds BW, Devabhakthuni S, et al. Dexmedetomidine as an adjunct for sedation in patients with traumatic brain injury. J Trauma Acute Care Surg. 2016;81(2):345-51.

Pecora Fulco P. Management of Venous Thromboembolism: Recent Advances in Oral Anticoagulation. Ann Pharmacother. 2016;50(10):892-3.

Perez A, Elrod S, Sanchez J. A comparison of the use and quality of antidiabetic medication regimens between non-Hispanic black and white adults with uncontrolled Type 2 diabetes in the US: NHANES 2003-2012. Diabetes Educ. 2016;42(2):234-42.

Petite SE, Bauer SR, Bollinger JE, Ahrens CL, Harinstein LM. Antimicrobial monotherapy versus combination therapy for the treatment of complicated intra-abdominal infections. Pharmacotherapy. 2016;36(11):1138-1144.

Petite SE, Bollinger JE, Eghtesad B. Antithymocyte globulin induction therapy in liver transplant: old drug, new uses. Ann Pharmacother. 2016;50(7):592-8.

Phe K, Shields RK, Tverdek FP, et al. Predicting the risk of nephrotoxicity in patients receiving colistimethate sodium: a multicentre, retrospective, cohort study. J Antimicrob Chemother. 2016;71(12):3585-3587.

Pogue JM, Ortwine JK, Kaye KS. Colistin dosing: does the fun ever start? Clin Infect Dis. 2016 Oct 6. Epub ahead of print

p>Pogue JM, Ortwine JK, Kaye KS. Are there any ways around the exposure-limiting nephrotoxicity of the polymyxins? Int J Antimicrob Agents. 2016;48(6):622-626.

Polinski JM, Moore JM, Kyrychenko P, Gagnon M, Matlin OS, Fredell JW, et al. An insurer's care transition program emphasizes medication reconciliation, reduces readmissions and costs. Health Aff (Millwood). 2016;35(7):1222-9.

Potter LM, Tichy EM, Horwedel TA, Shullo MA, et al; 2013 ACCP Certification Affairs Committee., Jacobi J, Sam T. Impact of the Pharmacy Practice Model Initiative on clinical pharmacy specialist practice: an alternative viewpoint. Pharmacotherapy. 2016;36(11):e195-e197.

Pratt Cleary J, Hodge L, Palmer B, Barreiro CJ, Ingemi A. 4-Factor prothrombin complex concentrate (PCC4, Kcentra®) protocol reduces blood requirements for heart transplantation: a novel protocol. Ann Transplant. 2016;21:531-7.

Ramanathan S, Custodio JM, Wei X, Wang H, Fordyce M, Dave A, Ling KH, Szwarcberg J, Kearney BP. Pharmacokinetics of co-formulated elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate after switch from efavirenz/emtricitabine/tenofovir disoproxil fumarate in healthy subjects. J Acquir Immune Defic Syndr. 2016;72(3):281-8.

Ramanathan S, Di Paolo JA, Jin F, Shao L, Sharma S, Robeson M, Kearney BP. Pharmacokinetics, pharmacodynamics, and safety of entospletinib, a novel pSYK inhibitor, following single and multiple oral dosing in healthy volunteers. Clin Drug Investig. 2016 Oct 26. Epub ahead of print

Ramanathan S, Jin F, Sharma S, Kearney BP. Clinical pharmacokinetic and pharmacodynamic profile of idelalisib. Clin Pharmacokinet. 2016;55(1):33-45.

Ridenour TA, Wittenborn AK, Raiff BR, Benedict N, Kane-Gill S. Illustrating idiographic methods for translation research: moderation effects, natural clinical experiments, and complex treatment-by-subgroup interactions. Transl Behav Med. 2016;6(1):125-34.

Riedy M, DePaula B, Puder M, Gura KM, Sztam KA. Higher doses of fish oil-based lipid emulsions used to treat inadequate weight gain and rising triene:tetraene ratio in a severely malnourished infant with intestinal failure-associated liver disease. JPEN J Parenter Enteral Nutr. 2016 Aug 1. Epub ahead of print

Rindfuss S, Wilson SA. Help Desk Answer: Is there an increased risk of GI bleeds with SSRIs? J Fam Pract. 2016;65(1):57,63.

Rivosecchi R, Then J, Durie N, Groetzinger L. 836: Predictors of dexmedetomidine failure for sedation in mechanically ventilated patients. Crit Care Med. 2016;44(12 Suppl 1):285.

Rivosecchi RM, Durkin J, Okonkwo DO, Molyneaux BJ. Safety and efficacy of warfarin reversal with four-factor prothrombin complex concentrate for subtherapeutic INR in intracerebral hemorrhage. Neurocrit Care. 2016 Apr 13. Epub ahead of print

Rivosecchi RM, Kane-Gill SL, Svec S, Campbell S, Smithburger PL. The implementation of a nonpharmacologic protocol to prevent intensive care delirium. J Crit Care. 2016;31(1):206-11.

Rivosecchi RM, Kellum JA, Dasta JF, Armahizer MJ, Bolesta S, Buckley MS, Dzierba AL, Frazee EN, Johnson HJ, Kim C, Murugan R, Smithburger PL, Wong A, Kane Gill SL. Drug class combination-associated acute kidney injury: a review of the literature. Ann Pharmacother. 2016 Jul 7. Epub ahead of print

Rochester-Eyeguokan CD, Pincus KJ, Patel RS, Reitz SJ. The current landscape of transitions of care practice models: a scoping review. Pharmacotherapy. 2016;36(1):117-33.

Rotz ME, Dueñas GG, Zanoni A, Grover AB. Designing and evaluating an interprofessional experiential course series involving medical and pharmacy students. Am J Pharm Educ. 2016;80(5):85.

Rotz ME, Dueñas GG. "Collaborative-ready" students: Exploring factors that influence collaboration during a longitudinal interprofessional education practice experience. J Interprof Care. 2016;30(2):238-41.

Schwier N, Tran N. Non-steroidal anti-inflammatory drugs and aspirin therapy for the treatment of acute and recurrent idiopathic pericarditis. Pharmaceuticals (Basel). 2016;9(2). pii: E17.

Seger D, Wong A, Amato M, et al. 1127: Comparison of overridden clinical decision support between a new commercial system and legacy system. Crit Care Med. 2016;44(12 Suppl 1):357.

Shah DN, Chan FS, Kachru N, Garcia KP, Balcer HE, Dyer AP, Emanuel JE, Jordan MD, Lusardi KT, Naymick G, Polisetty RS, et al. A multi-center study of fidaxomicin use for Clostridium difficile infection. Springerplus. 2016;5(1):1224.

Shields RK, Clancy CJ, Press EG, Nguyen MH. Aminoglycosides for treatment of bacteremia due to carbapenem-resistant Klebsiella pneumoniae. Antimicrob Agents Chemother. 2016;60(5):3187-92.

Shields RK, Potoski BA, Haidar G, et al. Clinical outcomes, drug toxicity and emergence of ceftazidime-avibactam resistance among patients treated for carbapenem-resistant Enterobacteriaceae infections. Clin Infect Dis. 2016 Sep 13. Epub ahead of print

Shoulders B, Smithburger P, Kane-Gill S, Tchen S. 1243: Is the risk as bad as it seems? Guideline evidence for off-label medication use in the ICU. Crit Care Med. 2016;44(12 Suppl 1):386.

Shoulders BR, Crow JR, Davis SL, et al. Impact of intraoperative continuous-infusion versus intermittent dosing of cefazolin therapy on the incidence of surgical site infections after coronary artery bypass grafting. Pharmacotherapy. 2016;36(2):166-73.

Shulenberger CE, Jiang A, Devabhakthuni S, et al. Efficacy and safety of intravenous chlorothiazide versus oral metolazone in patients with acute decompensated heart failure and loop diuretic resistance. Pharmacotherapy. 2016;36(8):852-60.

Smith MA, Siemianowski LA, Benedict N. Virtual patient case sharing across two schools of pharmacy. Am J Pharm Educ. 2016;80(9):153.

Snyder ME, Frail CK, Gernant SA, Bacci JL, Coley KC, Colip LM, Ferreri SP, Hagemeier NE, McGivney MS, et al. Fellowships in community pharmacy research: Experiences of five schools and colleges of pharmacy. J Am Pharm Assoc (2003). 2016;56(3):316-22.

Sorbera MA, Friedman ML, Cope R. New and emerging evidence on the use of second-generation direct acting antivirals for the treatment of hepatitis C virus in renal impairment. J Pharm Pract. 2016 Feb 22. Epub ahead of print

Starner CI, Qiu Y, Karaca-Mandic P, Gleason PP. Association of a controlled substance scoring algorithm with health care costs and hospitalizations: a cohort study. J Manag Care Spec Pharm. 2016;22(12):1403-1410.

Strnad K, Kim C, Shimko K, Schonder K. 635: Evaluation of thymoglobulin induction and adverse events requiring ICU care in kidney transplants. Crit Care Med. 2016;44(12 Suppl 1):235.

Taylor DM, Yap CY, Knott JC, Taylor SE, et al. Midazolam-droperidol, droperidol, or olanzapine for acute agitation: a randomized clinical trial. Ann Emerg Med. 2016 Oct 10. Epub ahead of print

Ternant D, Paintaud G, Trachtman H, Gipson DS, Joy MS. A possible influence of age on absorption and elimination of adalimumab in focal segmental glomerulosclerosis (FSGS). Eur J Clin Pharmacol. 2016;72(2):253-5.

Thaden JT, Pogue JM, Kaye KS. Role of newer and re-emerging older agents in the treatment of infections caused by carbapenem-resistant Enterobacteriaceae. Virulence. 2016:1-14.

Tilson H, Hines LE, McEvoy G, Weinstein DM, Hansten PD, Mautszewski K, le Comte M, Higby-Baker S, Hanlon JT, Pezzullo L, Vieson K, et al. Recommendations for selecting drug-drug interactions for clinical decision support. Am J Health Syst Pharm. 2016;73(8):576-85.

Tong MC, Wisniewski CS, Wolf B, Bosso JA. Comparison of linezolid and vancomycin for methicillin-resistant Staphylococcus aureus pneumonia: institutional implications. Pharmacotherapy. 2016;36(7):731-9.

Tran T, Hardidge A, Heland M, Taylor SE, et al. Slick scripts: impact on patient flow targets of pharmacists preparing discharge prescriptions in a hospital with an electronic prescribing system. J Eval Clin Pract. 2016. Epub ahead of print

Trombatt WD, Koerner PH, Craft ZN, et al. Retrospective analysis of the medication utilization and clinical outcomes of patients treated with various regimens for hepatitis C infection. J Pharm Pract. 2016 Jan 13. Epub ahead of print

Vacha M, Gommer J, Rege A, et al. Effects of ideal versus total body weight dosage of rabbit antithymocyte globulin on outcomes of kidney transplant patients with high immunologic risk. Exp Clin Transplant. 2016;14(5):511-517.

Vergidis P, Clancy CJ, Shields RK, et al. Intra-abdominal candidiasis: the importance of early source control and antifungal treatment. PLoS One. 2016;11(4):e0153247.

Viehman JA, Clancy CJ, Clarke L, Shields RK, et al. Surgical site infections after liver transplantation: emergence of multidrug-resistant bacteria and implications for prophylaxis and treatment strategies. Transplantation. 2016;100(10):2107-14.

Viehman JA, Oleksiuk LM, Sheridan KR, Byers KE, He P, Falcione BA, Shields RK. Adverse events lead to drug discontinuation more commonly among patients who receive nafcillin than among those who receive oxacillin. Antimicrob Agents Chemother. 2016;60(5):3090-5.

Walsh TL, Chan L, Konopka CI, Burkitt MJ, Moffa MA, Bremmer DN, et al. Appropriateness of antibiotic management of uncomplicated skin and soft tissue infections in hospitalized adult patients. BMC Infect Dis. 2016;16(1):721.

Weaver C, Kane-Gill S, Gunn S, Smithburger P. 871: Evaluating the efficacy of antipsychotics for the treatment of ICU delirium. Crit Care Med. 2016;44(12 Suppl 1):294.

Weiland T, Jelinek GA, Taylor SE, Taylor DM. Tobacco smoking by adult emergency department patients in Australia: a point-prevalence study. Public Health Res Pract. 2016;26(3). pii: 2631634.

Weycker D, Li X, Figueredo J, Barron R, Tzivelekis S, Hagiwara M. Risk of chemotherapy-induced febrile neutropenia in cancer patients receiving pegfilgrastim prophylaxis: does timing of administration matter? Support Care Cancer. 2016;24(5):2309-16.

Weycker D, Li X, Barron R, et al. Risk of chemotherapy-induced febrile neutropenia with early discontinuation of pegfilgrastim prophylaxis in US clinical practice. Support Care Cancer. 2016;24(6):2481-90.

Wilkening GL, Gannon JM, Ross C, Brennan JL, Fabian TJ, Marcsisin MJ, Benedict NJ. Evaluation of branched-narrative virtual patients for interprofessional education of psychiatry residents. Acad Psychiatry. 2016 Mar 14. Epub ahead of print

Wilkening LG, Hale GM, Ross C. Urine drug screens: considerations for the psychiatric pharmacist. Mental Health Clinician: Pharmacokinetics in Psychiatry and Neurology. 2016;6(1):42-47.

Wong A, Amato M, Seger D, et al. 1256: Evaluation of harm associated with overridden medication-related clinical decision support. Crit Care Med. 2016;44(12 Suppl 1):389.

Wong A, Pickering AJ, Potoski BA. Dosing practices of intravenous acyclovir for herpes encephalitis in obesity: results of a pharmacist survey. J Pharm Pract. 2016 Apr 10. Epub ahead of print

Yusuf AA, Matlon TJ, Grauer A, Barron R, Chandler D, Peng Y. Utilization of osteoporosis medication after a fragility fracture among elderly Medicare beneficiaries. Arch Osteoporos. 2016;11(1):31.

Zanni MV, Toribio M, Robbins GK, Burdo TH, Lu MT, Ishai AE, Feldpausch MN, Martin A, Melbourne K, et al. Effects of antiretroviral therapy on immune function and arterial inflammation in treatment-naive patients with human immunodeficiency virus infection. JAMA Cardiol. 2016;1(4):474-80.

Zhang H, Nguyen MH, Clancy CJ, Joshi R, Zhao W, Ensor C, Venkataramanan R, Shields RK. Pharmacokinetics of posaconazole suspension in lung transplant patients with and without cystic fibrosis. Antimicrob Agents Chemother. 2016;60(6):3558-62.

Zhao Y, Nagasaki Y, Kordalewska M, Press EG, Shields RK, et al. Rapid detection of FKS-associated echinocandin resistance in Candida glabrata. Antimicrob Agents Chemother. 2016 Aug 22. Epub ahead of print

Alakus H, Yost SE, Woo B, et al. BAP1 mutation is a frequent somatic event in peritoneal malignant mesothelioma. J Transl Med. 2015;13:122.

Aspinall SL, Good CB, Zhao X, Cunningham FE, Heron BB, et al. Adjuvant chemotherapy for stage III colon cancer: relative dose intensity and survival among veterans. BMC Cancer. 2015;15:62.

Barber KE, King ST, Stover KR, Pogue JM. Therapeutic options for vancomycin-resistant enterococcal bacteremia. Expert Rev Anti Infect Ther. 2015;13(3):363-77.

Benedict N, Hess MM. History and future of critical care pharmacy practice. Am J Health Syst Pharm. 2015;72:2101-2105.

Bonafede MM, Shi N, Bower AG, Barron RL, et al. Teriparatide treatment patterns in osteoporosis and subsequent fracture events: a US claims analysis. Osteoporos Int. 2015;26(3):1203-12.

Bondar A. A new practitioner’s perspective on combining interprofessional and cultural competence instruction in pharmacy school curriculum. Am J Pharm Educ. 2015;79(10): Article 160.

Brateanu A, Russo-Alvarez G, Nielsen C. Starting insulin in patients with type 2 diabetes: An individualized approach. Cleve Clin J Med. 2015;82(8):513-9.

Bremmer DN, Garavaglia JM, Shields RK. Spontaneous fungal peritonitis: a devastating complication of cirrhosis.Mycoses. 2015;58(7):387-93.

Cho JC, Salas DE, Trinh TD, Zmarlicka MT, Malepsy JM, Lockwood AM, Colley PD, Buehrle DJ. Postgraduate training and career opportunities in infectious diseases pharmacy.Am J Health Syst Pharm. 2015;72(19):1606-9.

Chopra T, Marchaim D, Johnson PC, Chalana IK, Tamam Z, Mohammed M, Alkatib S, Tansek R, Chaudhry K, Zhao JJ, Pogue JM, Kaye KS. Risk factors for bloodstream infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: A focus on antimicrobials including cefepime. Am J Infect Control. 2015;43(7):719-23.

Chui SH, Dooley C, Huang E, Wilson S, Pajoumand M, Stein D. 625: Weight-based heparin nomogram for critically ill patients with high bleeding risk. Crit Care Med. 2015;43(12 Suppl 1):158

Chuk AC, Saeed F, Kousar N, Burrill S, Barns B, Rickrode G, Fu J, Katrych O, Saunders-Hao P, Block C, Lahey T. Variable pharmacokinetics of extended interval tobramycin or gentamicin among critically ill patients undergoing continuous venovenous hemofiltration. Clin Nephrol. 2015;84(10):214-21.

Cochran G, Gordon AJ, Field C, Bacci J, et al. Developing a framework of care for opioid medication misuse in community pharmacy.Res Social Adm Pharm. 2015 May 8. Epub ahead of print

Cochran G, Rubinstein J, Bacci JL, et al. Screening community pharmacy patients for risk of prescription opioid misuse.J Addict Med. 2015;9(5):411-6.

Collins CD, Miller DE, Kenney RM, Mynatt RP, Tiberg MD, Cole K, Sutton JD, Pogue JM.The state of antimicrobial stewardship in Michigan: results of a statewide survey on antimicrobial stewardship efforts in acute care hospitals. Hosp Pharm. 2015;50(3):180-4.

Cope R, Pickering A, Glowa T, Faulds S, Veldkamp P, Prasad R. Majority of HIV/HCV patients need to switch antiretroviral therapy to accommodate direct acting antivirals. AIDS Patient Care STDS. 2015;29(7):379-83.

Davies ML, Schonder KS, Meyer SM, Hall DL. Changes in student performance and confidence with a standardized patient and standardized colleague interprofessional activity. Am J Pharm Educ. 2015;79(5):69.

Day SA, Cucci M, Droege ME, Holzhausen JM, Kram B, Kram S, Pajoumand M, Parker CR, Patel MK, Peitz GJ, Poore A, Turck CJ, Van Berkel MA, Wong A, Zomp A, Rech MA. Major publications in the critical care pharmacotherapy literature: January-December 2014. Am J Health Syst Pharm. 2015;72(22):1974-85.

Delgado O, Strauss EM, Ortega MA. Micromanagement: When to avoid it and how to use it effectively. Am J Health Syst Pharm. 2015;72(10):772, 774, 776.

Denduluri N, Patt DA, Wang Y, Bhor M, Li X, Favret AM, Morrow PK, Barron RL, et al. Dose delays, dose reductions, and relative dose intensity in patients with cancer who received adjuvant or neoadjuvant chemotherapy in community oncology practices. J Natl Compr Canc Netw. 2015;13(11):1383-93

Dzierba A, Smithburger P, Devlin J, et al; Critical Care Pharmacotherapy Trials Network. 587: A national evaluation of ICU delirium identification, prevention and treatment practices. Crit Care Med. 2015;43(12 Suppl 1):148.

Eckmann C, Nathwani D, Lawson W, Corman S, et al. Comparison of vancomycin and linezolid in patients with peripheral vascular disease and/or diabetes in an observational European study of complicated skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect. 2015;21 Suppl 2:S33-9.

Elliott JP, Cherpes G, Kamal K, Chopra I, Harrison C, Riedy M, Herk B, McCrossin M, Kalarchian M. Relationship between antipsychotics and weight in patients with Prader-Willi syndrome. Pharmacotherapy. 2015;35(3):260-8.

Eschenauer GA, Kwak EJ, Humar A, Potoski BA, Clarke LG, Shields RK, et al. Targeted versus universal antifungal prophylaxis among liver transplant recipients. Am J Transplant. 2015;15(1):180-9.

Farina N, Smithburger P, Kane-Gill S. Screening and management of delirium in critically ill patients. Hosp Pharm. 2015;50(8):667-71.

Fields MD, Abate MA, Hu L, Long DL, Blommel ML, et al. Parent and metabolite opioid drug concentrations in unintentional deaths involving opioid and benzodiazepine combinations.J Forensic Sci. 2015;60(4):950-6.

Fongemie J, Felix-Getzik E. A Review of Nebivolol Pharmacology and Clinical Evidence.  Drugs2015 Aug;75(12):1349-71

Gist KM, Goldstein SL, Joy MS, Vinks AA. Milrinone dosing issues in critically ill children with kidney injury: A review. J Cardiovasc Pharmacol. 2015 Oct 6. Epub ahead of print

Glick D, Dzierba AL, Abrams D, Muir J, Eisenberger A, Diuguid D, Abel E, et al. Clinically suspected heparin-induced thrombocytopenia during extracorporeal membrane oxygenation.J Crit Care. 2015;30(6):1190-4.

Gortney JS, Bray BS, Salinitri FD. Implementation and use of the Pharmacy Curriculum Outcomes Assessment at US schools of pharmacy. Am J Pharm Educ. 2015;79(9):137.

Groetzinger L, Rivosecchi R, McVerry B. 586: Ketamine infusion as adjunct sedation in mechanically ventilated critically ill patients. Crit Care Med. 2015;43(12 Suppl 1):148.

Gupta SK, Kitch D, Tierney C, Melbourne K, et al; AIDS Clinical Trials Group Study A5224s Team. Markers of renal disease and function are associated with systemic inflammation in HIV infection. HIV Med. 2015;16(10):591-8.

Hale GM, Brenner M. Atomoxetine for orthostatic hypotension in an elderly patient over 10 weeks: a case report. Pharmacotherapy. 2015;35(9):e141-8.

Hale G, Brenner M. Reviewing the risks and benefits of low molecular weight heparin and target-specific oral anticoagulant use in thromboprophylaxis for medically ill patients. Am J Cardiovasc Drugs. 2015 Oct;15(5):311-22

Hale G, Ebaugh S, Brenner M. A Comparative Evaluation of Adverse Drug Reactions and the Incidence of Stroke Amongst the Target Specific Oral Anticoagulants. Journal of Hematology & Thrombosis. 2015;1(2):1-6

Hale GM, Kane-Gill SL, Groetzinger L, Smithburger PL. An evaluation of adverse drug reactions associated with antipsychotic use for the treatment of delirium in the intensive care unit. J Pharm Pract. 2015 Jan 20. Epub ahead of print

Hammond DA, Thano E, Bohnenberger KA, et al. Ventricular tachycardia precipitated by the use of the diet supplement hydroxycut gummies.Hosp Pharm. 2015;50(7):615-8.

Henk HJ, Li X, Becker LK, Xu H, Gong Q, Deeter RG, Barron RL. Comparative effectiveness of colony-stimulating factors in febrile neutropenia prophylaxis: how results are affected by research design.J Comp Eff Res. 2015;4(1):37-50.

Huet AL, Frail CK, Lake LM, Snyder ME. Impact of passive and active promotional strategies on patient acceptance of medication therapy management services. J Am Pharm Assoc (2003). 2015;55(2):178-81.

Jackson C, DuBard A, Swartz M, Mahan A, McKee J, Pikoulas T, et al. Readmission patterns and effectiveness of transitional care among Medicaid patients with schizophrenia and medical comorbidity. N C Med J. 2015;76(4):219-26.

Jennings DL, Horn ET, Lyster H, Panos AL, Teuteberg JJ, Lehmkuhl HB, Perez A, Shullo MA. Assessing anticoagulation practice patterns in patients on durable mechanical circulatory support devices: An International Survey. ASAIO J. 2015 Aug 17. Epub ahead of print

Jentzer JC, Coons JC, Link CB, Schmidhofer M. Pharmacotherapy update on the use of vasopressors and inotropes in the intensive care unit. J Cardiovasc Pharmacol Ther 2015;20(3):249-60.

Kane-Gill SL, Sileanu FE, Murugan R, Trietley GS, Handler SM, Kellum JA. Risk factors for acute kidney injury in older adults with critical illness: a retrospective cohort study. Am J Kidney Dis. 2015;65(6):860-9.

Kane-Gill SL, Smithburger PL, Williams EA, Felton MA, Wang N, Seybert AL. Published cases of adverse drug reactions: has the quality of reporting improved over time? Ther Adv Drug Saf. 2015;6(2):38-44.

Kauffman YS, Schroeder AE, Witt DM. Patient specific factors influencing adherence to INR monitoring. Pharmacotherapy. 2015;35(8):740-7.

Kaye KS, Pogue JM. Infections caused by resistant Gram-negative bacteria: epidemiology and management. Pharmacotherapy. 2015;35(10):949-62.

Kernodle AR, Frail CK, Gernant SA, Pater KS, Doebbeling BN, Snyder ME. Patients' experiences using a brief screening tool for medication-related problems in a community pharmacy setting: a qualitative study. J Pharm Pract. 2015 Sep 29. Epub ahead of print

Khatri A, Naeger Murphy N, Wiest P, et al. Community-acquired pyelonephritis in pregnancy caused by KPC-producing Klebsiella pneumoniae. Antimicrob Agents Chemother. 2015;59(8):4375-8.

Kirby BJ, Symonds WT, Kearney BP, Mathias AA. Pharmacokinetic, pharmacodynamic, and drug-interaction profile of the hepatitis C virus NS5B polymerase inhibitor sofosbuvir. Clin Pharmacokinet.2015;54(7):677-90.

Kozak MA, Melton JR, Gernant SA, Snyder ME. A needs assessment of unused and expired medication disposal practices: A study from the Medication Safety Research Network of Indiana. Res Social Adm Pharm. 2015 Jun 12. Epub ahead of print

Kreys TJ, Phan SV. A literature review of quetiapine for generalized anxiety disorder. Pharmacotherapy. 2015;35(2):175-88.

Lawson W, Nathwani D, Eckmann C, Corman S, et al. Weight-based antibiotic dosing in a real-world European study of complicated skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect. 2015;21 Suppl 2:S40-6.

Lee BJ, Wang SK, So C, Chiu BG, Wang WY, Polisetty R, et al. A student-led health education initiative addressing health disparities in a Chinatown community. Am J Pharm Educ. 2015;79(9):132.

Li X, Luthra R, Morrow PK, Fisher MD, Reiner M, Barron RL, et al. Comorbidities among patients with cancer who do and do not develop febrile neutropenia during the first chemotherapy cycle.J Oncol Pharm Pract. 2015 Sep 15. Epub ahead of print

Lim MJ, Stebbings A, Lim SJ, et al. IV pentamidine for primary PJP prophylaxis in adults undergoing allogeneic hematopoietic progenitor cell transplant. Bone Marrow Transplant. 2015;50(9):1253-5.

Lyons PJ, Rivosecchi RM, Nery JP, Kane-Gill SL. Fentanyl-induced hyperalgesia in acute pain management. J Pain Palliat Care Pharmacother. 2015;29(2):153-60.

McD Taylor D, Joffe P, Taylor SE, et al. Off-label and unlicenced medicine administration to paediatric emergency department patients. Emerg Med Australas. 2015;27(5):440-6.

McGrane IR, Leung JG, St Louis EK, Boeve BF. Melatonin therapy for REM sleep behavior disorder: a critical review of evidence. Sleep Med. 2015;16(1):19-26.

McGrane IR, Loveland JG, Zaluski HJ, Foster KD. Serum quetiapine concentration changes with concomitant oxcarbazepine therapy in a boy with autism spectrum disorder. J Child Adolesc Psychopharmacol. 2015;25(9):729-730.

McGrane IR, Shuman MD, McDonald RW. Donepezil-related intractable hiccups: a case report. Pharmacotherapy. 2015;35(3):e1-5.

Mogalian E, German P, Kearney BP, et al. Use of multiple probes to assess transporter- and cytochrome P450-mediated drug-drug interaction potential of the pangenotypic HCV NS5A inhibitor velpatasvir. Clin Pharmacokinet. 2015 Oct 30. Epub ahead of print

Mohammadi F, MacLasco A, Paloucek FP. Inappropriate utilization of the Sheiner-Tozer equation to determine phenytoin toxicity. Am J Emerg Med. 2015;33(3):467-8.

Morrill HJ, Pogue JM, Kaye KS, LaPlante KL. Treatment options for carbapenem-resistant Enterobacteriaceae infections. Open Forum Infect Dis. 2015;2(2):ofv050.

Mouton JP, Mehta U, Parrish AG, et al. Mortality from adverse drug reactions in adult medical inpatients at four hospitals in South Africa: a cross-sectional survey. Br J Clin Pharmacol. 2015;80(4):818-26.

Natale JJ, Spinelli T, Calcagnile S, et al. Drug-drug interaction profile of components of a fixed combination of netupitant and palonosetron: Review of clinical data. J Oncol Pharm Pract. 2015 May 20. Epub ahead of print

Natale JJ. Reviewing current and emerging antiemetics for chemotherapy-induced nausea and vomiting prophylaxis. Hosp Pract (1995). 2015;43(4):226-34.

Nathwani D, Lawson W, Dryden M, Stephens J, Corman S, et al. Implementing criteria-based early switch/early discharge programmes: a European perspective. Clin Microbiol Infect. 2015;21 Suppl 2:S47-55.

Nuckles KB, Pratt JH, Cameron CM, Ingemi AI. Case series of four-factor prothrombin complex concentrate for warfarin reversal before heart transplantation. Transplant Proc. 2015;47(3):841-3

Olenik NL, Gonzalvo JD, Snyder ME, Nash CL, Smith CT. Perceptions of Spanish-speaking clientele of patient care services in a community pharmacy. Res Social Adm Pharm. 2015;11(2):241-52.

Orr KK, Lemay VA, Wojtusik AP, et al. Availability and accuracy of information regarding nonprescription emergency contraception. J Pharm Pract. 2015 Jan 29. Epub ahead of print

Ortwine JK, Kaye KS, Li J, Pogue JM. Colistin: understanding and applying recent pharmacokinetic advances. Pharmacotherapy. 2015;35(1):11-6.

Ortwine JK, Pogue JM, Faris J. Pharmacokinetics and pharmacodynamics of antibacterial and antifungal agents in adult patients with thermal injury: a review of current literature. J Burn Care Res. 2015;36(2):e72-84.

Ortwine JK, Sutton JD, Kaye KS, Pogue JM. Strategies for the safe use of colistin. Expert Rev Anti Infect Ther. 2015;13(10):1237-47.

Overton ET, Chan ES, Brown TT, Tebas P, McComsey GA, Melbourne KM, et al. Vitamin D and calcium attenuate bone loss with antiretroviral therapy initiation: a randomized trial. Ann Intern Med. 2015;162(12):815-24.

Patel P, Hemmeger H, Kozak MA, Gernant SA, Snyder ME. Community pharmacist participation in a practice-based research network: a report from the Medication Safety Research Network of Indiana (Rx-SafeNet). J Am Pharm Assoc (2003). 2015;55(6):649-55.

Patel RS, Scopelliti EM, Savelloni J. Therapeutic management of familial hypercholesterolemia: current and emerging drug therapies. Pharmacotherapy. 2015;35(12):1189-203.

Pavlik DJ, Simpson RW, Horn ET, et al. Pharmacotherapy of sepsis. Crit Care Nurs Q. 2015;38(2):121-36.

Pogue JM, Cohen DA, Marchaim D. Editorial commentary: Polymyxin-resistant Acinetobacter baumannii: urgent action needed. Clin Infect Dis. 2015;60(9):1304-7.

Pogue JM, Kaye KS, Cohen DA, Marchaim D. Appropriate antimicrobial therapy in the era of multidrug-resistant human pathogens. Clin Microbiol Infect. 2015;21(4):302-12.

Pogue JM, Ortwine JK, Kaye KS. Optimal usage of colistin: are we any closer? Clin Infect Dis. 2015 Sep 9. Epub ahead of print

Pogue JM, Rotschafer JC. Polymyxins in 2015: it's like déjà vu all over again. Pharmacotherapy. 2015;35(1):9-10.

Margaillan G, Rouleau M, Fallon JK, Caron P, Villeneuve L, Turcotte V, Smith PC, Joy MS, Guillemette C.  Quantitative profiling of human renal UDP-glucuronosyltransferases and glucuronidation activity: a comparison of normal and tumoral kidney tissues. Drug Metab Dispos. 2015;43(4):611-9.

Qureshi ZA, Hittle LE, O'Hara JA, Rivera JI, Syed A, Shields RK, et al. Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistance. Clin Infect Dis. 2015;60(9):1295-303.

Ramanathan S, Jin F, Sharma S, Kearney BP. Clinical pharmacokinetic and pharmacodynamic profile of idelalisib. Clin Pharmacokinet. 2015 Aug 5. Epub ahead of print

Rivosecchi R, Dasta J, Kellum J, Kane-Gill S. 975: A unique application of the GRADE criteria: drug-combination associated AKI. Crit Care Med. 2015;43(12 Suppl 1):245.

Rivosecchi R, Kane-Gill S, Garavaglia J, MacLasco A, Johnson H. 378: The effectiveness of intravenous vitamin K in cirrhotic patients with coagulopathy in the ICU. Crit Care Med. 2015;43(12 Suppl 1):96.

Rivosecchi RM, Garavaglia J, Kane-Gill SL. An evaluation of intravenous vitamin k for warfarin reversal: are guideline recommendations being followed? Hosp Pharm. 2015;50(1):18-24.

Rivosecchi RM, Smithburger PL, Svec S, et al. Nonpharmacological interventions to prevent delirium: an evidence-based systematic review. Crit Care Nurse. 2015;35(1):39-50; quiz 51.

Sakely H, Corbo J, Coley K, McGivney M, et al. Pharmacist-led collaborative practice for older adults. Am J Health Syst Pharm. 2015;72(8):606, 608-9.

Sartelli M, Malangoni MA, Abu-Zidan FM, (Jung P),et al WSES guidelines for management of Clostridium difficile infection in surgical patients. World J Emerg Surg. 2015;10:38.

Schwier NC, Coons JC, Rao SK. Pharmacotherapy update of acute idiopathic pericarditis. Pharmacotherapy. 2015;35(1):99-111.

Schwier NC. Pharmacotherapeutic considerations for the treatment of thyrotoxic pericarditis. Int J Cardiol. 2015;201:182-3.

Schwier NC.Pharmacotherapeutic considerations for using colchicine to treat idiopathic pericarditis in the USA. Am J Cardiovasc Drugs. 2015;15(5):295-306.

Shields RK, Clancy CJ, Hao B, et al. Effects of Klebsiella pneumoniae carbapenemase subtypes, extended-spectrum β-lactamases, and porin mutations on the in vitro activity of ceftazidime-avibactam against carbapenem-resistant K. pneumoniae. Antimicrob Agents Chemother. 2015;59(9):5793-7.

Shields RK, Nguyen MH, Clancy CJ. Clinical perspectives on echinocandin resistance among Candida species. Curr Opin Infect Dis. 2015;28(6):514-22.

Shields RK, Nguyen MH, Potoski BA, et al. Doripenem MICs and ompK36 porin genotypes of sequence type 258, KPC-producing Klebsiella pneumoniae may predict responses to carbapenem-colistin combination therapy among patients with bacteremia. Antimicrob Agents Chemother. 2015;59(3):1797-801.

Shields RK, Nguyen MH, Press EG, et al. Rate of FKS mutations among consecutive Candida isolates causing bloodstream infection. Antimicrob Agents Chemother. 2015;59(12):7465-7470.

Simasek M, Ballard SL, Phelps P, et al. Meeting resident scholarly activity requirements through a longitudinal quality improvement curriculum.J Grad Med Educ. 2015;7(1):86-90.

Singh LG, Accursi M, Korch Black K. Implementation and outcomes of a pharmacist-managed clinical video telehealth anticoagulation clinic. Am J Health Syst Pharm. 2015;72(1):70-3.

Smith MA, Benedict N. Effectiveness of educational technology to improve patient care in pharmacy curricula.Am J Pharm Educ. 2015;79(1):15.

Smith MA, Chan J, Mohammad RA. Ledipasvir-sofosbuvir: interferon-/ribavirin-free regimen for chronic hepatitis C virus infection. Ann Pharmacother. 2015;49(3):343-50.

Smith MA, Love BL, Mohammad RA. The changing landscape of adverse drug events associated with chronic hepatitis C virus therapy. Expert Opin Drug Saf. 2015;14(11):1649-52.

Smith MA, Mohammad RA. Ledipasvir-sofosbuvir for hepatitis C genotype 4 infection. Lancet Infect Dis. 2015;15(9):993-5.

Smith MA, Regal RE, Mohammad RA. Daclatasvir: a NS5A replication complex inhibitor for hepatitis C infection. Ann Pharmacother. 2015 Oct 20. Epub ahead of print

Smith MA, Lim A. Profile of paritaprevir/ritonavir/ombitasvir plus dasabuvir in the treatment of chronic hepatitis C virus genotype 1 infection. Drug Des Devel Ther. 2015;9:6083-94.

Smithburger P, Alexander S, Gries C, Korenoski A, Kane-Gill S. 552: Provider and family perceptions of family involvements in delirium prevention in an ICU. Crit Care Med. 2015;43(12 Suppl 1):139.

Smithburger PL, Buckley MS, Culver MA, et al. A multicenter evaluation of off-label medication use and associated adverse drug reactions in adult medical ICUs. Crit Care Med. 2015;43(8):1612-21.

Snyder ME, Earl TR, Gilchrist S, et al. Collaborative drug therapy management: case studies of three community-based models of care. Prev Chronic Dis. 2015;12:E39.

Snyder ME, Pater KS, Frail CK, et al. Utility of a brief screening tool for medication-related problems. Res Social Adm Pharm. 2015;11(2):253-64.

Sobel SI, Augustine M, Donihi AC, Reider JA,  Forte P, Korytkowski MT.  Safety and efficacy of a peri-operative protocol for patients with diabetes treated with continuous subcutaneous insulin infusion who are admitted to Same Day Surgery.  Endocr Pract. 2015;21(11):1269-1276.

Soltis R, Verlinden N, Kruger N, et al. Process-oriented guided inquiry learning strategy enhances students' higher level thinking skills in a pharmaceutical sciences course. Am J Pharm Educ. 2015;79(1):11.

Sutton JD, Mynatt RP, Kaye KS, Murray KP, Rybak MJ, Pogue JM. Nephrotoxicity comparison of two commercially available generic vancomycin products. Antimicrob Agents Chemother. 2015;59(9):5470-4.

Ternant D, Paintaud G, Trachtman H, Gipson DS, Joy MS. A possible influence of age on absorption and elimination of adalimumab in focal segmental glomerulosclerosis (FSGS). Eur J Clin Pharmacol. 2015 Oct 31. Epub ahead of print

Thurman JM, Wong M, Renner B, Frazer-Abel A, Giclas PC, Joy MS, et al. Complement activation in patients with focal segmental glomerulosclerosis. PLoS One. 2015;10(9):e0136558.

Tsapepas DS, Martin ST, Miao J, Shah SA, Scheffert J, Fester K, Ma K, Lat A, et al. Clostridium difficile infection, a descriptive analysis of solid organ transplant recipients at a single center. Diagn Microbiol Infect Dis. 2015;81(4):299-304.

Turner RB, Martello JL, Malhotra A.Worsening renal function in patients with baseline renal impairment treated with intravenous voriconazole: A systematic review. Int J Antimicrob Agents. 2015;46(4):362-6.

VanScoy BD, McCauley J, Ellis-Grosse EJ, Okusanya OO, et al. Exploration of the pharmacokinetic-pharmacodynamic relationships for fosfomycin efficacy using an in vitro infection model. Antimicrob Agents Chemother. 2015;59(12):7170-7177.

Verlinden NJ, Coons JC. Disopyramide for hypertrophic cardiomyopathy: a pragmatic reappraisal of an old drug. Pharmacotherapy. 2015;35(12):1164-72.

Viswesh V, Yost SE, Kaplan B. The prevalence and implications of BK virus replication in non-renal solid organ transplant recipients: A systematic review. Transplant Rev (Orlando). 2015;29(3):175-80.

Wang T, Benedict N, Olsen KM, et al. Effect of critical care pharmacist's intervention on medication errors: A systematic review and meta-analysis of observational studies. J Crit Care. 2015 Jun 24. Epub ahead of print

Wan Y, Sun SX, Corman S, Huang X, Gao X, Shorr AF. A longitudinal, retrospective cohort study on the impact of roflumilast on exacerbations and economic burden among chronic obstructive pulmonary disease patients in the real world. Int J Chron Obstruct Pulmon Dis. 2015;10:2127-36.

Wang L, Baser O, Kutikova L, Page JH, Barron R. The impact of primary prophylaxis with granulocyte colony-stimulating factors on febrile neutropenia during chemotherapy: a systematic review and meta-analysis of randomized controlled trials. Support Care Cancer. 2015;23(11):3131-40.

Weaver C, Rivosecchi R, Kane-Gill S, Smithburger P, Durkin J. 401: Off-label use of 4-factor prothrombin complex concentrate for direct oral anticoagulant reversal. Crit Care Med. 2015;43(12 Suppl 1):102.

Wellman BR, Frail CK, Zillich AJ, Snyder ME. Pharmacists' experiences with a telephonic medication therapy management program for home health care patients. Consult Pharm. 2015;30(3):163-74.

Wen X, Thorne G, Hu L, Joy MS, Aleksunes LM.Activation of NRF2 signaling in HEK293 cells by a first-in-class direct KEAP1-NRF2 iInhibitor. J Biochem Mol Toxicol. 2015;29(6):261-6.

Weycker D, Chandler D, Barron R, et al. Risk of infection among patients with non-metastatic solid tumors or non-Hodgkin's lymphoma receiving myelosuppressive chemotherapy and antimicrobial prophylaxis in US clinical practice. J Oncol Pharm Pract. 2015 Nov 14. Epub ahead of print.

Witcher R, Dzierba A, Kim C, Smithburger P, Kane-Gill S. 173: Adverse drug reactions during therapeutic hypothermia after cardiac arrest. Crit Care Med. 2015;43(12 Suppl 1):44-45.

Wong A, Benedict NJ, Kane-Gill SL. Multicenter evaluation of pharmacologic management and outcomes associated with severe resistant alcohol withdrawal.J Crit Care. 2015;30(2):405-9.

Wong A, Benedict NJ, Lohr BR, Pizon AF, Kane-Gill SL. Management of benzodiazepine-resistant alcohol withdrawal across a healthcare system: Benzodiazepine dose-escalation with or without propofol. Drug Alcohol Depend. 2015;154:296-9.

Wong A, Smithburger PL, Kane-Gill SL. Review of adjunctive dexmedetomidine in the management of severe acute alcohol withdrawal syndrome. Am J Drug Alcohol Abuse. 2015;41(5):382-91.

Wright EA, Gettig J. Discussion of learning assessments in postgraduate teaching and learning curricula. Am J Health Syst Pharm. 2015;72(9):688.

Zachariah JP, McNeal CJ, Copeland LA, Fang-Hollingsworth Y, Stock EM, Sun F, Song JJ, Gregory ST, Tom JO, Wright EA, VanWormer JJ, Cassidy-Bushrow AE. Temporal trends in lipid screening and therapy among youth from 2002 to 2012. J Clin Lipidol. 2015;9(5 Suppl):S77-87.

Ahmad F, Pogue JM, Marchaim D, et al. Evaluation of the potential impact of a carbapenem de-escalation program in an academic healthcare system. J Infect Public Health. 2014;7(1):50-3.

Allen EN, Gomes M, Yevoo L, Egesah O, Clerk C, Byamugisha J, Mbonye A, Were E, Mehta U, Atuyambe LM. Influences on participant reporting in the World Health Organisation drugs exposure pregnancy registry; a qualitative study. BMC Health Serv Res. 2014;14(1):525.

Almaghrabi R, Clancy CJ, Doi Y, Hao B, Chen L, Shields RK, et al. Carbapenem-resistant Klebsiella pneumoniae strains exhibit diversity in aminoglycoside-modifying enzymes, which exert differing effects on plazomicin and other agents. Antimicrob Agents Chemother. 2014;58(8):4443-51.

Alwan LM, Grossmann K, Sageser D, et al. Comparison of acute toxicity and mortality after two different dosing regimens of high-dose interleukin-2 for patients with metastatic melanoma. Target Oncol. 2014;9(1):63-71.

Bacci JL, McGrath SH, Pringle JL, Maguire MA, McGivney MS. Implementation of targeted medication adherence interventions within a community chain pharmacy practice: The Pennsylvania Project. J Am Pharm Assoc (2003) 2014;54(6):584-593.

Bakhtar O, Thajudeen B, Braunhut BL, Yost SE, et al. A case of thrombotic microangiopathy associated with antiphospholipid antibody syndrome successfully treated with eculizumab. Transplantation. 2014;98(3):e17-8.

Benedict N, Felbinger M, Ridenour T, Anthes A, Altawalbeh S, Kane-Gill S. Correlation of patient-reported outcomes of sedation and sedation assessment scores in critically ill patients. J Crit Care. 2014;29(6):1132.e5-9.

Bogan C, Kaye KS, Chopra T, Hayakawa K, Pogue JM, et al. Outcomes of carbapenem-resistant Enterobacteriaceae isolation: matched analysis. Am J Infect Control. 2014;42(6):612-20.

Bohnenberger KA, Krenzelok EP. Retrospective review of trend in modafinil overexposures reported to American poison information centers. Asia Pac J Med Toxicol 2014;3(2):50-4.

Bremmer DN, Clancy CJ, Press EG, Almaghrabi R, Chen L, Doi Y, Nguyen MH, Shields RK. KPC-Producing Klebsiella pneumoniae strains that harbor AAC(6')-Ib exhibit intermediate resistance to amikacin. Antimicrob Agents Chemother. 2014;58(12):7597-600.

Brennan BM, Coyle JR, Marchaim D, Pogue JM, et al. Statewide surveillance of carbapenem-resistant enterobacteriaceae in Michigan. Infect Control Hosp Epidemiol. 2014;35(4):342-9.

Casapao AM, Davis SL, Barr VO, Klinker KP, Goff DA, Barber KE, Kaye KS, Mynatt RP, Molloy LM, Pogue JM, Rybak MJ. Large retrospective evaluation of the effectiveness and safety of ceftaroline fosamil therapy. Antimicrob Agents Chemother. 2014;58(5):2541-6.

Casapao AM, Davis SL, McRoberts JP, et al. Evaluation of vancomycin population susceptibility analysis profile as a predictor of outcomes for patients with infective endocarditis due to methicillin-resistant Staphylococcus aureus.Antimicrob Agents Chemother. 2014;58(8):4636-41.

Chivukula S, Shullo MA, Kormos RL, et al. Cancer-free survival following alemtuzumab induction in heart transplantation. Transplant Proc. 2014;46(5):1481-8.

Chopra T, Marchaim D, Johnson PC, Awali RA, Doshi H, Chalana I, Davis N, Zhao JJ, Pogue JM, et al. Risk factors and outcomes for patients with bloodstream infection due to Acinetobacter baumannii-calcoaceticus complex. Antimicrob Agents Chemother. 2014;58(8):4630-5.

Clancy CJ, Bartsch SM, Nguyen MH, Stuckey DR, Shields RK, Lee BY. A computer simulation model of the cost-effectiveness of routine Staphylococcus aureus screening and decolonization among lung and heart-lung transplant recipients. Eur J Clin Microbiol Infect Dis. 2014;33(6):1053-61.

Clancy CJ, Hao B, Shields RK, et al. Doripenem, gentamicin, and colistin, alone and in combinations, against gentamicin-susceptible, KPC-producing Klebsiella pneumoniae strains with various ompK36 genotypes. Antimicrob Agents Chemother. 2014;58(6):3521-5.

Cogdill BR, Ross CA, Hurst JM, Garrison KL, Drayton SJ, Wisniewski CS. Evaluation of urinalyses ordered for diagnosis of urinary tract infections at an inpatient psychiatric hospital. Int J Psychiatry Med. 2014;47:17-24.

Connor SE, Scharf DM, Jonkman LJ, Herbert MI. Focusing on the five A's: a comparison of homeless and housed patients' access to and use of pharmacist-provided smoking cessation treatment.Res Social Adm Pharm. 2014;10(2):369-77.

Coons JC, Miller T. Strategies to reduce bleeding risk in acute coronary syndromes and percutaneous coronary intervention: new and emerging pharmacotherapeutic considerations.Pharmacotherapy. 2014;34(9):973-90.

Coons JC, Schwier N, Harris J, Seybert AL. Pharmacokinetic evaluation of prasugrel for the treatment of myocardial infarction.Expert Opin Drug Metab Toxicol. 2014;10(4):609-20.

Custodio JM, Rhee M, Shen G, Ling KH, Kearney BP, Ramanathan S. Pharmacokinetics and safety of boosted elvitegravir in subjects with hepatic impairment.Antimicrob Agents Chemother. 2014;58(5):2564-9.

Custodio JM, Wang H, Hao J, Lepist EI, Ray AS, Andrews J, Ling KH, Cheng A, Kearney BP, Ramanathan S. Pharmacokinetics of cobicistat boosted-elvitegravir administered in combination with rosuvastatin. J Clin Pharmacol. 2014;54(6):649-56.

Custodio JM, Yin X, Hepner M, Ling KH, Cheng A, Kearney BP, Ramanathan S. Effect of food on rilpivirine/emtricitabine/tenofovir disoproxil fumarate, an antiretroviral single-tablet regimen for the treatment of HIV infection.J Clin Pharmacol. 2014;54(4):378-85.

Daubresse M, Gleason PP, Peng Y, et al. Impact of a drug utilization review program on high-risk use of prescription controlled substances.Pharmacoepidemiol Drug Saf. 2014;23(4):419-27.

Delate T, Kauffman YS, Botts SR, Wong C, Gaughan KM. Metabolic monitoring in commercially insured pediatric patients newly initiated to take a second-generation antipsychotic. JAMA Pediatr. 2014;168(7):679-81.

Deutsch S, Koerner P, Miller RT, et al. Utilization patterns for oral oncology medications in a specialty pharmacy cycle management program.J Oncol Pharm Pract. 2014 Oct 8. [Epub ahead of print]

Dzierba AL, Abel EE, Buckley MS, Lat I. A review of inhaled nitric oxide and aerosolized epoprostenol in acute lung injury or acute respiratory distress syndrome.Pharmacotherapy. 2014;34(3):279-90.

Eisenhower C. Impact of pharmacist-conducted medication reconciliation at discharge on readmissions of elderly patients with COPD.Ann Pharmacother. 2014;48(2):203-8.

Elewa HF, DeRemer CE, Keller K, Gujral J, Joshua TV. Patients satisfaction with warfarin and willingness to switch to dabigatran: a patient survey.J Thromb Thrombolysis. 2014;38(1):115-20.

Eschenauer GA, Kwak EJ, Humar A, Potoski BA, Clarke LG, Shields RK, et al. Targeted versus universal antifungal prophylaxis among liver transplant recipients. Am J Transplant. 2014 Oct 30. [Epub ahead of print]

Eschenauer GA, Nguyen MH, Shoham S, Vazquez JA, Morris AJ, Pasculle WA, Kubin CJ, Klinker KP, Carver PL, Hanson KE, Chen S, Lam SW, Potoski BA, Clarke LG, Shields RK, Clancy CJ. Real-world experience with echinocandin MICs against Candida species in a multicenter study of hospitals that routinely perform susceptibility testing of bloodstream isolates. Antimicrob Agents Chemother. 2014;58(4):1897-906.

Everett CM, Thorpe CT, Palta M, Carayon P, Gilchrist VJ, Smith MA. The roles of primary care PAs and NPs caring for older adults with diabetes. JAAPA. 2014;27(4):45-9.

Falcione BA, Meyer SM. Development of an antimicrobial stewardship-based infectious diseases elective that incorporates human patient simulation technology.Am J Pharm Educ. 2014;78(8):151.

Farooq S, Hayakawa K, Marchaim D, Pogue JM, Kaye KS. Extended-spectrum β-lactamase-producing Escherichia coli isolation among older adults: epidemiology and outcomes. Am J Infect Control. 2014;42(5):565-8.

Fedorenko M, Lam SW, Harinstein LM, et al. Compliance with institutional antimicrobial dosing guidelines in patients receiving continuous venovenous hemodialysis.J Pharm Pract. 2014 Jan 22. [Epub ahead of print]

Ferreri SP, Greco AJ, Michaels NM, et al. Implementation of a pharmacogenomics service in a community pharmacy.J Am Pharm Assoc (2003). 2014;54(2):172-80.

Frail CK, Kline M, Snyder ME. Patient perceptions of e-prescribing and its impact on their relationships with providers: A qualitative analysis. J Am Pharm Assoc (2003). 2014;54(6):630-3.

Glaholt S, Hayes GL, Wisniewski CS. Evaluation of discharge medication orders following automatic therapeutic substitution of commonly exchanged drug classes. P T. 2014;39(4):267-77.

Goldsack JC, Reilly C, Bush C, McElligott S, Bristol MN, Motanya UN, Field R, Vozniak JM, et al. Impact of shortages of injectable oncology drugs on patient care. Am J Health Syst Pharm. 2014;71(7):571-8.

Grover B, Hayes BD, Watson K. Feedback in clinical pharmacy education. Am J Health Syst Pharm. 2014;71(18):1592-6.

Gurbel PA, Baker BA, Bailey WL, Bliden KP, Tantry US. Unravelling the smokers' paradox: cigarette smoking, high-risk coronary artery disease and enhanced clinical efficacy of oral P2Y₁₂ inhibitors. Thromb Haemost. 2014;111(6):1187-90.

Harris JR, Coons JC. Ticagrelor use in a patient with a documented clopidogrel hypersensitivity. Ann Pharmacother. 2014;48(9):1230-1233.

Hayakawa K, Martin ET, Gudur UM, Marchaim D, Dalle D, Alshabani K, Muppavarapu KS, Jaydev F, Bathina P, Sundaragiri PR, Rajuri SD, Khatri J, Pogue JM, et al. Impact of different antimicrobial therapies on clinical and fiscal outcomes of patients with bacteremia due to vancomycin-resistant enterococci. Antimicrob Agents Chemother. 2014;58(7):3968-75.

Henao JP, Peperzak KA, Lichvar AB, et al. Extrapyramidal symptoms following administration of oral perphenazine 4 or 8 mg: an 11-year retrospective analysis. Eur J Anaesthesiol. 2014;31(4):231-5.

Hester EK, McBane SE, Bottorff MB, Carnes TA, Dell K, Gonyeau MJ, Greco AJ, et al. Educational outcomes necessary to enter pharmacy residency training.Pharmacotherapy. 2014;34(4):e22-5.

Holliday SF, Kane-Gill SL, Empey PE, Buckley MS, Smithburger PL. Interpatient variability in dexmedetomidine response: a survey of the literature. ScientificWorldJournal. 2014;2014:805013.

Hung WY, Abreu Lanfranco O. Contemporary review of drug-induced pancreatitis: A different perspective.World J Gastrointest Pathophysiol. 2014;5(4):405-15.

Innis CJ, Braverman H, Cavin JM, Ceresia ML, et al. Diagnosis and management of Enterococcus spp infections during rehabilitation of cold-stunned Kemp's ridley turtles (Lepidochelys kempii): 50 cases (2006-2012).J Am Vet Med Assoc. 2014;245(3):315-23.

Irefin SA, Sonny A, Harinstein L, Popovich MJ. Postoperative adverse effects after recent or remote lithium therapy.J Clin Anesth. 2014;26(3):231-4.

Jentzer JC, Coons JC, Link CB, Schmidhofer M. Pharmacotherapy update on the use of vasopressors and inotropes in the intensive care unit.J Cardiovasc Pharmacol Ther. 2014 Nov 28. [Epub ahead of print]

Johnson HM, Thorpe CT, Bartels CM, Schumacher JR, Palta M, Pandhi N, Sheehy AM, Smith MA. Undiagnosed hypertension among young adults with regular primary care use. J Hypertens. 2014;32(1):65-74.

Johnson LS, Shields RK, Clancy CJ. Epidemiology, clinical manifestations, and outcomes of Scedosporium infections among solid organ transplant recipients. Transpl Infect Dis. 2014;16(4):578-87.

Joy MS, Frye RF, Nolin TD, et al. In vivo alterations in drug metabolism and transport pathways in patients with chronic kidney diseases.Pharmacotherapy. 2014;34(2):114-22.

Joy MS, Roberts BV, Wang J, et al. A pilot study of leukocyte expression patterns for drug metabolizing enzyme and transporter transcripts in autoimmune glomerulonephritis.Int J Clin Pharmacol Ther. 2014;52(4):303-13.

Kane-Gill SL, LeBlanc JM, Dasta JF, Devabhakthuni S; Critical Care Pharmacotherapy Trials Network. A multicenter study of the point prevalence of drug-induced hypotension in the ICU.Crit Care Med. 2014;42(10):2197-203.

Kane-Gill SL, Rubin EC, Smithburger PL, et al. The cost of opioid-related adverse drug events. J Pain Palliat Care Pharmacother. 2014;28(3):282-93.

Kim JJ, Langworthy DR, Hennessey EK. Clinical implications of statin therapy in patients undergoing hemodialysis.Am J Health Syst Pharm. 2014;71(9):703-10.

Kim JJ, Mohammad RA, Coley KC, Donihi AC. Use of an iPad to provide warfarin video education to hospitalized patients.J Patient Saf. 2014 Feb 11. [Epub ahead of print]

Kloet MA, Lohr BR, Smithburger PL, Seybert AL, Kane-Gill SL. Prospective Assessment of Inpatient Boxed Warning Prescriber Adherence. J Patient Saf. 2014 Mar 18. [Epub ahead of print]

Knapp KK, Mészáros K, Goldsmith PC, McCarter GC, Hester EK, McBane SE, Bottorff MB, Carnes TA, Dell K, Gonyeau MJ, Greco AJ, et al. Alternative viewpoint: preparation for residency.Pharmacotherapy. 2014;34(8):e157-8.

Koerner PH, Miller RT, Higginbotham S. Development of a community residency program with a focus on specialty pharmacy.Am J Health Syst Pharm. 2014;71(23):2067-72.

Korytkowski MT, Koerbel GL, Kotagal L, Donihi A, DiNardo MM. Pilot trial of diabetes self-management education in the hospital setting.Prim Care Diabetes. 2014;8(3):187-94.

Lampert BC, Teuteberg JJ, Shullo MA, Holtz J, Smith KJ. Cost-effectiveness of routine surveillance endomyocardial biopsy after 12 months post-heart transplantation. Circ Heart Fail. 2014;7(5):807-13.

Marchaim D, Pogue JM, Tzuman O, et al. Major variation in MICs of tigecycline in Gram-negative bacilli as a function of testing method. J Clin Microbiol. 2014;52(5):1617-21.

McGrane IR, Corman SL. Role in Therapy of Melatonin for the Treatment of Insomniain Children and Adults. Ment Health Clin. 2014(4(2):44.

McGrane IR, Leung JG, St Louis EK, Boeve BF. Melatonin therapy for REM sleep behavior disorder: a critical review of evidence.Sleep Med. 2014 Oct 13. [Epub ahead of print]

Mehta U, Dheda M, Steel G, et al. Strengthening pharmacovigilance in South Africa. S Afr Med J. 2014;104(2):104-6.

Micek ST, Arnold H, Juang P, et al. Effects of empiric antifungal therapy for septic shock on time to appropriate therapy for Candida infection: a pilot study.Clin Ther. 2014;36(9):1226-32.

Mouton JP, Mehta U, Parrish AG, et al. Mortality from adverse drug reactions in adult medical inpatients at four hospitals in South Africa: a cross-sectional survey.Br J Clin Pharmacol. 2014 Dec 5. [Epub ahead of print]

Mukerji AN, Karachristos A, Maloo M, Johnson D, Jain A. Do postliver transplant patients need thromboprophylactic anticoagulation?Clin Appl Thromb Hemost. 2014;20(7):673-7.

Mummaneni P, Shord SS. Epigenetics and oncology. Pharmacotherapy. 2014;34(5):495-505.

Nayak S, Magaji V, Donihi AC, et al. Efficacy and safety of continuous insulin infusion protocols with glycemic targets of 110-140 mg/dL in patients with and without diabetes following cardiac surgery.J Diabetes Sci Technol. 2014;8(2):425-426.

Ness GL, Sheehan AH, Snyder ME. Graduating student pharmacists' perspectives on e-professionalism and social media: qualitative findings. J Am Pharm Assoc (2003). 2014;54(2):138-43.

Nestor J, Huggins T, Kummerfeldt C, Wisniewski CS, Davis J, Doelken P, Sahn S. Dasatinib-induced chylous pleural effusions. Clin Pulm Med. 2014;21:42-5.

Okusanya OO, Bhavnani SM, Hammel JP, et al. Evaluation of the pharmacokinetics and pharmacodynamics of liposomal amikacin for inhalation in cystic fibrosis patients with chronic pseudomonal infections using data from two phase 2 clinical studies. Antimicrob Agents Chemother. 2014;58(9):5005-15.

Oleksiuk LM, Nguyen MH, Press EG, Updike CL, O'Hara JA, Doi Y, Clancy CJ, Shields RK. In vitro responses of Acinetobacter baumannii to two- and three-drug combinations following exposure to colistin and doripenem. Antimicrob Agents Chemother. 2014;58(2):1195-9.

Ortwine JK, Kaye KS, Li J, Pogue JM. Colistin: understanding and applying recent pharmacokinetic advances. Pharmacotherapy. 2014 Sep 3. [Epub ahead of print]

Ortwine JK, Pogue JM, Faris J. Pharmacokinetics and pharmacodynamics of antibacterial and antifungal agents in adult patients with thermal injury: a review of current literature. J Burn Care Res. 2014 Aug 27. [Epub ahead of print]

Paladino JA, Jacobs DM, Shields RK, et al. Use of ceftaroline after glycopeptide failure to eradicate meticillin-resistant Staphylococcus aureus bacteraemia with elevated vancomycin minimum inhibitory concentrations. Int J Antimicrob Agents. 2014;44(6):557-63.

Patel RS, Marcum ZA, Peron EP, Ruby CM. Prevalence of and factors associated with therapeutic failure-related hospitalizations in the elderly. Consult Pharm. 2014;29(6):376-86.

Pogue JM, Mynatt RP, Marchaim D, et al. Automated alerts coupled with antimicrobial stewardship intervention lead to decreases in length of stay in patients with gram-negative bacteremia. Infect Control Hosp Epidemiol. 2014;35(2):132-8.

Pogue JM, Neelakanta A, Mynatt RP, et al. Carbapenem-resistance in gram-negative bacilli and intravenous minocycline: an antimicrobial stewardship approach at the Detroit Medical Center. Clin Infect Dis. 2014;59 Suppl 6:S388-93.

Pogue JM, Potoski BA, Postelnick M, et al. Bringing the "power" to Cerner's PowerChart for antimicrobial stewardship. Clin Infect Dis. 2014;59(3):416-24.

Qureshi ZA, Syed A, Clarke LG, Doi Y, Shields RK. Epidemiology and clinical outcomes of patients with carbapenem-resistant Klebsiella pneumoniae bacteriuria. Antimicrob Agents Chemother. 2014;58(6):3100-4.

Rafie S, McIntosh J, Shealy KM, Borgelt LM, Forinash A, Shrader SP, Koepf ER, et al.Roles of the pharmacist in the use of safe and highly effective long-acting reversible contraception: an opinion of the women's health practice and research network of the American College of Clinical Pharmacy. Pharmacotherapy. 2014;34(9):991-9.

Rivosecchi RM, Rice MJ, Smithburger PL, Buckley MS, Coons JC, Kane-Gill SL. An evidence based systematic review of remifentanil associated opioid-induced hyperalgesia.Expert Opin Drug Saf. 2014;13(5):587-603.

Rowe AS, Goodwin H, Brophy GM, Bushwitz J, Castle A, Deen D, et al; Neurocritical Care Society Pharmacy Section. Seizure prophylaxis in neurocritical care: a review of evidence-based support. Pharmacotherapy. 2014;34(4):396-409.

Sakoulas G, Moise PA, Casapao AM, et al. Antimicrobial salvage therapy for persistent Staphylococcal bacteremia Using daptomycin plus ceftaroline. Clin Ther. 2014 Jul 10. pii: S0149-2918(14)00319-1. [Epub ahead of print]

Sherman EM, Elrod S, Allen D, Eckardt P. Pharmacist testers in multidisciplinary health care team expand HIV point-of-care testing program.J Pharm Pract. 2014;27(6):578-81.

Shields RK, Nguyen MH, Press EG, Clancy CJ. Abdominal candidiasis is a hidden reservoir of echinocandin resistance. Antimicrob Agents Chemother. 2014;58(12):7601-5.

Shuman MD, Mcgrane IR. Rationale for iloperidone in the treatment of posttraumatic stress disorder.Innov Clin Neurosci. 2014;11(5-6):23-5.

Smith MA, Chan J, Mohammad RA. Ledipasvir-sofosbuvir: interferon-/ribavirin-free regimen for chronic hepatitis C virus infection. Ann Pharmacother. 2014 Dec 16. [Epub ahead of print]

Smith MA, Hibino M, Falcione BA, Eichinger KM, Patel R, Empey KM. Immunosuppressive aspects of analgesics and sedatives used in mechanically ventilated patients: an underappreciated risk factor for the development of ventilator-associated pneumonia in critically ill patients.Ann Pharmacother. 2014;48(1):77-85.

Smith MA, Johnson HJ, Chopra K, Dunn M, Ulrich A, Mohammad RA. Incidence and management of rash in telaprevir-treated patients: lessons for simeprevir? Ann Pharmacother. 2014; 48 (9): 1166-71.

Smith MA, Mohammad RA, Benedict N. Use of virtual patients in an advanced therapeutics pharmacy course to promote active, patient-centered learning. Am J Pharm Educ. 2014;78(6):125.

Smith MA, Mohammad RA. Vedolizumab: an α4β7 integrin inhibitor for inflammatory bowel diseases. Ann Pharmacother. 2014;48(12):1629-1635.

Smithburger PL, Smith RB, Kane-Gill SL, Empey PE. Patient predictors of dexmedetomidine effectiveness for sedation in intensive care units. Am J Crit Care. 2014;23(2):160-5.

Snyder ME, Frail CK, Jaynes H, Pater KS, Zillich AJ. Predictors of medication-related problems among medicaid patients participating in a pharmacist-provided telephonic medication therapy management program. Pharmacotherapy. 2014;34(10):1022-32.

Snyder ME, Pater KS, Frail CK, et al. Utility of a brief screening tool for medication-related problems. Res Social Adm Pharm. 2014 Oct 8. [Epub ahead of print]

Starner CI, Alexander GC, Bowen K, Qiu Y, Wickersham PJ, Gleason PP. Specialty drug coupons lower out-of-pocket costs and may improve adherence at the risk of increasing premiums.Health Aff (Millwood). 2014;33(10):1761-9.

Starner CI, McClelland RS, Qiu, Y, Zabinski, RA, Cotter N, Gleason PP. A Linezolid Prior Authorization Program: Clinical and Economic Outcomes. American Journal of Pharmacy Benefit 2014;6(2):81-88.

Stoudenmire LG, DeRemer CE, Elewa H. Telephone versus office-based management of warfarin: impact on international normalized ratios and outcomes.Int J Hematol. 2014;100(2):119-24.

Tawbi H, Christner SM, Lin Y, Johnson M, Mowrey ET, Cherrin C, Chu E, Lee JJ, Puhalla S, Stoller R, Appleman LR, Miller BM, Beumer JH. Calcium carbonate does not affect imatinib pharmacokinetics in healthy volunteers. Cancer Chemother Pharmacol. 2014;73(1):207-11.

Thorpe CT, Johnson H, Dopp AL, Thorpe JM, Ronk K, Everett CM, Palta M, Mott DA, Chewning B, Schleiden L, Smith MA. Medication oversupply in patients with diabetes. Res Social Adm Pharm. 2014 Sep 11. [Epub ahead of print]

Trinkley KE, Nikels SM, Page RL 2nd, Joy MS. Automating and estimating glomerular filtration rate for dosing medications and staging chronic kidney disease.Int J Gen Med. 2014;7:211-8.

Turner RB, Smith CB, Martello JL, Slain D. Role of doxycycline in Clostridium difficile infection acquisition.Ann Pharmacother. 2014;48(6):772-6.

Watson K, Gottlieb SS. Walking the line of euvolemia. J Card Fail. 2014;20(8):623-4.

Watson K, Grover BE, Wilson SL, et al. Design and implementation of a strategy for preceptor development in multiple residency programs. Am J Health Syst Pharm. 2014;71(7):526-8.

Werth SR, Sachdeva N, Roberts AW, Garrettson M, Ringwalt C, Moss LA, Pikoulas T, Skinner AC. North Carolina Medicaid recipient management lock-in program: the pharmacist's perspective. J Manag Care Spec Pharm. 2014;20(11):1122-9.

Wisniewski CS, Robert S, Ball S. Collaboration between a drug information center and an academic detailing program. Am J Health Syst Pharm. 2014;71(2):128-33.

Wong A, Benedict NJ, Armahizer MJ, Kane-Gill SL. Evaluation of adjunctive ketamine to benzodiazepines for management of alcohol withdrawal syndrome.Ann Pharmacother. 2014 Oct 16. [Epub ahead of print]

Wright EA, Brown B, Gettig J, Martello JL, McClendon KS, et al. Teaching and learning curriculum programs: recommendations for postgraduate pharmacy experiences in education. Am J Health Syst Pharm. 2014;71(15):1292-302.

Yoon CH, Watson K. Biologics for the treatment of dyslipidemias: a look beyond conventional therapy. Ann Pharmacother. 2014;48(2):238-49.

Yost SE, Echeverria A, Jie T, Kaplan B. Panresistant cytomegalovirus in a kidney transplant recipient. Pharmacotherapy. 2014;34(1):e1-3.

Zillich AJ, Snyder ME, Frail CK, et al. A randomized, controlled pragmatic trial of telephonic medication therapy management to reduce hospitalization in home health patients. Health Serv Res. 2014;49(5):1537-54.

Spinler SA, Cziraky MJ, Tang F, Dueñas GG, et al. Assessing Medicare beneficiary eligibility for medication therapy management programs using PINNACLE, a National Cardiovascular Data Registry.Am Health Drug Benefits. 2013;6(7):367-74.

Adams AJ, Clark DR, DeLander GE, Mackinnon GE 3rd, Malloy M, McGivney MS, et al. Report of the AACP task force on patient-centered medical homes and accountable care organizations. Am J Pharm Educ. 2013;77(7):142.

Akajagbor DS, Wilson SL, Shere-Wolfe KD, et al. Higher incidence of acute kidney injury with intravenous colistimethate sodium compared with polymyxin B in critically ill patients at a tertiary care medical center. Clin Infect Dis. 2013;57(9):1300-3.

Allen EN, Chandler CI, Mandimika N, Pace C, Mehta U, Barnes KI. Evaluating harm associated with anti-malarial drugs: a survey of methods used by clinical researchers to elicit, assess and record participant-reported adverse events and related data. Malar J. 2013;12(1):325.

Allen EN, Mushi AK, Massawe IS, Vestergaard LS, Lemnge M, Staedke SG, Mehta U, Barnes KI, Chandler CI. How experiences become data: the process of eliciting adverse event, medical history and concomitant medication reports in antimalarial and antiretroviral interaction trials. BMC Med Res Methodol. 2013;13(1):140.

American College of Clinical Pharmacy, Shord SS, Schwinghammer TL, Badowski M, et al. Desired professional development pathways for clinical pharmacists. Pharmacotherapy. 2013;33(4):e34-42.

Anthes AM, Harinstein LM, Smithburger PL, Seybert AL, Kane-Gill SL. Improving adverse drug event detection in critically ill patients through screening intensive care unit transfer summaries. Pharmacoepidemiol Drug Saf. 2013;22(5):510-6.

Armahizer MJ, Kane-Gill SL, Smithburger PL, Anthes AM, Seybert AL. Comparing DDI severity for clinician opinion to proprietary databases. ISRN Critical Care volume 2013, article ID 347346, http://www.hindawi.com/isrn/cc/aip/347346/

Armahizer MJ, Johnson D, Deusenberry CM, Foley JJ, Krenzelok EP, Pummer TL. Evaluation of pharmacist utilization of a poison center as a resource for patient care. J Pharm Pract. 2013;26(3):220-7.

Armahizer MJ, Seybert AL, Smithburger PL, Kane-Gill SL. Corrected QT interval for possible drug-drug interactions in the intensive care unit. J Crit Care. 2013.

Armahizer MJ, Seybert AL, Smithburger PL, Kane-Gill SL. Drug-drug interactions contributing to QT prolongation in cardiac intensive care units. J Crit Care. 2013;28(3):243-9.

Arnold HM, Hollands JM, Skrupky LP, Smith JR, Juang PH, et al. Prolonged infusion antibiotics for suspected gram-negative infections in the ICU: a before-after study. Ann Pharmacother. 2013;47(2):170-80.

Benedict N, Schonder K, McGee J. Promotion of self-directed learning using virtual patient cases. Am J Pharm Educ. 2013;77(7):151.

Bliden KP, Baker BA, Nolin TD, Jeong YH, Bailey WL, et al. Thienopyridine efficacy and cigarette smoking status. Am Heart J. 2013;165(5):693-703.

Boyce JM, Pop OF, Abreu-Lanfranco O, Hung WY, et al. A trial of discontinuation of empiric vancomycin therapy in patients with suspected methicillin-resistant Staphylococcus aureus health care-associated pneumonia. Antimicrob Agents Chemother. 2013;57(3):1163-8.

Bruce RD, Winkle P, Custodio JM, Wei LX, Rhee MS, Kearney BP, et al. The pharmacokinetic and pharmacodynamic interactions between buprenorphine/naloxone and elvitegravir/cobicistat in subjects receiving chronic buprenorphine/naloxone treatment. J Acquir Immune Defic Syndr. 2013;63(4):480-4.

Bruce RD, Winkle P, Custodio JM, Wei X, Rhee MS, Kearney BP, et al. Investigation of the interactions between methadone and elvitegravir-cobicistat in subjects receiving chronic methadone maintenance. Antimicrob Agents Chemother. 2013;57(12):6154-7.

Buckley MS, Harinstein LM, Clark KB, Smithburger PL, Eckhardt DJ, Alexander E, Devabhakthuni S, et al. Impact of a clinical pharmacy admission medication reconciliation program on medication errors in "high-risk" patients.Ann Pharmacother. 2013;47(12):1599-610.

Bulitta JB, Okusanya OO, Forrest A, et al. Population pharmacokinetics of fusidic acid: rationale for front-loaded dosing regimens due to autoinhibition of clearance. Antimicrob Agents Chemother. 2013;57(1):498-507.

Burcham PK, Abel EE, Gerlach AT, et al. Development and implementation of a nurse-driven, sliding-scale nomogram for bivalirudin in the management of heparin-induced thrombocytopenia. Am J Health Syst Pharm. 2013;70(11):980-7.

Burghardt KJ, Bowman MR, Hibino M, et al. Using educational games to promote the seeking of a pharmacist and to teach key medication use messages: results from an inner city health party. Res Social Adm Pharm. 2013;9(5):542-52.

Casapao AM, Kullar R, Davis SL, et al. Multicenter study of high-dose daptomycin for treatment of enterococcal infections. Antimicrob Agents Chemother. 2013;57(9):4190-6.

Casapao AM, Leonard SN, Davis SL, et al. Clinical outcomes in patients with heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) bloodstream infection. Antimicrob Agents Chemother. 2013

Cesarz JL, Steffenhagen AL, Svenson J, Hamedani AG. Emergency department discharge prescription interventions by emergency medicine pharmacists. Ann Emerg Med. 2013;61(2):209-14.e1.

Chopra T, Marchaim D, Awali RA, Krishna A, Johnson P, Tansek R, Chaudary K, Lephart P, Slim J, Hothi J, Ahmed H, Pogue JM, et al. Epidemiology of bloodstream infections caused by Acinetobacter baumannii and impact of drug resistance to both carbapenems and ampicillin-sulbactam on clinical outcomes. Antimicrob Agents Chemother. 2013;57(12):6270-5.

Clancy CJ, Chen L, Hong JH, Cheng S, Hao B, Shields RK, et al. Mutations of the ompK36 porin gene and promoter impact responses of sequence type 258, KPC-2-producing Klebsiella pneumoniae strains to doripenem and doripenem-colistin. Antimicrob Agents Chemother. 2013;57(11):5258-65.

Clancy CJ, Chen L, Shields RK, et al. Epidemiology and molecular characterization of bacteremia due to carbapenem-resistant Klebsiella pneumoniae in transplant recipients. Am J Transplant. 2013;13(10):2619-33.

Clauson KA, Elrod S, Fox BI, Hajar Z, Dzenowagis JH. Opportunities for pharmacists in mobile health. Am J Health Syst Pharm. 2013;70(15):1348-52.

Coons JC, Clarke M, Wanek MR, et al. Safe and effective use of prostacyclins to treat pulmonary arterial hypertension. Am J Health Syst Pharm. 2013;70(19):1716-23.

Cooper BE, Sejnowski CA. Serotonin syndrome: recognition and treatment. AACN Adv Crit Care. 2013;24(1):15-20.

Custodio JM, Yin X, Hepner M, Ling J, Cheng A, Kearney BP, Ramanathan S. Effect of food on rilpivirine/emtricitabine/tenofovir disoproxil fumarate, an antiretroviral single-tablet regimen for the treatment of HIV infection. J Clin Pharmacol. 2013 Oct 19. [Epub ahead of print]

Daubresse M, Gleason PP, Peng Y, et al. Impact of a drug utilization review program on high-risk use of prescription controlled substances. Pharmacoepidemiol Drug Saf. 2013 Jul 24. [Epub ahead of print]

Dulisse B, Li X, Gayle JA, Barron RL, et al. A retrospective study of the clinical and economic burden during hospitalizations among cancer patients with febrile neutropenia. J Med Econ. 2013;16(6):720-35.

Eisenhower C. Residents' perspective on the faculty hiring process. Am J Pharm Educ. 2013;77(4):85.

Elewa HF, Deremer CE, Keller K, et al. Patients satisfaction with warfarin and willingness to switch to dabigatran: a patient survey. J Thromb Thrombolysis. 2013 Aug 6. [Epub ahead of print]

Eschenauer GA, Carver PL, Lin SW, Klinker KP, Chen YC, Potoski BA, Shields RK, et al. Fluconazole versus an echinocandin for Candida glabrata fungaemia: a retrospective cohort study. J Antimicrob Chemother. 2013;68(4):922-6.

Felix-Getzik E, Sylvia LM. Prasugrel use in a patient allergic to clopidogrel: effect of a drug shortage on selection of dual antiplatelet therapy. Am J Health Syst Pharm. 2013;70(6):511-3.

Gillespie M, Yost SE, Meister E, Kaplan B. A cautionary tale of BK virus. Transpl Int. 2013;26(11):e99.

Gim S, Vincent WR 3rd. Contemporary approaches for evidence-based pharmacotherapy. J Pharm Pract. 2013;26(2):95-102.

Gleason PP, Alexander GC, Starner CI, et al. Health plan utilization and costs of specialty drugs within 4 chronic conditions. J Manag Care Pharm. 2013;19(7):542-8.

Gleason PP, Phillips J, Fenrick BA, et al. Dalfampridine prior authorization program: a cohort study. J Manag Care Pharm. 2013;19(1):18-25.

Gortney JS, Seed S, Borja-Hart N, et al. The prevalence and characteristics of dual PharmD/MPH programs offered at US colleges and schools of pharmacy. Am J Pharm Educ. 2013;77(6):116.

Greco AJ, Ferreri SP, Persky AM, Marciniak MW. Characteristics of postgraduate year two pharmacy residency programs with a secondary emphasis on academia. Am J Pharm Educ. 2013;77(7):143.

Gray EN, Shuman MD, McGrane IR. The Role of Prepulse Inhibition in Medication Management of PTSD : A Case Report. Ment Health Clin. 2013;2(7):34.

Gurbel PA, Bliden KP, Logan DK, Kereiakes DJ, Lasseter KC, White A, Angiolillo DJ, Nolin TD, Maa JF, Bailey WL, et al. The influence of smoking status on the pharmacokinetics and pharmacodynamics of clopidogrel and prasugrel: the PARADOX study. J Am Coll Cardiol. 2013;62(6):505-12.

Harinstein LM, Morgan JW, Russo N. Treatment of dabigatran-associated bleeding: case report and review of the literature. J Pharm Pract. 2013;26(3):264-9.

Havrda DE, Engle JP, Anderson KC, Ray SM, Haines SL, Kane-Gill SL, Ballard SL, et al. Guidelines for resident teaching experiences. Pharmacotherapy. 2013;33(7):e147-61.

Hawkins K, Donihi AC, Korytkowski MT. Glycemic management in medical and surgical patients in the non-ICU setting. Curr Diab Rep. 2013;13(1):96-106.

Hayakawa K, Gattu S, Marchaim D, Bhargava A, Palla M, Alshabani K, Gudur UM, Pulluru H, Bathina P, Sundaragiri PR, Sarkar M, Kakarlapudi H, Ramasamy B, Nanjireddy P, Mohin S, Dasagi M, Datla S, Kuchipudi V, Reddy S, Shahani S, Upputuri V, Marrey S, Gannamani V, Madhanagopal N, Annangi S, Sudha B, Muppavarapu KS, Moshos JA, Lephart PR, Pogue JM, et al. Epidemiology and risk factors for isolation of Escherichia coli producing CTX-M-type extended-spectrum β-lactamase in a large U.S. Medical Center. Antimicrob Agents Chemother. 2013;57(8):4010-8.

Hayakawa K, Marchaim D, Bathina P, Martin ET, Pogue JM, et al. Independent risk factors for the co-colonization of vancomycin-resistant Enterococcus faecalis and methicillin-resistant Staphylococcus aureus in the region most endemic for vancomycin-resistant Staphylococcus aureus isolation. Eur J Clin Microbiol Infect Dis. 2013;32(6):815-20.

Hayakawa K, Marchaim D, Palla M, Gudur UM, Pulluru H, Bathina P, Alshabani K, Govindavarjhulla A, Mallad A, Abbadi DR, Chowdary D, Kakarlapudi H, Guddati H, Das M, Kannekanti N, Vemuri P, Doddamani R, Mundra VR, Guddeti RR, Policherla R, Bai S, Lohithaswa S, Shashidharan SP, Chidurala S, Diviti S, Sukayogula K, Joseph M, Pogue JM, et al. Epidemiology of vancomycin-resistant Enterococcus faecalis: a case-case-control study. Antimicrob Agents Chemother. 2013;57(1):49-55.

Hong JH, Clancy CJ, Cheng S, Shields RK, et al. Characterization of porin expression in Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae identifies isolates most susceptible to the combination of colistin and carbapenems. Antimicrob Agents Chemother. 2013;57(5):2147-53.

Jang SY, Dooley MA, Joy MS. Impact of severe hypothyroidism on cyclophosphamide disposition and routes of metabolism and transport in a patient with treatment-resistant lupus nephritis. Ann Pharmacother. 2013;47(7-8):e35.

Joy MS, Frye RF, Nolin TD, et al. In Vivo Alterations in Drug Metabolism and Transport Pathways in Patients with Chronic Kidney Diseases. Pharmacotherapy. 2013 Sep 6. [Epub ahead of print]

Juang P, Hardesty JS. Role of fidaxomicin for the treatment of clostridium difficile infection. J Pharm Pract. 2013;26(5):491-7.

Kanwar M, Agarwal R, Barnes M, Coons J, et al. Role of phosphodiesterase-5 inhibitors in heart failure: emerging data and concepts. Curr Heart Fail Rep 2013;10:26-35.

Kauffman Y, Jonkman L, Lupu A, Connor S. Exploring the value of clinical pharmacy services for patients with diabetes in safety net settings. Res Social Adm Pharm. 2013;9(6):770-6.

Kelly A, Kennedy A, John BM, Duane B, Lemanowicz J, Little J. A comparison of heart rate changes associated with levalbuterol and racemic albuterol in pediatric cardiology patients. Ann Pharmacother. 2013;47(5):644-50.

Khandhar SJ, Yamamoto H, Teuteberg JJ, Shullo MA, et al. Optical coherence tomography for characterization of cardiac allograft vasculopathy after heart transplantation (OCTCAV study). J Heart Lung Transplant. 2013;32(6):596-602.

Kimmel SE, French B, Kasner SE, et al; COAG Investigators. A pharmacogenetic versus a clinical algorithm for warfarin dosing.N Engl J Med. 2013;369(24):2283-93. DeRemer CE part of investigative group.

Koppula S, Yost SE, Sussman A, et al. Successful conversion to belatacept after thrombotic microangiopathy in kidney transplant patients. Clin Transplant. 2013;27(4):591-7.

Kreys TJ, Fabian TJ, Saul MI, Haskett R, Coley KC. An evaluation of inpatient treatment continuation and hospital readmission rates in patients with bipolar disorder treated with aripiprazole or quetiapine. J Psychiatr Pract. 2013;19(4):288-95.

Kucukarslan SN, Corpus K, Mehta N, et al. Evaluation of a dedicated pharmacist staffing model in the medical intensive care unit.Hosp Pharm. 2013;48(11):922-30.

Kullar R, Casapao AM, Davis SL, et al. A multicentre evaluation of the effectiveness and safety of high-dose daptomycin for the treatment of infective endocarditis. J Antimicrob Chemother. 2013;68(12):2921-6.

Kullar R, Davis SL, Kaye KS, Levine DP, Pogue JM, Rybak MJ. Implementation of an antimicrobial stewardship pathway with daptomycin for optimal treatment of methicillin-resistant Staphylococcus aureus bacteremia. Pharmacotherapy. 2013;33(1):3-10.

Lampert BC, Eckert C, Weaver S, Scanlon A, Lockard K, Allen C, Kunz N, Bermudez C, Bhama JK, Shullo MA, et al. Blood pressure control in continuous flow left ventricular assist devices: efficacy and impact on adverse events. Ann Thorac Surg. 2013 Sep 25. [Epub ahead of print]

Martin ET, Tansek R, Collins V, Hayakawa K, Abreu-Lanfranco O, Chopra T, Lephart PR, Pogue JM, et al. The carbapenem-resistant Enterobacteriaceae score: a bedside score to rule out infection with carbapenem-resistant Enterobacteriaceae among hospitalized patients. Am J Infect Control. 2013;41(2):180-2.

Mebel ER, Ortega M, Massey LR, et al. Recommendations for Smooth Career Transitions in Pharmacy Leadership. Hospital Pharmacy 2013; 48(6):520-525.

Ménard V, Lévesque E, Chen S, Eap O, Joy MS, et al. Expression of UGT2B7 is driven by two mutually exclusive promoters and alternative splicing in human tissues: changes from prenatal life to adulthood and in kidney cancer. Pharmacogenet Genomics. 2013;23(12):684-96.

Minces LR, Nguyen MH, Mitsani D, Shields RK, et al. Ganciclovir-resistant cytomegalovirus (CMV) infections among lung transplant recipients are associated with poor outcomes despite treatment with foscarnet-containing regimens. Antimicrob Agents Chemother. 2013 Oct 21. [Epub ahead of print]

Momper JD, Zhao Y, Shapiro R, Schonder KS, et al. Pharmacokinetics of low-dose cidofovir in kidney transplant recipients with BK virus infection. Transpl Infect Dis. 2013;15(1):34-41.

Monroe PS, Heck WD, Lavsa SM. Comparative properties of U-500 and U-100 regular human insulin. Am J Health Syst Pharm. 2013;70(15):1284.

Murtaza UI, Ortmann MJ, Mando-Vandrick J, Lee AS. Management of first-trimester complications in the emergency department. Am J Health Syst Pharm. 2013;70(2):99-111.

Ness GL, Sheehan AH, Snyder ME, et al. Graduating pharmacy students' perspectives on e-professionalism and social media. Am J Pharm Educ. 2013;77(7):146.

Omotola AM, Li Y, Martin ET, Alshabani K, Yadav D, Sarkar M, Thapa SD, Kumar V, Mahabashya A, Ahmad S, Bhargava A, Marchaim D, Pogue JM, et al. Risk factors for and epidemiology of community-onset vancomycin-resistant Enterococcus faecalis in southeast Michigan. Am J Infect Control. 2013 Sep 5. [Epub ahead of print]

Pogue JM, Kaye KS. Is there really no benefit to combination therapy with colistin? Expert Rev Anti Infect Ther. 2013;11(9):881-4.

Pogue JM, Mann T, Barber KE, Kaye KS. Carbapenem-resistant Acinetobacter baumannii: epidemiology, surveillance and management. Expert Rev Anti Infect Ther. 2013;11(4):383-93.

Pogue JM, Marchaim D, Abreu-Lanfranco O, et al. Fosfomycin activity versus carbapenem-resistant Enterobacteriaceae and vancomycin-resistant Enterococcus, Detroit, 2008-10. J Antibiot (Tokyo). 2013;66(10):625-7.

Pogue JM, Marchaim D, Chopra T, Bheemreddy S, Lee J, Mudegowdra NS, Chaudhry A, Kaye KS. Evaluation of the potential impact of a carbapenem de-escalation program in an academic healthcare system. J Infect Public Health. 2013 Nov 5. [Epub ahead of print]

Rafie S, Borgelt L, Koepf ER, et al. Novel oral contraceptive for heavy menstrual bleeding: estradiol valerate and dienogest. Int J Womens Health. 2013;5:313-21.

Rafie S, McIntosh J, Gardner DK, Gawronski KM, Karaoui LR, Koepf ER, et al. Over-the-counter access to emergency contraception without age restriction: an opinion of the Women's Health Practice and Research Network of the American College of Clinical Pharmacy. Pharmacotherapy. 2013;33(5):549-57.

Raina A, Coons JC, Kanwar M, et al. Transitioning from parenteral treprostinil to inhaled treprostinil in patients with pulmonary arterial hypertension. Pulm Circ. 2013;3(1):116-20.

Ramanathan S, Mathias A, Wei X, Shen G, Koziara J, Cheng A, Kearney BP. Pharmacokinetics of once-daily boosted elvitegravir when administered in combination with acid-reducing agents. J Acquir Immune Defic Syndr. 2013;64(1):45-50.

Rivkin A, Gim S. Student preferences regarding teaching methods in a drug-induced diseases and clinical toxicology course. Am J Pharm Educ. 2013;77(6):123.

Roberts BV, Susano I, Gipson DS, Trachtman H, Joy MS. Contribution of renal and non-renal clearance on increased total clearance of adalimumab in glomerular disease. J Clin Pharmacol. 2013;53(9):919-24.

Sales I, Dzierba AL, Smithburger PL, Rowe D, Kane-Gill SL. Use of acetylcysteine for non-acetaminophen-induced acute liver failure. Ann Hepatol. 2013;12(1):6-10.

Sales I, Jonkman L, Connor S, Hall D. A comparison of educational interventions to enhance cultural competency in pharmacy students. Am J Pharm Educ. 2013;77(4):76.

Shields RK, Clancy CJ, Minces LR, et al. Epidemiology and outcomes of deep surgical site infections following lung transplantation. Am J Transplant. 2013;13(8):2137-45.

Shields RK, Nguyen MH, Press EG, et al. Anidulafungin and micafungin MIC breakpoints are superior to that of caspofungin for identifying FKS mutant Candida glabrata strains and echinocandin resistance. Antimicrob Agents Chemother. 2013;57(12):6361-5.

Shields RK, Nguyen MH, Press EG, et al. Caspofungin MICs correlate with treatment outcomes among patients with Candida glabrata invasive candidiasis and prior echinocandin exposure. Antimicrob Agents Chemother. 2013;57(8):3528-35.

Smith MA, Bell HS, Kissack JC, et al. Report of the 2012-2013 standing committee on advocacy: advocacy tools and resources: a framework for increasing member engagement. Am J Pharm Educ. 2013;77(10):S17.

Smithburger PL, Campbell S, Kane-Gill SL. Alteplase treatment of acute pulmonary embolism in the intensive care unit. Crit Care Nurse. 2013;33(2):17-27.

Smithburger PL, Kane-Gill SL, Kloet MA, Lohr B, Seybert AL. Advancing interprofessional education through the use of high fidelity human patient simulators. Pharm Pract (Granada). 2013;11(2):61-5.

Grinder D, Steffenhagen A, Valdovinos K, Carrell L. The Journal: Instructions for authors. JPSW. 2013;16(2):57-58.

Tawbi H, Christner SM, Lin Y, Johnson M, Mowrey ET, Cherrin C, Chu E, Lee JJ, Puhalla S, Stoller R, Appleman LR, Miller BM, Beumer JH. Calcium carbonate does not affect imatinib pharmacokinetics in healthy volunteers. Cancer Chemother Pharmacol. 2013 Oct 30. [Epub ahead of print]

Tawbi HA, Tran AL, Christner SM, Lin Y, Johnson M, Mowrey E, Appleman LR, Stoller R, Miller BM, Egorin MJ, Beumer JH. Calcium carbonate does not affect nilotinib pharmacokinetics in healthy volunteers. Cancer Chemother Pharmacol. 2013;72(5):1143-7.

Taylor SE, McD Taylor D, Jao K, et al. Nurse-initiated analgesia pathway for paediatric patients in the emergency department: a clinical intervention trial. Emerg Med Australas. 2013;25(4):316-23.

Toussaint KA, Watson K, Marrs JC, et al. Prevalence of and factors that influence board certification among pharmacy practice faculty at United States colleges and schools of pharmacy. Pharmacotherapy. 2013;33(1):105-11.

Tripathi RS, Burcham PK, Abel EE. Letter from tripathi et Al regarding article, "perioperative dexmedetomidine improves outcomes of cardiac surgery". Circulation. 2013;128(16):e337.

Vanscoy B, Mendes RE, Castanheira M, McCauley J, Bhavnani SM, Forrest A, Jones RN, Okusanya OO, et al. Relationship between ceftolozane-tazobactam exposure and drug resistance amplification in a hollow-fiber infection model. Antimicrob Agents Chemother. 2013;57(9):4134-8.

Vanscoy B, Mendes RE, McCauley J, Bhavnani SM, Bulik CC, Okusanya OO, et al. Pharmacological Basis of β-Lactamase Inhibitor Therapeutics: Tazobactam in Combination with Ceftolozane. Antimicrob Agents Chemother. 2013;57(12):5924-30.

VanScoy B, Mendes RE, Nicasio AM, Castanheira M, Bulik CC, Okusanya OO, et al. Pharmacokinetics-pharmacodynamics of tazobactam in combination with ceftolozane in an in vitro infection model. Antimicrob Agents Chemother. 2013;57(6):2809-14.

Wen Y, Kolonich HR, Kruszewski KM, et al. Retaining antibodies in tumors with a self-assembling injectable system. Mol Pharm. 2013;10(3):1035-44.

Yost SE, Kaplan B. Comparing kidney transplant outcomes; caveats and lessons. Nephrol Dial Transplant. 2013;28(1):9-11.

Abel EE, Kane-Gill SL, Seybert AL, Kellum JA. Direct thrombin inhibitors for management of heparin-induced thrombocytopenia in patients receiving renal replacement therapy: Comparison of clinical outcomes. Am J Health Syst Pharm. 2012;69(18):1559-67.

Alaniz C, Pogue JM. Vancomycin versus linezolid in the treatment of methicillin-resistant Staphylococcus aureus nosocomial pneumonia: implications of the ZEPHyR trial. Ann Pharmacother. 2012;46(10):1432-5.

American College of Clinical Pharmacy, Rathbun RC, Hester EK, Arnold LM, Chung AM, Dunn SP, Harinstein LM, Leber M, Murphy JA, Schonder KS, et al. Importance of direct patient care in advanced pharmacy practice experiences. Pharmacotherapy. 2012;32(4):e88-97.

Arif SA, Gim S, Nogid A, Shah B. Journal clubs during advanced pharmacy practice experiences to teach literature-evaluation skills. Am J Pharm Ed. 2012;76(5):2012:Article 88.

Armahizer MJ, Johnson D, Deusenberry CM, Foley JJ, Krenzelok EP, Pummer TL. Evaluation of pharmacist utilization of a poison center as a resource for patient care. J Pharm Pract. 2012 Jul 25. [Epub ahead of print]

Aspinall SL, Cunningham FE, Zhao X, et al; ESA Clinic Study Group. Impact of pharmacist-managed erythropoiesis-stimulating agents clinics for patients with non-dialysis-dependent CKD. Am J Kidney Dis. 2012;60(3):371-9.

Berdine H, Dougherty T, Ference J, Karpa K, Klootwyk J, Kozminski M, et al. The pharmacists' role in the Patient-Centered Medical Home (PCMH): a white paper created by the Health Policy Committee of the Pennsylvania Pharmacists Association (PPA). Ann Pharmacother. 2012;46(5):723-50.

Blume OR, Yost SE, Kaplan B. Antibody-mediated rejection: pathogenesis, prevention, treatment, and outcomes. J Transplant. 2012;2012:201754.

Cahoon WD, Ensor CR, Shullo MA. Alemtuzumab for cytolytic induction of immunosuppression in heart transplant recipients. Prog Transplant. 2012;22(4):344-9; quiz 350.

Campbell ML, Marchaim D, Pogue JM, et al. Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents. Ann Pharmacother. 2012;46(12):1587-97.

Casapao AM, Steed ME, Levine DP, Rybak MJ. Ceftaroline fosamil for community-acquired bacterial pneumonia and acute bacterial skin and skin structure infection. Expert Opin Pharmacother. 2012;13(8):1177-86.

Castelli G. An innovative way to provide student pharmacists with interprofessional education. Am J Pharm Educ. 2012;76(9):182. [Letter]

Cesarz JL, Steffenhagen AL, Svenson J, Hamedani AG. Emergency department discharge prescription interventions by emergency medicine pharmacists. Ann Emerg Med. 2012 May 24. [Epub ahead of print]

Chopra T, Marchaim D, Veltman J, Johnson P, Zhao JJ, Tansek R, Hatahet D, Chaudhry K, Pogue JM, et al. Impact of cefepime therapy on mortality among patients with bloodstream infections caused by extended-spectrum-β-lactamase-producing Klebsiella pneumoniae and Escherichia coli. Antimicrob Agents Chemother. 2012;56(7):3936-42.

Collins VL, Marchaim D, Pogue JM, et al. Efficacy of ertapenem for treatment of bloodstream infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother. 2012;56(4):2173-7.

Cribb J. O'Brien K. DeRemer CE.  Rifaximin in combination with metronidazole and oral vancomycin for the treatment of an initial episode of Clostridium difficile associated diarrhea: case report and literature review.  Hosp Pharm 2012;47(3):1-8.

Curtin LB, Cawley MJ. Immunoassay cross-reactivity of phenylephrine and methamphetamine. Pharmacotherapy. 2012;32(5):e98-102.

DeJesus E, Rockstroh JK, Henry K, Molina JM, Gathe J, Ramanathan S, Wei X, Yale K, Szwarcberg J, White K, Cheng AK, Kearney BP; GS-236-0103 Study Team. Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomized, double-blind, phase 3, non-inferiority trial. Lancet. 2012;379(9835):2429-38.

Desimone ME, Blank GE, Virji M, Donihi A, et al. Effect of an educational Inpatient Diabetes Management Program on medical resident knowledge and measures of glycemic control: a randomized controlled trial. Endocr Pract. 2012;18(2):238-49.

Deusenberry CM, Coley KC, Korytkowski MT, Donihi AC. Hypoglycemia in hospitalized patients treated with sulfonylureas. Pharmacotherapy. 2012 Jul;32(7):613-7.

Devabhakthuni S, Armahizer MJ, Dasta JF, Kane-Gill SL. Analgosedation: A paradigm shift in intensive care unit sedation practice. Ann Pharmacother. 2012;46:530-540.

Devabhakthuni S, Gonzales JP, Tata AL et al. Evaluation of vancomycin dosing and monitoring in adult medicine patients. Hosp Pharm. 2012;47(6):451-459.

Eisenhower C, Farrington EA. Advancements in the treatment of head lice in pediatrics. J Pediatr Health Care. 2012;26(6):451-61.

Elliott JP, Koerner PH, Heasley J, Kamal KM. The impact of elective active-learning courses in pregnancy/lactation and pediatric pharmacotherapy. Am J Pharm Educ. 2012;76(2):26.

Elliott RA, Tran T, Taylor SE, et al. Impact of a pharmacist-prepared interim residential care medication administration chart on gaps in continuity of medication management after discharge from hospital to residential care: a prospective pre- and post-intervention study (MedGap Study). BMJ Open. 2012;25;2(3).

Elliott RA, Tran T, Taylor SE, et al. Gaps in continuity of medication management during the transition from hospital to residential care: an observational study (MedGap Study). Australas J Ageing. 2012;31(4):247-54.

Fink JC, Joy MS, St Peter WL, Wahba IM; ASN Chronic Kidney Disease Advisory Group. Finding a common language for patient safety in CKD. Clin J Am Soc Nephrol. 2012;7(4):689-95.

Firstenberg MS, Abel EE, Papadimos TJ, Tripathi RS. Nonconvective forces: a critical and often ignored component in the echocardiographic assessment of transvalvular pressure gradients. Cardiol Res Pract. 2012;2012:383217.

Firstenberg MS, Nelson K, Abel E, McGregor J, Eiferman D. Extracorporeal membrane oxygenation for complex multiorgan system trauma. Case Rep Surg. 2012;2012:897184.

Firstenberg MS, Tripathi RS, Grose NA, Abel E, Peters SB, Papadimos TJ. Calciphylaxis following coronary artery bypass surgery: an underappreciated cause of wound complications? Heart Surg Forum. 2012;15(4):E218-20.

Fukuta Y, Clarke LG, Shields RK, et al. Lack of seasonality in the occurrence of multidrug-resistant Acinectobacter baumannii complex. Infect Control Hosp Epidemiol. 2012;33(10):1051-2.

German P, Liu HC, Szwarcberg J, Hepner M, Andrews J, Kearney BP, Mathias A. Effect of cobicistat on glomerular filtration rate in subjects with normal and impaired renal function. J Acquir Immune Defic Syndr. 2012;61(1):32-40.

Gleason P. Lessons from the Real World: Designing Specialty Pharmacy Benefits to Maximize Value. Benefits Magazine 2012;10:38-41.

Gokhman R, Seybert AL, Phrampus P, Darby J, Kane-Gill SL. Medication errors during medical emergencies in a large, tertiary care, academic medical center. Resuscitation. 2012;83(4):482-7.

Griffiths RI, Barron RL, Gleeson ML, et al. Granulocyte-colony stimulating factor use and medical costs after initial adjuvant chemotherapy in older patients with early-stage breast cancer. Pharmacoeconomics. 2012;30(2):103-18.

Guetschow T, Steffenhagen A. Justification of a pharmacy technician position: An evaluation of the benefits of a pharmacy technician completing pre-surgical patient medication histories pre-operatively by telephone. JPSW. 2012 May/June;15(3):52-53.

Harinstein LM, Kane-Gill SL, Smithburger PL, et al. Use of an abnormal laboratory value-drug combination alert to detect drug-induced thrombocytopenia in critically Ill patients. J Crit Care. 2012;27(3):242-9.

Hawkins K, Donihi AC, Korytkowski MT. Glycemic management in medical and surgical patients in the non-ICU setting. Curr Diab Rep. 2012 Oct 26. [Epub ahead of print]

Hayakawa K, Marchaim D, Divine GW, Pogue JM, et al. Growing prevalence of Providencia stuartii associated with the increased usage of colistin at a tertiary health care center. Int J Infect Dis. 2012;16(9):e646-8.

Hayakawa K, Marchaim D, Pogue JM, et al. Predictors and outcomes of linezolid-resistant vancomycin-resistant Enterococcus: a case-case-control study. Am J Infect Control. 2012;40(10):e261-3.

Hayakawa K, Marchaim D, Martin ET, Tiwari N, Yousuf A, Sunkara B, Pulluru H, Kotra H, Hasan A, Bheemreddy S, Sheth P, Lee DW, Kamatam S, Bathina P, Nanjireddy P, Chalana IK, Patel S, Kumar S, Vahia A, Ku K, Yee V, Swan J, Pogue JM, Lephart PR, Rybak MJ, Kaye KS. Comparison of the clinical characteristics and outcomes associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant E. faecium bacteremia. Antimicrob Agents Chemother. 2012;56(5):2452-8.

Hayakawa K, Marchaim D, Palla M, Mahesh Gudur U, Pulluru H, Bathina P, Alshabani K, Govindavarjhulla A, Mallad A, Reddy Abbadi D, Chowdary D, Kakarlapudi H, Guddati H, Das M, Kannekanti N, Vemuri P, Doddamani R, Ram Rakesh Mundra V, Reddy Guddeti R, Policherla R, Bai S, Lohithaswa S, Prasad Shashidharan S, Chidurala S, Diviti S, Sukayogula K, Joseph M, Pogue JM, et al. Epidemiology of vancomycin-resistant Enterococcus faecalis: a case-case-control study. Antimicrob Agents Chemother. 2012 Oct 15. [Epub ahead of print]

Hegde SS, Okusanya OO, Skinner R, et al. Pharmacodynamics of TD-1792, a novel glycopeptide-cephalosporin heterodimer antibiotic used against Gram-positive bacteria, in a neutropenic murine thigh model. Antimicrob Agents Chemother. 2012;56(3):1578-83.

Innis CJ, Ceresia ML, Merigo C, Scott Weber E 3rd, Papich MG. Single-dose pharmacokinetics of ceftazidime and fluconazole during concurrent clinical use in cold-stunned Kemp's ridley turtles (Lepidochelys kempii). J Vet Pharmacol Ther. 2012;35(1):82-9.

Jernigan MG, Press EG, Nguyen MH, Clancy CJ, Shields RK. The combination of doripenem and colistin is bactericidal and synergistic against colistin-resistant, carbapenemase-producing Klebsiella pneumoniae. Antimicrob Agents Chemother. 2012;56(6):3395-8.

Joy MS, La M, Wang J, et al. Cyclophosphamide and 4-hydroxycyclophosphamide pharmacokinetics in patients with glomerulonephritis secondary to lupus and small vessel vasculitis. Br J Clin Pharmacol. 2012;74(3):445-55.

Joy MS. Clinical Pharmacokinetics, 5th Edition. Ann Pharmacother. 2012 Mar 6. [Epub ahead of print]

Joy MS. Impact of glomerular kidney diseases on the clearance of drugs. J Clin Pharmacol. 2012;52(1 Suppl):23S-34S.

Judge T, Pogue JM, Marchaim D, et al. Epidemiology of vancomycin-resistant enterococci with reduced susceptibility to daptomycin. Infect Control Hosp Epidemiol. 2012;33(12):1250-4.

Kane-Gill SL, Forsberg EA, Verrico MM, Handler SM. Comparison of three pharmacovigilance algorithms in the ICU setting: a retrospective and prospective evaluation of ADRs. Drug Saf. 2012 Aug 1;35(8):645-53.

Kane-Gill SL, Post JP, Smithburger PL, Seybert AL. "Bump": using a mobile app to enhance learning in simulation scenarios. Simul Healthc. 2012;7(5):326-7.

Kauffman Y, Nair V, Herist K, et al. HIV medication therapy management services in community pharmacies. J Am Pharm Assoc (2003). 2012;52(6):e287-91.

Kauffman YS, Jonkman LJ, Lupu AM, Connor SE. Exploring the value of clinical pharmacy services for patients with diabetes in safety net settings. Res Social Adm Pharm 2012; Dec 3.

Khandhar SJ, Shah HV, Shullo MA, et al. Long-term effects on renal function of dose-reduced calcineurin inhibitor and sirolimus in cardiac transplant patients. Clin Transplant. 2012;26(1):42-9.

Kim JJ, Culley CM, Mohammad RA. Telaprevir: An oral protease inhibitor for hepatitis C virus infection. Am J Health Syst Pharm. 2012;69(1):19-33.

Ku K, Pogue JM, Moshos J, et al. Retrospective evaluation of colistin versus tigecycline for the treatment of Acinetobacter baumannii and/or carbapenem-resistant Enterobacteriaceae infections. Am J Infect Control. 2012 Mar 21. [Epub ahead of print]

Labelle A, Juang P, Reichley R, et al. The determinants of hospital mortality among patients with septic shock receiving appropriate initial antibiotic treatment. Crit Care Med. 2012;40(7):2016-21.

Lombardi LR, Miano TA, Davis JL, Morgan SC, Goldstein SC, Vardhanabhuti S, Mitra N, Vozniak JM. A retrospective analysis of the effect of patient-specific factors on voriconazole concentrations in oncology patients.J Oncol Pharm Pract. 2012;18(1):3-9.

Lowery JB, Donihi AC, Korytkowski MT. U-500 insulin as a component of basal bolus insulin therapy in type 2 diabetes. Diabetes Technol Ther. 2012;14(6):505-7.

Lupu AM, Stewart AL, O'Neil C. Comparison of active-learning strategies for motivational interviewing skills, knowledge, and confidence in first-year pharmacy students. Am J Pharm Educ. 2012;76(2):28.

Lyman GH, Barron RL, Natoli JL, Miller RM. Systematic review of efficacy of dose-dense versus non-dose-dense chemotherapy in breast cancer, non-Hodgkin lymphoma, and non-small cell lung cancer. Crit Rev Oncol Hematol. 2012;81(3):296-308.

Mack DM, Kim JJ.  Pharmacokinetic and Clinical Implications of Dabigatran Use in Severe Renal Impairment for Stroke Prevention in Non-Valvular Atrial Fibrillation.  The Annals of Pharmacotherapy.  2012;46:1105-10. 

Magaji V, Nayak S, Donihi AC, et al. Comparison of insulin infusion protocols targeting 110-140 mg/dL in patients after cardiac surgery. Diabetes Technol Ther. 2012;14(11):1013-7.

Marchaim D, Chopra T, Bhargava A, Bogan C, Dhar S, Hayakawa K, Pogue JM, et al. Recent exposure to antimicrobials and carbapenem-resistant Enterobacteriaceae: the role of antimicrobial stewardship. Infect Control Hosp Epidemiol. 2012;33(8):817-30.

Marchaim D, Chopra T, Bogan C, Bheemreddy S, Sengstock D, Jagarlamudi R, Malani A, Lemanek L, Moshos J, Lephart PR, Ku K, Hasan A, Lee J, Khandker N, Blunden C, Geffert SF, Moody M, Hiro R, Wang Y, Ahmad F, Mohammadi T, Faruque O, Patel D, Pogue JM, et al. The burden of multidrug-resistant organisms on tertiary hospitals posed by patients with recent stays in long-term acute care facilities. Am J Infect Control. 2012;40(8):760-5.

Marchaim D, Perez F, Lee J, Bheemreddy S, Hujer AM, Rudin S, Hayakawa K, Lephart PR, Blunden C, Shango M, Campbell ML, Varkey J, Manickam P, Patel D, Pogue JM, et al. "Swimming in resistance": Co-colonization with carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii or Pseudomonas aeruginosa. Am J Infect Control. 2012;40(9):830-5.

Marchaim D, Taylor AR, Hayakawa K, Bheemreddy S, Sunkara B, Moshos J, Chopra T, Abreu-Lanfranco O, Martin ET, Pogue JM, et al. Hospital bath basins are frequently contaminated with multidrug-resistant human pathogens. Am J Infect Control. 2012;40(6):562-4.

Mark SM, McMillen K, Davis SJ. Hidden costs of pharmacy technology. Hosp Pharm. 2012;47(8):653-660.

Martello JL, Woytowish MR, Chambers H. Ecallantide for treatment of acute attacks of hereditary angioedema. Am J Health Syst Pharm. 2012 Apr 15;69(8):651-7.

Martin ET, Tansek R, Collins V, Hayakawa K, Abreu-Lanfranco O, Chopra T, Lephart PR, Pogue JM, et al. The carbapenem-resistant Enterobacteriaceae score: A bedside score to rule out infection with carbapenem-resistant Enterobacteriaceae among hospitalized patients. Am J Infect Control. 2012 Aug 30. [Epub ahead of print]

McComsey GA, Kitch D, Daar ES, Tierney C, Jahed NC, Melbourne K, Ha B, Brown TT, Bloom A, Fedarko N, Sax PE. Inflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavir. AIDS. 2012;26(11):1371-85.

Mebel E, Davlin M. Managing the logistics of transitioning between PGY1 and PGY2 pharmacy residencies. Am J Health Syst Pharm. 2012;69(5):374-5.

Mehta U, Clerk C, Allen E, et al. Protocol for a drugs exposure pregnancy registry for implementation in resource-limited settings. BMC Pregnancy Childbirth. 2012;12(1):89.

Michels SL, Barron RL, Reynolds MW, et al. Costs associated with febrile neutropenia in the US. Pharmacoeconomics. 2012;30(9):809-23

Mitsani D, Nguyen MH, Shields RK, et al. Prospective, observational study of voriconazole therapeutic drug monitoring among lung transplant recipients receiving prophylaxis: factors impacting levels of and associations between serum troughs, efficacy, and toxicity. Antimicrob Agents Chemother. 2012;56(5):2371-7.

Monroe PS, Heck WD, Lavsa SM. Changes to medication-use processes after overdose of U-500 regular insulin. Am J Health Syst Pharm. 2012;69(23):2089-93.

Momper JD, Zhao Y, Shapiro R, Schonder KS, et al. Pharmacokinetics of low-dose cidofovir in kidney transplant recipients with BK virus infection. Transpl Infect Dis. 2012 Oct 2. [Epub ahead of print]

Neofytos D, Lombardi LR, Shields RK, et al. Administration of voriconazole in patients with renal dysfunction. Clin Infect Dis. 2012;54(7):913-21.

Newton M, Martello JL. Surviving in a cofunded faculty appointment. Am J Health Syst Pharm. 2012;69: 102-104.

O'Connor SK, Ferreri SP, Michaels NM, Greco AJ, et al. Exploratory planning and implementation of a pilot pharmacogenetic program in a community pharmacy. Pharmacogenomics. 2012;13(8):955-62.

Osborne M, Snyder M, Hall D, et al.  Evaluating Pennsylvania Pharmacists' Provision of Community-based Patient Care Services to Develop a Statewide Practice Network.  INNOVATIONS in Pharmacy.  2011; 2(4): Article 61.

Pikoulas TE, Fuller MA. Dalfampridine: a medication to improve walking in patients with multiple sclerosis. Ann Pharmacother. 2012;46(7-8):1010-5.

Pincus KJ, Tata AL, Watson K. Risk of venous thromboembolism in patients with chronic liver disease and the utility of venous thromboembolism prophylaxis. Ann Pharmacother. 2012;46(6):873-8.

Polischuk E, Vetterly CG, Crowley KL, et al. Implementation of a standardized process for ordering and dispensing of high-alert emergency medication infusions. J Pediatr Pharmacol Ther. 2012;17(2):166-72.

Raina A, Horn ET, Benza RL. The pathophysiology of endothelin in complications after solid organ transplantation: a potential novel therapeutic role for endothelin receptor antagonists. Transplantation. 2012 Oct 3. [Epub ahead of print]

Sax PE, DeJesus E, Mills A, Zolopa A, Cohen C, Wohl D, Gallant JE, Liu HC, Zhong L, Yale K, White K, Kearney BP, Szwarcberg J, Quirk E, Cheng AK; GS-US-236-0102 study team. Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomized, double-blind, phase 3 trial, analysis of results after 48 weeks. Lancet. 2012;379(9835):2439-48. Erratum in: Lancet. 2012 Aug 25;380(9843):730.

Seybert AL, Smithburger PL, Kobulinsky LR, Kane-Gill SL. Simulation-based learning versus problem-based learning in an acute care pharmacotherapy course. Simul Healthc. 2012;7(3):162-5.

Shah S, Sarwar U, King EA, Lat A. Chryseobacterium indologenes subcutaneous port-related bacteremia in a liver transplant patient. Transpl Infect Dis. 2012;14(4):398-402.

Shields RK, Clancy CJ, Gillis LM, et al. Epidemiology, clinical characteristics and outcomes of extensively drug-resistant Acinetobacter baumannii infections among solid organ transplant recipients. PLoS One. 2012;7(12):e52349.

Shields RK, Clancy CJ, Minces LR, et al. Staphylococcus aureus infections in the early period after lung transplantation: Epidemiology, risk factors, and outcomes. J Heart Lung Transplant. 2012;31(11):1199-206.

Shields RK, Nguyen MH, Press EG, et al. The presence of an FKS mutation rather than MIC is an independent risk factor for failure of echinocandin therapy among patients with invasive candidiasis due to Candida glabrata. Antimicrob Agents Chemother. 2012;56(9):4862-9.

Shields RK, Nguyen MH, Shullo MA, et al. Invasive aspergillosis among heart transplant recipients is rare but causes rapid death due to septic shock and multiple organ dysfunction syndrome. Scand J Infect Dis. 2012 Jul 25. [Epub ahead of print]

Shill J, Taylor DM, Ngui B, Taylor SE, et al. Factors associated with high levels of patient satisfaction with pain management. Acad Emerg Med. 2012;19(10):1212-1215.

Singh-Franco D, Elrod S, Harrington C, McLaughlin-Middlekauff J. Response letter. Diabetes Obes Metab. 2012;14(11):1056-7.

Singh-Franco D, McLaughlin-Middlekauff J, Elrod S, Harrington C. The effect of linagliptin on glycaemic control and tolerability in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetes Obes Metab. 2012;14(8):694-708.

Smithburger PL, Kane-Gill SL, Ruby CM, Seybert AL. Comparing effectiveness of 3 learning strategies: simulation-based learning, problem-based learning, and standardized patients. Simul Healthc. 2012;7(3):141-6.

Smithburger PL, Kane-Gill SL, Seybert AL. Drug-drug interactions in the medical intensive care unit: an assessment of frequency, severity and the medications involved. Int J Pharm Pract. 2012;20(6):402-8.

Starner CI, Fenrick B, Coleman J, Wickersham P, Gleason PP. Rosiglitazone prior authorization safety policy: a cohort study. J Manag Care Pharm. 2012;18(3):225-33.

Thompson J. Interprofessional education: thoughts of a current pharmacy resident. Am J Pharm Educ. 2012;76(8):161.

Tungol A, Starner CI, Gunderson BW, Schafer JA, Qiu Y, Gleason PP. Generic drug discount programs: are prescriptions being submitted for pharmacy benefit adjudication? J Manag Care Pharm. 2012;18(9):690-700.

Tulman DB, Tripathi RS, Abel EE, Papadimos TJ. Cardiac cachexia and the aged: death by water, wind, Earth, and fire. J Am Geriatr Soc. 2012;60(10):1999-2000.

Wanek MR, Horn ET, Elapavaluru S, et al. Safe use of hemodialysis for dabigatran removal before cardiac surgery. Ann Pharmacother. 2012;46(9):e21.

Wisniewski CS, Robert S. Strategies for transitioning therapy to aripiprazole from other antipsychotics in schizophrenia. Ann Pharmacother. 2012;46(7-8):1097-104.

Yost SE, Kaplan B. Comparing kidney transplant outcomes; caveats and lessons. Nephrol Dial Transplant. 2012 Sep 17. [Epub ahead of print]

Zillich AJ, Jaynes HA, Snyder ME, et al. Evaluation of specialized medication packaging combined with medication therapy management: adherence, outcomes, and costs among Medicaid patients. Med Care. 2012;50(6):485-93.

Abu-Ramaileh AM, Shane R, Churchill W, Steffenhagen A et al. Evaluating and classifying pharmacists' quality interventions in the emergency department. Am J Health Syst Pharm. 2011;68(23):2271-5.

Benedict N, Schonder K. Patient simulation software to augment an advanced pharmaceutics course. Am J Pharm Educ. 2011;75(2):21.

Bhama JK, Pilewski JM, Zaldonis D, Fontes PA, DeVera ME, Shullo MA et al. Does simultaneous lung-liver transplantation provide an immunologic advantage compared with isolated lung transplantation? J Thorac Cardiovasc Surg. 2011;141(5):e36-8.

Blommel ML, Blommel AL. Dabigatran etexilate: A novel oral direct thrombin inhibitor. Am J Health Syst Pharm. 2011;68(16):1506-19.

Bragg SW. Positive educational impact of mandatory student teaching sessions. Am J Pharm Educ.

Brown M, Polisetty R, Gracely EJ, Cuhaci B, Schlecht HP. Weight-based loading of vancomycin in patients on hemodialysis. Clin Infect Dis. 2011;53(2):164-6.

Byrne R, Yost SE, Kaplan B. Mycophenolate mofetil monitoring: is there evidence that it can improve outcomes? Clin Pharmacol Ther. 2011 Aug;90(2):204-6.

Cohen C, Elion R, Ruane P, Shamblaw D, DeJesus E, Rashbaum B, Chuck SL, Yale K, Liu HC, Warren DR, Ramanathan S, Kearney BP. Randomized, phase 2 evaluation of two single-tablet regimens elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate for the initial treatment of HIV infection. AIDS. 2011;25(6):F7-12.

Coons JC, McGraw M, Murali S. Pharmacotherapy for acute heart failure syndromes. Am J Health Syst Pharm. 2011;68(1):21-35.

Crowther DM, Buck ML, McCarthy MW, Barton VW. Improving pediatric adverse drug event reporting through clinical pharmacy services. J Pediatr Pharmacol Ther. 2011;16(4):285-90.

Curtin LB, Finn LA, Czosnowski QA, et al. Computer-based simulation training to improve learning outcomes in mannequin-based simulation exercises. Am J Pharm Educ. 2011;75(6):113.

Davis SJ. Proposal for pharmacy residency leadership certificates. Am J Health Syst Pharm. 2011;68(18):1693-4.

DeRemer CE, Fleming VH, Brown S, May JR. Evaluation of pain management documentation. South Med J. 2011;104(9):629-33.

DeRemer CE, Gujral JS, Thornton JW, Sorrentino RA. Dabigatran falsely elevates point of care international normalized ratio results. Am J Med. 2011;124(9):e5-6.

Devabhakthuni S, Pajoumand M, Williams C, Kufera JA, Watson K, Stein DM. Evaluation of Dexmedetomidine: Safety and Clinical Outcomes in Critically Ill Trauma Patients. J Trauma. 2011;71(5):1164-1171.

Devabhakthuni S, Seybert AL. Oral antiplatelet therapy for the management of acute coronary syndromes: defining the role of prasugrel. Crit Care Nurse. 2011;31(1):51-63. Epub 2010 Jun 30.

DiNardo M, Donihi AC, Forte P, Gieraltowski L, Korytkowski M. Standardized glycemic management and perioperative glycemic outcomes in patients with diabetes mellitus who undergo same-day surgery. Endocr Pract. 2011;17(3):404-11.

Donihi AC, Gibson JM, Noschese ML et al. Effect of a targeted glycemic management program on provider response to inpatient hyperglycemia. Endocr Pract. 2011;17(4):552-7.

Elion R, Cohen C, Gathe J, Shalit P, Hawkins T, Liu HC, Mathias AA, Chuck SL, Kearney BP, Warren DR; GS-US-216-0105 Study Team. Phase 2 study of cobicistat versus ritonavir each with once-daily atazanavir and fixed-dose emtricitabine/tenofovir df in the initial treatment of HIV infection. AIDS. 2011;25(15):1881-6.

Ensor CR, Trofe-Clark J, Gabardi S, McDevitt-Potter LM, Shullo MA. Generic maintenance immunosuppression in solid organ transplant recipients. Pharmacotherapy. 2011;31(11):1111-29.

Falcione BA, Joyner PU, Blouin RA et al. New directions in pharmacy education. J Am Pharm Assoc (2003). 2011;51(6):678-82.

Ference JD. STEPS approach allows patient to participate in decision making. Am Fam Physician. 2011;83(1):8.

Firstenberg MS, Abel E, Blais D et al. Temporary extracorporeal circulatory support and pulmonary embolectomy for catastrophic amniotic fluid embolism. Heart Surg Forum. 2011;14(3):E157-9.

Firstenberg MS, Abel EE, Papadimos TJ, Tripathi RS. Nonconvective forces: a critical and often ignored component in the echocardiographic assessment of transvalvular pressure gradients. Cardiol Res Pract. 2012;2012:383217.

Firstenberg MS, Blais D, Abel E, Go MR. Superior vena cava bypass with cryopreserved ascending aorta allograft. Ann Thorac Surg. 2011;91(3):905-7.

Garwood CL, Gortney JS, Corbett TL. Is there a role for fondaparinux in perioperative bridging? Am J Health Syst Pharm. 2011;68(1):36-42.

Gokhman R, Seybert AL, Phrampus P, Darby J, Kane-Gill SL. Medication errors during medical emergencies in a large, tertiary care, academic medical center. Resuscitation. 2011 Oct 14. [Epub ahead of print]

Griffiths RI, Barron RL, Gleeson ML et al. Granulocyte-Colony Stimulating Factor Use and Medical Costs after Initial Adjuvant Chemotherapy in Older Patients with Early-Stage Breast Cancer. Pharmacoeconomics. 2011 Oct 3. [Epub ahead of print]

Guglielmo BJ, Edwards DJ, Franks AS, Naughton CA, Schonder KS,  et al. A critical appraisal of and recommendations for faculty development. Am J Pharm Educ. 2011;75(6):122.

Hanigan MH, Dela Cruz BL, Shord SS et al. Optimizing chemotherapy: concomitant medication lists. Clin Pharmacol Ther. 2011;89(1):114-9. Epub 2010 Dec 1.

Hardesty JS, Juang P. Fidaxomicin: a macrocyclic antibiotic for the treatment of Clostridium difficile infection. Pharmacotherapy. 2011;31(9):877-86.

Hayakawa K, Marchaim D, Vidaillac C, Lephart P, Pogue JM et al. Growing prevalence of vancomycin-resistant Enterococcus faecalis in the region with the highest prevalence of vancomycin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol. 2011 Sep;32(9):922-4.

Innis CJ, Ceresia ML, Merigo C, Scott Weber E 3rd, Papich MG. Single-dose pharmacokinetics of ceftazidime and fluconazole during concurrent clinical use in cold-stunned Kemp's ridley turtles (Lepidochelys kempii). J Vet Pharmacol Ther. 2011. [Epub ahead of print]

Jao K, McD Taylor D, Taylor SE, Khan M, Chae J. Simple clinical targets associated with a high level of patient satisfaction with their pain management. Emerg Med Australas. 2011;23(2):195-201.

Kane-Gill SL, Smithburger PL. Transitioning knowledge gained from simulation to pharmacy practice. Am J Pharm Educ. 2011;75(10):210.

Khandhar SJ, Shah HV, Shullo MA et al. Long-term effects on renal function of dose-reduced calcineurin inhibitor and sirolimus in cardiac transplant patients. Clin Transplant. 2011. [Epub ahead of print]

Knapp E, Watson K. Medication management of atrial fibrillation: emerging therapies for rhythm control and stroke prevention. P T. 2011;36(8):518-28.

Kozminski M, Busby R, McGivney MS et al. Pharmacist integration into the medical home: qualitative analysis. J Am Pharm Assoc (2003). 2011;51(2):173-83.

Kullar R, Leonard SN, Davis SL, Delgado G Jr, Pogue JM, Wahby KA, Falcione B, Rybak MJ. Validation of the effectiveness of a vancomycin nomogram in achieving target trough concentrations of 15-20 mg/L suggested by the vancomycin consensus guidelines. Pharmacotherapy. 2011;31(5):441-8.

Kullar R, Leonard SN, Davis SL, Delgado G Jr, Pogue JM, Wahby KA, Falcione B, Rybak MJ. Validation of the effectiveness of a vancomycin nomogram in achieving target trough concentrations of 15-20 mg/L suggested by the vancomycin consensus guidelines. Pharmacotherapy. 2011;31(5):441-8.

Last AR, Ference JD, Falleroni J. Pharmacologic treatment of hyperlipidemia. Am Fam Physician. 2011;84(5):551-8.

Lat A, Clock SA, Wu F, Whittier S, Della-Latta P, Fauntleroy K, Jenkins SG, Saiman L, Kubin CJ. Comparison of polymyxin B, tigecycline, cefepime, and meropenem MICs for KPC-producing Klebsiella pneumoniae by broth microdilution, Vitek 2, and Etest. J Clin Microbiol. 2011;49(5):1795-8. Epub 2011 Mar 2.

Lat A, Thompson GR 3rd. Update on the optimal use of voriconazole for invasive fungal infections. Infect Drug Resist. 2011;4:43-53. Epub 2011 Feb 3.

Lauffenburger JC, Jonkman LJ, Lange CE, Connor SE, Sibale C. A public-health approach to site-specific formulary management: addressing deficient drug supplies in Malawi.Int J Pharm Pract. 2011 Jun;19(3):201-5. Epub 2011 Apr 11.

Lavsa SM, Corman SL, Culley CM, Pummer TL.  Reliability of Wikipedia as a medication information source for pharmacy students.  Currents in Pharmacy Teaching & Learning 2011;3:154-8.

Lavsa SM, Holzworth A, Ansani NT. Selection of a validated scale for measuring medication adherence. J Am Pharm Assoc (2003). 2011;51(1):90-4.

Little J, Davis S, Goff J, Mulvanity M, Mark SM. Director's Forum-Developing Patient-Centered Services, Part 4: Considerations in implementing a pediatric pharmacy practice model. Hosp Pharm. 2011;46(4):291-296.

Luong ML, Clancy CJ, Vadnerkar A, Kwak EJ, Silveira FP, Wissel MC, Grantham KJ, Shields RK, et al. Comparison of an Aspergillus real-time polymerase chain reaction assay with galactomannan testing of bronchoalvelolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in lung transplant recipients. Clin Infect Dis. 2011;52(10):1218-26.

Lyman GH, Barron RL, Natoli JL, Miller RM. Systematic review of efficacy of dose-dense versus non-dose-dense chemotherapy in breast cancer, non-Hodgkin lymphoma, and non-small cell lung cancer. Crit Rev Oncol Hematol. 2011 May 31. [Epub ahead of print]

Marchaim D, Chopra T, Perez F, Hayakawa K, Lephart PR, Bheemreddy S, Blunden C, Hujer AM, Rudin S, Shango M, Campbell M, Varkey J, Slim J, Ahmad F, Patel D, Chen TY, Pogue JM, et al. Outcomes and genetic relatedness of carbapenem-resistant enterobacteriaceae at Detroit Medical Center. Infect Control Hosp Epidemiol. 2011;32(9):861-71.

Marchaim D, Chopra T, Pogue JM et al. Outbreak of colistin-resistant, carbapenem-resistant Klebsiella pneumoniae in metropolitan Detroit, Michigan. Antimicrob Agents Chemother. 2011;55(2):593-9. Epub 2010 Nov 29.

McCarthy MW. Valuing your medical practice--Part 2: Understanding the components used to determine a fair and marketable price. Md Med. 2011;12(1):23-4, 33.

McComsey GA, Kitch D, Sax PE, Tebas P, Tierney C, Jahed NC, Myers L, Melbourne K, Ha B, and Daar ES.   Peripheral and Central Fat Changes in Subjects Randomized to Abacavir-Lamivudine or Tenofovir-Emtricitabine With Atazanavir-Ritonavir or Efavirenz: ACTG Study A5224s. Clinical Infectious Diseases 2011;53(2):185–196.

McComsey GA, Kitch D, Daar ES , Tierney C , Jahed NC, Tebas P, Myers L, Melbourne K, Ha B, and Sax PE Bone Mineral Density and Fractures in Antiretroviral-Naive Persons Randomized to Receive Abacavir-Lamivudine or Tenofovir Disoproxil Fumarate-Emtricitabine Along With Efavirenz or Atazanavir-Ritonavir: AIDS Clinical Trials Group A5224s, a Substudy of ACTG A5202. The Journal of Infectious Diseases 2011;203:1791–801.

McGivney MS, Hall DL, Stoehr GP, Donegan TE. An introductory pharmacy practice experience providing pharmaceutical care to elderly patients. Am J Pharm Educ. 2011;75(8):159.

Momper JD, Ridenour TA, Schonder KS, Shapiro R, Humar A, Venkataramanan R. The impact of conversion from prograf to generic tacrolimus in liver and kidney transplant recipients with stable graft function. Am J Transplant. 2011;11(9):1861-7. Epub 2011 Jun 30.

Nyman HA, Dowling TC, Hudson JQ, Peter WL, Joy MS, Nolin TD. Comparative Evaluation of the Cockcroft-Gault Equation and the Modification of Diet in Renal Disease (MDRD) Study Equation for Drug Dosing: An Opinion of the Nephrology Practice and Research Network of the American College of Clinical Pharmacy. Pharmacotherapy. 2011;31(11):1130-44.

Okusanya OO, Tsuji BT, Bülitta JB, Forrest A, Bulik CC, Bhavnani SM, Fernandes P, Ambrose PG. Evaluation of the pharmacokinetics-pharmacodynamics of fusidic acid against Staphylococcus aureus and Streptococcus pyogenes using in vitro infection models: implications for dose selection. Diagn Microbiol Infect Dis. 2011 May;70(1):101-11.

Oyelami-Adeleye I, Abate MA, Blommel ML. Pharmacy patrons 'awareness of pharmacists' education and routine patient care responsibilities. J Pharm Pharm Sci. 2011;14(3):306-14.

Phan SV, Kreys TJ. Adjunct mirtazapine for negative symptoms of schizophrenia. Pharmacotherapy. 2011;31(10):1017-30.

Pogue JM, Alaniz C, Carver PL et al. Role of unit-specific combination antibiograms for improving the selection of appropriate empiric therapy for gram-negative pneumonia. Infect Control Hosp Epidemiol. 2011;32(3):289-92.

Pogue JM, Lee J, Marchaim D, Yee V, Zhao JJ, Chopra T, Lephart P, Kaye KS. Incidence of and risk factors for colistin-associated nephrotoxicity in a large academic health system. Clin Infect Dis. 2011;53(9):879-84. Epub 2011 Sep 7.

Pogue JM, Marchaim D, Kaye D, Kaye KS. Revisiting "older" antimicrobials in the era of multidrug resistance. Pharmacotherapy. 2011;31(9):912-21.

Ramanathan S, Mathias AA, German P, Kearney BP. Clinical pharmacokinetic and pharmacodynamic profile of the HIV integrase inhibitor elvitegravir. Clin Pharmacokinet. 2011;50(4):229-44.

Rivkin A, Gim S. Rifaximin: new therapeutic indication and future directions. Clin Ther. 2011;33(7):812-27. Epub 2011 Jul 7.

Rodis JL, Schommer JC, Maguire MA. Building capacity for pharmacist-provided patient care services. J Am Pharm Assoc (2003). 2011;51(1):10-4.

Saely S, Kaye KS, Fairfax MR, Chopra T, Pogue JM. Investigating the impact of the definition of previous antibiotic exposure related to isolation of extended spectrum β-lactamase-producing Klebsiella pneumoniae. Am J Infect Control. 2011;39(5):390-5. Epub 2011 Jan 21.

Schonder KS. Pharmacology of immunosuppressive medications in solid organ transplantation. Crit Care Nurs Clin North Am. 2011;23(3):405-23. Epub 2011 Aug 11.

Schwartz JL, Rountree W, Kashuba AD, Brache V, Creinin MD, Poindexter A, Kearney BP. A multi-compartment, single and multiple dose pharmacokinetic study of the vaginal candidate microbicide 1% tenofovir gel. PLoS One. 2011;6(10):e25974. Epub 2011 Oct 19.

Shields RK, Clancy CJ, Vadnerkar A et al. Posaconazole serum concentrations among cardiothoracic transplant recipients: factors impacting trough levels and correlation with clinical response to therapy. Antimicrob Agents Chemother. 2011;55(3):1308-11. Epub 2010 Dec 28.

Shields RK, Kwak EJ, Potoski BA et al. High mortality rates among solid organ transplant recipients infected with extensively drug-resistant Acinetobacter baumannii: using in vitro antibiotic combination testing to identify the combination of a carbapenem and colistin as an effective treatment regimen. Diagn Microbiol Infect Dis. 2011;70(2):246-52. Epub 2011 Feb 25.

Shields RK, Nguyen MH, Du C et al. Paradoxical effect of caspofungin against Candida bloodstream isolates is mediated by multiple pathways but eliminated in human serum. Antimicrob Agents Chemother. 2011;55(6):2641-7. Epub 2011 Mar 21.

Shields RK, Nguyen MH, Press EG, Clancy CJ. Five-minute exposure to caspofungin results in prolonged postantifungal effects and eliminates the paradoxical growth of Candida albicans. Antimicrob Agents Chemother. 2011;55(7):3598-602. Epub 2011 May 2.

Smithburger PL, Buckley MS, Bejian S et al. A critical evaluation of clinical decision support for the detection of drug-drug interactions. Expert Opin Drug Saf. 2011;10(6):871-82. Epub 2011 May 4.

Tan H, Tomic K, Hurley D, Daniel G, Barron R, Malin J. Comparative effectiveness of colony-stimulating factors for febrile neutropenia: a retrospective study. Current Medical Research & Opinion 2011;27:79-86.

Tran T, Elliott RA, Taylor SE, Woodward MC. A Self-Administration of Medications Program to Identify and Address Potential Barriers to Adherence in Elderly Patients (January). Ann Pharmacother. 2011 Jan 12. [Epub ahead of print]

Tsuji BT, Okusanya OO, Bulitta JB, Forrest A, Bhavnani SM, Fernandez PB, Ambrose PG. Application of pharmacokinetic-pharmacodynamic modeling and the justification of a novel fusidic acid dosing regimen: raising Lazarus from the dead. Clin Infect Dis. 2011 Jun;52 Suppl 7:S513-9.

Weycker D, Malin J, Barron R, Edelsberg J, Kartashov A, Oster G. Comparative effectiveness of filgrastim, pegfilgrastim, and sargramostim as prophylaxis against hospitalization for neutropenic complications in patients with cancer receiving chemotherapy. American Journal of Clinical Oncology. Published online March 2, 2011.

Wombwell E, Murray C, Davis SJ et al. Leadership journal club. Am J Health Syst Pharm. 2011;68(21):2026-7.

Yee LL, Wright EA. Pitavastatin calcium: clinical review of a new antihyperlipidemic medication. Clin Ther. 2011 Aug;33(8):1023-42. Epub 2011 Aug 4.

Yost SE, Byrne R, Kaplan B. Transplantation: mTOR inhibition in kidney transplant recipients. Nat Rev Nephrol. 2011;7(10):553-5.

Yost SE, Srinivas T, Kaplan B. Ethical considerations regarding disparities pertaining to kidney transplant patients. Clin Pharmacol Ther. 2011;90(2):212-4.

Yost SE, Ranga KV, Kaplan B. Belatacept in renal transplantation. Dialysis and Transplant. 2011; 40: 33-36.

Yu JM, Shord SS, Cuellar S. Transfusions increase with nationally driven reimbursement changes of erythropoiesis stimulating agents for chemotherapy-induced anemia. J Oncol Pharm Pract. 2011;17(4):360-5.

Aspinall SL, Zhao X, Handler SM, Stone RA, Kosmoski JC, Libby EA, Francis SD, Goodman DA, Roman RD, et al. The quality of warfarin prescribing and monitoring in Veterans Affairs nursing homes. J Am Geriatr Soc. 2010;58:1475-1480.

Ballard SL, Wellborn-Kim JJ, Clauson KA. Effects of commercial energy drink consumption on athletic performance and body composition. Phys Sportsmed. 2010;38(1):107-17.

Benedict N. Virtual patients and problem-based learning in advanced therapeutics. Am J Pharm Educ. 2010;74(8):143.

Beri R, Chunduri S, Sweiss K, Peace DJ, Mactal-Haaf C, Dobogai LC, Shord S, et al. Reliability of a pretransplant i.v. BU test dose performed 2 weeks before myeloablative FluBu conditioning regimen. Bone Marrow Transplant. 2010;45(2):249-53.

Chan EW, Taylor SE, Marriott J, Barger B. An intervention to encourage ambulance paramedics to bring patients' own medications to the ED: impact on medications brought in and prescribing errors. Emerg Med Australas. 2010;22(2):151-8.

Coons JC, Plauger KM, Seybert AL, Sokos GG. Worsening heart failure in the setting of dronedarone initiation. Ann Pharmacother. 2010;44(9):1496-500.

Corman SL, Mohammad RA. Eltrombopag: a novel oral thrombopoietin receptor agonist. Ann Pharmacother. 2010;44(6):1072-9.

Costanzo MR, Costanzo MR, Dipchand A, Starling R, Anderson A, Chan M, Desai S, Fedson S, Fisher P, Gonzales-Stawinski G, Martinelli L, McGiffin D, Smith J, Taylor D, Meiser B, Webber S, Baran D, Carboni M, Dengler T, Feldman D, Frigerio M, Kfoury A, Kim D, Kobashigawa J, Shullo M, et al; International Society of Heart and Lung Transplantation Guidelines. The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. J Heart Lung Transplant. 2010;29(8):914-56.

D'Antonio N. Including motivational interviewing skills in the PharmD curriculum. Am J Pharm Educ. 2010;74(8):152d.

Devabhakthuni S, Seybert AL. Oral antiplatelet therapy for the management of acute coronary syndromes: defining the role of prasugrel. Crit Care Nurse. 2010 Jun 30 [published ahead of print]

Diehl JL, Daw JR, Coley KC, Rayburg R. Medical utilization associated with palivizumab compliance in a commercial and managed Medicaid health plan. J Manag Care Pharm. 2010;16(1):23-31.

Eisenhower C, Wilson SA. Comment: diabetes medications related to an increased risk of falls and fall-related morbidity in the elderly. Ann Pharmacother. 2010;44(12):2039; author reply 2039-40.

Felix-Getzik E, Kuvin J, Karas R. Non-optimal HDL-C Levels Are Highly Prevalent in Patients Presenting with ACS and Well-Controlled LDL-C Levels. J Clin Lipidology. 2010;4(4):265-271.

Firstenberg M, Abel E, Blais D, Andritsos M. Delayed malignant hyperthermia after routine coronary artery bypass. Ann Thorac Surg. 2010;89(3):947-8.

Firstenberg MS, Abel E, Blais D, Louis LB, Steinberg S, Sai-Sudhakar C, Martin S, Sun B. The use of extracorporeal membrane oxygenation in severe necrotizing soft tissue infections complicated by septic shock. Am Surg. 2010;76(11):1287-9.

Firstenberg MS, Blais D, Abel E, Newton HB, Crestanello J. Emergent pulmonary embolectomy and advanced glioblastoma multiforme. Case Report Med. 2010;2010:862028. Epub 2010 Dec 20.

Firstenberg MS, Blais D, Abel E et al. Fulminant Neisseria meningitidis: role for extracorporeal membrane oxygenation. Heart Surg Forum. 2010;13(6):E376-8.

Firstenberg MS, Hasan A, Abel E, et al. Aortic rupture in a heart transplant patient following recent blunt aortic trauma. J Card Surg. 2010;25(2):240-2.

Fisher CL, Wilson SA. Pharmacy students' exposure to a culture of safety and their communication of medication errors. Am J Pharm Educ. 2010;74(9):176a; author reply 176b.

Ford DG, Seybert AL, Smithburger PL, Kobulinsky LR, Samosky JT, Kane-Gill SL. Impact of simulation-based learning on medication error rates in critically ill patients. Intensive Care Med. 2010;36(9):1526-31.

German P, Warren D, West S, Hui J, Kearney BP. Pharmacokinetics and bioavailability of an integrase and novel pharmacoenhancer-containing single-tablet fixed-dose combination regimen for the treatment of HIV. J Acquir Immune Defic Syndr. 2010 Jul 30. [Epub ahead of print]

Gokhman R, Smithburger PL, Kane-Gill SL, Seybert AL. Pharmacologic and pharmacokinetic rationale for combination therapy in pulmonary arterial hypertension. J Cardiovasc Pharmacol. 2010 Sep 25. [Epub ahead of print]

Huang Y, Jiang B, Nuntanakorn P, Kennelly EJ, Shord S, Lawal TO, Mahady GB. Fukinolic acid derivatives and triterpene glycosides from black cohosh inhibit CYP isozymes, but are not cytotoxic to Hep-G2 cells in vitro. Curr Drug Saf. 2010;5(2):118-24.

Jain L, Abraham S, Shord SS. The interactions of anti-cancer drugs approved in the last decade in the United States with membrane transporters. Anticancer Agents Med Chem. 2010;10(8):601-16.

Joy MS, Boyette T, Hu Y, et al. Effects of uridine diphosphate glucuronosyltransferase 2B7 and 1A7 pharmacogenomics and patient clinical parameters on steady-state mycophenolic acid pharmacokinetics in glomerulonephritis. Eur J Clin Pharmacol. 2010 Jun 22. [Epub ahead of print]

Joy MS, Frye RF, Stubbert K, et al. Use of enantiomeric bupropion and hydroxybupropion to assess CYP2B6 activity in glomerular kidney diseases. J Clin Pharmacol. 2010;50(6):714-20.

Joy MS, Gipson DS, Powell L, et al. Phase 1 trial of adalimumab in focal segmental glomerulosclerosis (FSGS): II. Report of the FONT (Novel Therapies for Resistant FSGS) study group. Am J Kidney Dis. 2010;55(1):50-60

Lat A, Bhadelia N, Miko B, Furuya EY, Thompson GR 3rd. Invasive aspergillosis after pandemic (H1N1) 2009. Emerg Infect Dis. 2010;16(6):971-3.

Lavsa SM, Fabian TJ, Saul MI, Corman SL, Coley KC. Influence of medications and diagnoses on fall risk in psychiatric inpatients. Am J Health-Syst Pharm. 2010;67(15):1274-80.

Luong ML, Sareyyupoglu B, Nguyen MH, Silveira FP, Shields RK et al. Lactobacillus probiotic use in cardiothoracic transplant recipients: a link to invasive Lactobacillus infection? Transpl Infect Dis. 2010;12(6):561-4. Epub 2010 Oct 7.

Martello JL, Pummer TL, Krenzelok EP. Cost minimization analysis comparing enteral N-acetylcysteine to intravenous acetylcysteine in the management of acute acetaminophen toxicity. Clin Toxicol (Phila). 2010;48(1):79-83.

Mathias AA, German P, Murray BP, Wei L, Jain A, West S, Warren D, Hui J, Kearney BP. Pharmacokinetics and pharmacodynamics of GS-9350: a novel pharmacokinetic enhancer without anti-HIV activity. Clin Pharmacol Ther. 2010;87(3):322-9.

McGrath SH, Snyder ME, Dueñas GG, Pringle JL, Smith RB, McGivney MS. Physician perceptions of pharmacist-provided medication therapy management: qualitative analysis. J Am Pharm Assoc (2003). 2010;50(1):67-71.

Minces LR, Gallagher DS, Shields RK. Acute retinal necrosis in a monocular patient complicated by acyclovir-induced nephrotoxicity. J Clin Virol. 2010;49(1):1-3.

Minces LR, Shields RK, Sheridan K, et al. Peptostreptococcus infective endocarditis and bacteremia. Analysis of cases at a tertiary medical center and review of the literature. Anaerobe. 2010;16(4):327-30.

Momper JD, Zhang S, Randhawa PS, Shapiro R, Schonder KS, Venkataramanan R. Determination of cidofovir in human plasma after low dose drug administration using high-performance liquid chromatography-tandem mass spectrometry. J Pharm Biomed Anal. 2010;53(4):1015-21.

Papadopoulos J, Smithburger PL. Common drug interactions leading to adverse drug events in the intensive care unit: management and pharmacokinetic considerations. Crit Care Med. 2010 Jun;38(6 Suppl):S126-35.

Pittenger AL, Starner CI, Thompson K, Gleason PP. Pharmacy students' views of managed care pharmacy and PBMS: should there be more exposure to managed care in the pharmacy curriculum? J Manag Care Pharm. 2010;16(5):346-54.

Pogue JM, Potoski BA, Kaye KS. Aminoglycoside use in intensive care units and aminoglycoside nephrotoxicity. Antimicrob Agents Chemother. 2010;54(6):2750. [Letter]

Rager A, Frey N, Goldstein SC, Reshef R, Hexner EO, Loren A, Luger SM, Perl A, Tsai D, Davis J, Vozniak M, et al. Inflammatory cytokine inhibition with combination daclizumab and infliximab for steroid-refractory acute GVHD. Bone Marrow Transplant. 2010 May 24. [Epub ahead of print]

Ramanathan S, Abel S, Tweedy S, West S, Hui J, Kearney BP. Pharmacokinetic interaction of ritonavir-boosted elvitegravir and maraviroc. J Acquir Immune Defic Syndr. 2010;53(2):209-14.

Randhawa PS, Schonder K, Shapiro R, Farasati N, Huang Y. Polyomavirus BK neutralizing activity in human immunoglobulin preparations. Transplantation. 2010;89(12):1462-5.

Reddy T, Chopra T, Marchaim D, Pogue JM, et al. Trends in antimicrobial resistance of Acinetobacter baumannii isolates from a metropolitan Detroit health system. Antimicrob Agents Chemother. 2010;54(5):2235-8.

Rickman S, Taylor DM, Taylor SE. An intervention trial increases the evidence-based use of bupivacaine in hand injuries. Emerg Med J. 2010;27(1):17-21.

Rothschild JM, Churchill W, Erickson A, Munz K, Schuur JD, Salzberg CA, Lewinski D, Shane R, Aazami R, Patka J, Jaggers R, Steffenhagen A, Rough S, Bates DW. Medication errors recovered by emergency department pharmacists. Ann Emerg Med. 2010;55(6):513-21.

Russo-Alvarez G. Encouraging the development of emotional intelligence in pharmacy schools. Am J Pharm Educ. 2010;74(8):152e.

Sam WJ, Joy MS. Population pharmacokinetics of mycophenolic acid and metabolites in patients with glomerulonephritis. Ther Drug Monit. 2010;32(5):594-605.

Schafer JA, Kjesbo NK, Gleason PP. Dronedarone: current evidence and future questions. Cardiovasc Ther. 2010;28(1):38-47.

Schafer JA, Kjesbo NK, Gleason PP. Formulary review of 2 new biologic agents: tocilizumab for rheumatoid arthritis and ustekinumab for plaque psoriasis. J Manag Care Pharm. 2010;16(6):402-16.

Schafer JA, Gunderson BW, Gleason PP. Price increases and new drugs drive increased expenditures for multiple sclerosis. J Manag Care Pharm. 2010;16(9):713-7.

Schonder KS, Corman SL, Hung WY. Early risk factors for persistent anemia after kidney transplantation. Pharmacotherapy. 2010;30(12):1214-20.

Schonder KS, Mazariegos GV, Weber RJ. Adverse effects of immunosuppression in pediatric solid organ transplantation. Paediatr Drugs. 2010;12(1):35-49.

Sheridan KR, Potoski BA, Shields RK, Nau GJ. Presence of adequate intravitreal concentrations of daptomycin after systemic intravenous administration in a patient with endogenous endophthalmitis. Pharmacotherapy. 2010;30(12):1247-51.

Shord SS, Chan LN, Camp JR, et al. Effects of oral clotrimazole troches on the pharmacokinetics of oral and intravenous midazolam. Br J Clin Pharmacol. 2010;69(2):160-6.

Shullo MA, Schonder K, Teuteberg JJ. Elevated tacrolimus levels associated with intravenous azithromycin and ceftriaxone: a case report. Transplant Proc. 2010;42(5):1870-2.

Smithburger PL, Kane-Gill SL, Benedict NJ, Falcione BA, Seybert AL. Grading the severity of drug-drug interactions in the intensive care unit: a comparison between clinician assessment and proprietary database severity rankings. Ann Pharmacother. 2010;44(11):1718-24.

Smithburger PL, Kane-Gill SL, Nestor BL, Seybert AL. Recent advances in the treatment of hypertensive emergencies. Crit Care Nurse. 2010;30(5):24-30.

Smithburger PL, Kane-Gill SL, Seybert AL. Drug-drug interactions in cardiac and cardiothoracic intensive care units: an analysis of patients in an academic medical centre in the US. Drug Saf. 2010;33(10):879-88.

Smithburger PL, Seybert AL, Armahizer MJ, Kane-Gill SL. QT prolongation in the intensive care unit: commonly used medications and the impact of drug-drug interactions. Expert Opin Drug Saf. 2010;9(5):699-712.

Stanton ML, Joy MS, Frye RF. Validation and application of a liquid chromatography-tandem mass spectrometric method for quantification of the drug transport probe fexofenadine in human plasma using 96-well filter plates. J Chromatogr B Analyt Technol Biomed Life Sci. 2010;878(3-4):497-501.

Summers KM, Martin KE, Watson K. Impact and clinical management of depression in patients with coronary artery disease. Pharmacotherapy. 2010;30(3):304-22.

Sun HY, Shields RK, Cacciarelli TV, Muder RR, Singh N.A novel combination regimen for the treatment of refractory bacteremia due to multidrug-resistant Pseudomonas aeruginosa in a liver transplant recipient. Transpl Infect Dis. 2010 Jul 6. [Epub ahead of print]

Teuteberg JJ, Shullo MA, Zomak R, et al. Alemtuzumab induction prior to cardiac transplantation with lower intensity maintenance immunosuppression: one-year outcomes. Am J Transplant. 2010;10(2):382-8.

Thomas L, Culley EJ, Gladowski P, Goff V, Fong J, Marche SM. Longitudinal analysis of the costs associated with inpatient initiation and subsequent outpatient continuation of proton pump inhibitor therapy for stress ulcer prophylaxis in a large managed care organization. J Manag Care Pharm. 2010;16(2):122-9.

Weycker D, Barron RL. Comparison of hospitalization risk and associated costs among patients receiving sargramostim, filgrastim, and pegfilgrastim for chemotherapy-induced neutropenia. Cancer. 2010;116(12):3073. [letter]

Wisniewski CS. Rufinamide: a new antiepileptic medication for the treatment of seizures associated with lennox-gastaut syndrome. Ann Pharmacother. 2010;44(4):658-67.

Witsil JC, Aazami R, Murtaza UI, Hays DP, Fairbanks RJ. Strategies for implementing emergency department pharmacy services: results from the 2007 ASHP Patient Care Impact Program. Am J Health-Syst Pharm. 2010;67(5):375-9.

Yu JM, Shord SS, Cuellar S. Transfusions increase with nationally driven reimbursement changes of erythropoiesis stimulating agents for chemotherapy-induced anemia. J Oncol Pharm Pract. 2010 Sep 8. [Epub ahead of print]

Zolopa AR, Berger DS, Lampiris H, Zhong L, Chuck SL, Enejosa JV, Kearney BP, Cheng AK. Activity of elvitegravir, a once-daily integrase inhibitor, against resistant HIV Type 1: results of a phase 2, randomized, controlled, dose-ranging clinical trial. J Infect Dis. 2010;201(6):814-22.

American College of Clinical Pharmacy, Blair MM, Freitag RT, Keller DL, Kiser TH, Marrs JC, McGivney MS, Mohammad RA, Twedt EL; ACCP Certification Affairs Committee. Proposed revision to the existing specialty and specialist certification framework for pharmacy practitioners. Pharmacotherapy. 2009;29(4):3e-13e.

Bellamy CJ, Kane-Gill SL, Falcione BA, Seybert AL. Neuroleptic malignant syndrome in traumatic brain injury patients treated with haloperidol. J Trauma. 2009;66(3):954-8.

Campara M, Shord SS, Haaf CM. Single-dose rasburicase for tumour lysis syndrome in adults: weight-based approach. J Clin Pharm Ther. 2009;34(2):207-13.

Ceresia ML, Fasser CE, Rush JE et al. The role and education of the veterinary pharmacist. Am J Pharm Educ. 2009;73(1):16.

Chan EW, Taylor SE, Marriott JL, Barger B. Bringing patients' own medications into an emergency department by ambulance: effect on prescribing accuracy when these patients are admitted to hospital. Med J Aust. 2009;191(7):374-7.

Coons JC, Barnes M, Kusick K. Takotsubo cardiomyopathy. Am J Health Syst Pharm. 2009;66(6):562-6.

Desai D, Goldbach-Mansky R, Milner JD et al. Anaphylactic reaction to anakinra in a rheumatoid arthritis patient intolerant to multiple nonbiologic and biologic disease-modifying antirheumatic drugs. Ann Pharmacother. 2009;43:967-972.

Donihi AC, Weber RJ, Sirio CA, Mark SM, Meyer SM. An advanced pharmacy practice experience in inpatient medication education. Am J Pharm Educ. 2009;73(1):11.

Drusano GL, Okusanya OO, Okusanya AO et al. Impact of spore biology on the rate of kill and suppression of resistance in Bacillus anthracis. Antimicrob Agents Chemother. 2009 Aug 17. [Epub ahead of print]

Egorin MJ, Shah DD, Christner SM, Yerk MA, Komazec KA, Appleman LR, Redner RL, Miller BM, Beumer JH. Effect of a proton pump inhibitor on the pharmacokinetics of imatinib. Br J Clin Pharmacol. 2009;68(3):370-4.

Felix-Getzik E, Sylvia LM. Vancomycin-induced leukocytoclastic vasculitis. Pharmacotherapy. 2009;29(7):846-51.

Ference JD, Last AR. Choosing topical corticosteroids. Am Fam Physician. 2009;79(2):135-40.

Forsberg EA. Response to Trujillo's article on "A Drug Interactions Elective Course". Am J Pharm Educ. 2009;73(7):126. [Letter]

Freeman MK, Lauderdale SA,Kendrach MG, Woolley TW. Google scholar versus PubMed in locating primary literature to answer drug-related questions . Ann Pharmacother. 2009;43(3):478-484.

Garcia GM, Snyder ME, McGrath SH, Smith RB, McGivney MS. Generating demand for pharmacist-provided medication therapy management: identifying patient-preferred marketing strategies. J Am Pharm Assoc (2003). 2009;49(5):611-6.

Gleason PP, Starner CI, Gunderson BW et al. Association of prescription abandonment with cost share for high-cost specialty pharmacy medications. J Manag Care Pharm. 2009;15(8):648-58.

Gortney JS, Fagan A, Kissack JC. Neuroleptic malignant syndrome secondary to quetiapine. Ann Pharmacother. 2009;43(4):785-91.

Hall DL, Corman SL, Drab SR, Meyer SM, Smith RB. Instructor satisfaction with a technology-based resource for diabetes education. Am J Pharm Educ. 2009;73(3):45.

Hansen RA, Chin H, Blalock S, Joy MS. Predialysis chronic kidney disease: evaluation of quality of life in clinic patients receiving comprehensive anemia care. Res Social Adm Pharm. 2009;5(2):143-53.

Havrilla PL, Kane-Gill SL, Verrico MM, Seybert AL, Reis SE. Coronary vasospasm and atrial fibrillation associated with ondansetron therapy. Ann Pharmacother. 2009;43:532-536.

Hung WY, Kogelman L, Volpe G, Iafrati M, Davidson L. Tigecycline-induced acute pancreatitis: case report and literature review. Int J Antimicrob Agents. 2009;34:486-9.

Joy MS, Dornbrook-Lavender K, Blaisdell J et al. CYP2C9 genotype and pharmacodynamic responses to losartan in patients with primary and secondary kidney diseases. Eur J Clin Pharmacol. 2009;65(9):947-53.

Joy MS, Gipson DS, Dike M et al. Phase I trial of rosiglitazone in FSGS: I. Report of the FONT Study Group. Clin J Am Soc Nephrol. 2009;4(1):39-47.

Joy MS, Hilliard T, Hu Y et al. Influence of clinical and demographic variables on mycophenolic acid pharmacokinetics in antineutrophil cytoplasmic antibody-associated vasculitis. Ann Pharmacother. 2009;43(6):1020-7.

Joy MS, Hilliard T, Hu Y et al. Pharmacokinetics of mycophenolic acid in patients with lupus nephritis. Pharmacotherapy. 2009;29(1):7-16.

Kane-Gill SL, Bellamy CJ, Verrico MM, Handler SM, Weber RJ. Evaluating the positive predictive values of antidote signals to detect potential adverse drug reactions (ADRs) in the medical intensive care unit (ICU). Pharmacoepidemiol Drug Saf. 2009; 18:1185-1191.

Kearney BP, Mathias A. Lack of effect of tenofovir disoproxil fumarate on pharmacokinetics of hormonal contraceptives. Pharmacotherapy. 2009;29(8):924-9.

Kelley LR, Corman SL, Weber RJ. A pharmacy director’s primer on the American Recovery and Reinvestment Act of 2009. Hospital Pharmacy 2009;44:813-18.

Lauster CD, Gibson JM, DiNella JV, DiNardo M, Korytkowski MT, Donihi AC. Implementation of standardized instructions for insulin at hospital discharge. J Hosp Med. 2009;4(8):E41-2.

Lavsa SM, Corman SL, Verrico MM, Pummer TL. Effect of drug information request templates on pharmacy student compliance with the modified systematic approach to answering drug information questions. Ann Pharmacother. 2009;43(11):1795-801.

Lyman GH, Lalla A, Barron RL, Dubois RW. Cost-effectiveness of pegfilgrastim versus filgrastim primary prophylaxis in women with early-stage breast cancer receiving chemotherapy in the United States. Clin Ther. 2009;31(5):1092-104.

Mathias AA, West S, Hui J, Kearney BP. Dose-response of ritonavir on hepatic CYP3A activity and elvitegravir oral exposure. Clin Pharmacol Ther. 2009;85(1):64-70.

McHayleh W, Sehgal R, Redner RL, Raptis A, Agha M, Natale J, et al. Mitoxantrone and etoposide in patients with newly diagnosed acute myeloid leukemia with persistent leukemia after a course of therapy with cytarabine and idarubicin. Leuk Lymphoma. 2009;50(11):1848-53.

Momary KM, Shapiro NL, Brace LD, Shord SS, Grossi E, Viana MA, Helgason CM, Nutescu EA, Cavallari LH. Influence of cyclooxygenase-1 genotype on ex vivo aspirin response in patients at risk for stroke. Cerebrovasc Dis. 2009;27(6):585-93.

Naeger Murphy N, Pile JC. Clinical Indications for Newer Antifungal Agents. Journal of Hospital Medicine 2009;4:102-11.

Nathan JP, Gim S. Responding to drug information requests. Am J Health Syst Pharm. 2009;66 706-711.

Noschese ML, DiNardo MM, Donihi AC et al. Patient outcomes after implementation of a protocol for inpatient insulin pump therapy. Endocr Pract. 2009;15(5):415-24.

Okusanya OO, Bhavnani SM, Hammel J et al. Pharmacokinetic and pharmacodynamic evaluation of liposomal amikacin for inhalation in cystic fibrosis patients with chronic pseudomonal infection. Antimicrob Agents Chemother. 2009;53(9):3847-54.

Palkovic LB, Coley KC, Sokos DR. Factors associated with inappropriate inpatient prescribing of acid-suppressive therapy. International Journal of Pharmacy Practice 2009;17:73-75.

Patel GW, Patel N, Lat A et al. Outcomes of extended infusion piperacillin/tazobactam for documented Gram-negative infections. Diagn Microbiol Infect Dis. 2009;64(2):236-40.

Pogue JM, DePestel DD, Kaul DR et al. Systemic absorption of oral vancomycin in a peripheral blood stem cell transplant patient with severe graft-versus-host disease of the gastrointestinal tract. Transpl Infect Dis. 2009;11(5):467-70.

Reider J, Donihi A, Korytkowski MT. Practical implications of the revised guidelines for inpatient glycemic control. Pol Arch Med Wewn. 2009;119(12):801-9.

Sahi J, Shord SS, Lindley C, Ferguson S, LeCluyse EL. Regulation of cytochrome P450 2C9 expression in primary cultures of human hepatocytes. J Biochem Mol Toxicol. 2009;23(1):43-58.

Schafer JA, Kjesbo NK, Gleason PP. Critical review of prasugrel for formulary decision makers. J Manag Care Pharm. 2009;15(4):335-43.

Shields RK, Martello JL, Potoski BA. Is vancomycin ototoxicity a significant risk? Antimicrob Agents Chemother. 2009;53(10):4572.

Shord SS, Shah K, Lukose A. Drug--botanical interactions: a review of the laboratory, animal, and human data for 8 common botanicals. Integr Cancer Ther. 2009;8(3):208-27.

Shord SS, Patel SR. Paclitaxel alters the expression and specific activity of deoxycytidine kinase and cytidine deaminase in non-small cell lung cancer cell lines. J Exp Clin Cancer Res. 2009;28:76.

Shord SS, Bressler LR, Tierney LA, Cuellar S, George A. Understanding and managing the possible adverse effects associated with bevacizumab. Am J Health Syst Pharm. 2009;66(11):999-1013.

Shord SS, Cavallari LH, Gao W, Jeong HY, Deyo K, Patel SR, Camp JR, Labott SM, Molokie RE. The pharmacokinetics of codeine and its metabolites in Blacks with sickle cell disease. Eur J Clin Pharmacol. 2009;65(7):651-8.

Shrank WH, Gleason PP, Canning C, et al Can improved prescription medication labeling influence adherence to chronic medications? An evaluation of the target pharmacy label. J Gen Intern Med. 2009;24(5):570-8.

Shrank WH, Patrick A, Gleason PP et al. An evaluation of the relationship between the implementation of a newly designed prescription drug label at Target pharmacies and health outcomes. Med Care. 2009;47(9):1031-5.

Snyder ME, McGivney MS, Smith RB. Establishing a community practice research fellowship. Am J Pharm Educ. 2009;73(7):126.

Song X, Fowler R, Ruiz K, Hurley D, Barron RL. Impact of neutropenic complications on short-term disability in patients with cancer receiving chemotherapy. J Med Econ. 2009;12(2):154-63.

Starner CI, Norman SA, Reynolds RG, Gleason PP. Effect of a retrospective drug utilization review on potentially inappropriate prescribing in the elderly. Am J Geriatr Pharmacother. 2009;7(1):11-9.

Suhrie EM, Hanlon JT, Jaffe EJ et al. Impact of a geriatric nursing home palliative care service on unnecessary medication prescribing. Am J Geriatr Pharmacother. 2009;7(1):20-5.

Watson K, Summers KM. Depression in patients with heart failure: clinical implications and management. Pharmacotherapy. 2009;29(1):49-63.

Wisniewski CS, Pummer TL, Krenzelok EP. Documenting drug information questions using software for poison information documentation. Am J Health Syst Pharm. 2009;66 1039-1043.

Wong AK, Stephens SB, Aspinall MB, Visweswaran S, Hanlon JT, Handler SM. Assessing the quality of prescribing and monitoring erythropoiesis-stimulating agents in the nursing home setting. J Am Med Dir Assoc. 2009;10(6):436-9.

Yeoh BS, Taylor DM, Taylor SE. Education initiative improves the evidence-based use of metoclopramide following morphine administration in the emergency department. Emerg Med Australas. 2009;21(3):178-83.

Ambrose PG, Anon JB, Bhavnani SM, Okusanya OO, Jones RN, Paglia MR, Kahn J, Drusano GL. Use of pharmacodynamic endpoints for the evaluation of levofloxacin for the treatment of acute maxillary sinusitis. Diagn Microbiol Infect Dis. 2008;61(1):13-20.

Barkell M. Bleeding associated with warfarin use: improving outcomes. Arch Intern Med. 2008;168(2):236-7. Letter.

Bliden KP, DiChiara J, Lawal L, Singla A, Antonino MJ, Baker BA, Bailey WL, Tantry US, Gurbel PA. The Association of Cigarette Smoking With Enhanced Platelet Inhibition by Clopidogrel. J Am Coll Cardiol 2008;52:531-3.

Coons JC, Battistone S. 2007 guideline update for unstable angina/ non-ST-segment elevation myocardial infarction: focus on antiplatelet and anticoagulant therapies. Ann Pharmacother 2008;42:989-1001.

Dauner DG, Deremer CE, Haburchak D. Clozapine-induced pericardial effusion. J Clin Psychopharmacol. 2008;28(4):455-6. Letter.

DeRemer CE. Vanlandingham J. Carswell J. Killough D. Pharmacy Outreach Education Program in Local Community. [letter]. American Journal of Pharmaceutical Education 2008;72(4) Article 94:1.

Donihi AC, Yang E, Mark SM, Sirio CA, Weber RJ. Scheduling of pharmacist-provided medication education for hospitalized patients. Hosp Pharm. 2008;43:121-126.

Drusano GL, Okusanya OO, Okusanya A et al. Is 60 days of ciprofloxacin administration necessary for postexposure prophylaxis for Bacillus anthracis? Antimicrob Agents Chemother. 2008;52(11):3973-9.

Elion R, Cohen C, Ward D, Ruane P, Ortiz R, Reddy YS, Ebrahimi R, McColl D, Kearney B, Fisher A, Flaherty J. BATON Study Group. Evaluation of efficacy, safety, pharmacokinetics, and adherence in HIV-1-infected, antiretroviral-naive patients treated with ritonavir-boosted atazanavir plus fixed-dose tenofovir DF/emtricitabine given once daily. HIV Clin Trials. 2008;9(4):213-24.

Ference JD, Medina MS. Modifying a traditional course for the PharmD curriculum. Am J Pharm Educ. 2008;72(5):122.

Gilreath JA, Sageser DS, Jorgenson JA, Rodgers GM. Establishing an anemia clinic for optimal erythropoietic-stimulating agent use in hematology-oncology patients. J Natl Compr Canc Netw. 2008;6(6):577-84.

Harris IM, Baker E, Berry TM, Halloran MA, Lindauer K, Ragucci KR, McGivney MS, Taylor AT, Haines ST. Developing a business-practice model for pharmacy services in ambulatory settings. Pharmacotherapy. 2008;28(2):285.

Israeli RS, Ryan CW, Jung LL. Managing bone loss in men with locally advanced prostate cancer receiving androgen deprivation therapy. J Urol. 2008;179(2):414-23.

Johnson JL, McCarthy MW. Enteral administration of three proton-pump-inhibitor formulations. Am J Health-Syst Pharm. 2008;65(24):2324-5.

Jones KE, Puccio AM, Harshman KJ, Falcione B, Benedict N et al. Levetiracetam versus phenytoin for seizure prophylaxis in severe traumatic brain injury. Neurosurg Focus. 2008;25(4):E3.

Joy MS, Dornbrook-Lavender KA, Chin H et al. Effects of atorvastatin on Lp(a) and lipoprotein profiles in hemodialysis patients. Ann Pharmacother. 2008;42(1):9-15.

Lewis NJ, Bugdalski-Stutrud C, Abate MA, Blommel M, Wu CH, Gaither CA. The Medication Assessment Program: comprehensive medication assessments for persons taking multiple medications for chronic diseases. J Am Pharm Assoc. 2008;48(2):171-80.

Lionaki S, Hogan SL, Falk RJ, Joy MS, Jennette CE, Nachman PH, Jennette JC. Vasculitis and anti-thyroid medication. Nephrol Dial Transplant. 2008;23(5):1766-8. Letter.

Mathias AA, Hinkle J, Shen G, Enejosa J, Piliero PJ, Sekar V, Mack R, Tomaka F, Kearney BP. Effect of ritonavir-boosted tipranavir or darunavir on the steady-state pharmacokinetics of elvitegravir. J Acquir Immune Defic Syndr. 2008;49(2):156-62.

Mehta U, Durrheim DN, Blockman M, Kredo T, Gounden R, Barnes KI. Adverse drug reactions in adult medical inpatients in a South African hospital serving a community with a high HIV/AIDS prevalence: prospective observational study. Br J Clin Pharmacol. 2008;65(3):396-406.

Nkansah NT, Brewer JM, Connors R, Shermock KM. Clinical outcomes of patients with diabetes mellitus receiving medication management by pharmacists in an urban private physician practice. Am J Health-Syst Pharm. 2008;65(2):145-9.

Noschese M, Donihi AC, Koerbel G et al. Effect of a diabetes order set on glycaemic management and control in the hospital. Qual Saf Health Care. 2008;17(6):464-8.

Ramanathan S, Kakuda TN, Mack R, West S, Kearney BP. Pharmacokinetics of elvitegravir and etravirine following coadministration of ritonavir-boosted elvitegravir and etravirine. Antivir Ther. 2008;13(8):1011-7.

Rea RS, Capitano B, Bies R et al. Suboptimal aminoglycoside dosing in critically ill patients. Ther Drug Monit. 2008;30(6):674-81.

Refaat M, McNamara D, Teuteberg J, Kormos R, McCurry K, Shullo M, Toyoda Y, Bermudez C. Successful cidofovir treatment in an adult heart transplant recipient with severe adenovirus pneumonia. J Heart Lung Transplant. 2008;27(6):699-700. Letter.

Schwartz RN, Vozniak M. Current and emerging treatments for multiple myeloma. J Manag Care Pharm. 2008;14(7 Suppl):12-9.

Sevene E, Mariano A, Mehta U et al. Spontaneous adverse drug reaction reporting in rural districts of Mozambique. Drug Saf. 2008;31(10):867-76.

Shermock KM, Horn E, Rice TL. Erythropoietic agents for anemia of critical illness. Am J Health-Syst Pharm. 2008;65(6):540-6.

Shord SS, Bressler LR, Radhakrishnan L, Chen N, Villano JL. Evaluation of the Modified Diet in Renal Disease equation for calculation of carboplatin dose. Ann Pharmacother. 2009;43(2):235-41.

Shord SS, Cavallari LH, Viana MA, Momary K, Neceskas J, Molokie RE, Deyo K, Patel SR. HYPERLINK "http://preview.ncbi.nlm.nih.gov/pubmed/18793590?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=10" Cytochrome P450 2C9 mediated metabolism in people with and without cancer. Int J Clin Pharmacol Ther. 2008;46(7):365-74.

Shord SS, Chew L, Villano J. Evaluation of opioid induced nausea and vomiting in sickle cell disease. Am J Hematol. 2008;83(3):196-9.

Shord SS, Cuellar S. Chemotherapy-induced anemia at an urban academic medical center: iron studies and supplementation. J Am Pharm Assoc (2003). 2008;48(4):487-93.

Shord SS, Hamilton JM Jr, Cuellar S. Parenteral iron with erythropoiesis-stimulating agents for chemotherapy-induced anemia. J Oncol Pharm Pract. 2008;14(1):5-22.

Snyder CM, Helms BE, Hall DL. Evaluation of INR Monitoring Frequency and Time in Therapeutic Range. J Pharm Technol. 2008;24:255-60.

Starner C, Schafer S, Heaton AH, Gleason PP. Rosiglitazone and Pioglitazone Utilization from January 2007 Through May 2008 Associated with Five Risk-Warning Events. Journal of Managed Care Pharmacy2008;14(6):523-31.

Starner C, Gleason PP. Cholinesterase Inhibitor Utilization Patterns: Just Because It Can Be Counted Does Not Mean It Counts. Journal of Managed Care Pharmacy 2008;14(5):462-464.

Sweiss KI, Beri R, Shord SS. Encephalopathy after high-dose Ifosfamide: a retrospective cohort study and review of the literature. Drug Saf. 2008;31(11):989-96.

Tobia CC, Aspinall SL, Good CB, Fine MJ, Hanlon JT. Appropriateness of antibiotic prescribing in veterans with community-acquired pneumonia, sinusitis, or acute exacerbations of chronic bronchitis: a cross-sectional study. Clin Therap. 2008;30(6):1135-44.

Tomlinson D, Isitt JJ, Barron RL et al. Determining the understandability and acceptability of an oral mucositis daily questionnaire. J Pediatr Oncol Nurs. 2008;25(2):107-11

Van Rompay KK, Durand-Gasselin L, Brignolo LL, Ray AS, Abel K, Cihlar T, Spinner A, Jerome C, Moore J, Kearney BP, Marthas ML, Reiser H, Bischofberger N. Chronic administration of tenofovir to rhesus macaques from infancy through adulthood and pregnancy: summary of pharmacokinetics and biological and virological effects. Antimicrob Agents Chemother. 2008;52(9):3144-60.

Vila T, Gommer J, Scates AC. Role of gabapentin in the treatment of uremic pruritus. Ann Pharmacother. 2008;42(7):1080-4.

Vourvahis M, Tappouni HL, Patterson KB, Chen YC, Rezk NL, Fiscus SA, Kearney BP, Rooney JF, Hui J, Cohen MS, Kashuba AD. The pharmacokinetics and viral activity of tenofovir in the male genital tract. J Acquir Immune Defic Syndr. 2008;47(3):329-33.

Walbrown MA, Aspinall SL, Bayliss NK, Stone RA, Cunningham F, Squier CL, Good CB. Evaluation of Clostridium difficile-associated diarrhea with a drug formulary change in preferred fluoroquinolones. J Manag Care Pharm. 2008;14(1):34-40.

Abate MA, Blommel ML. A self-assessment tool for drug information advanced pharmacy practice experience. Am J Pharm Education 2007; 71(1): Article 02.

Benedict N, Seybert A, Mathier M, MD. Evidence-Based Pharmacologic Management of Pulmonary Arterial Hypertension. Clinical Therapeutics. 2007;29(10):2134-2153.

Benedict NJ. Sitaxsentan in the management of pulmonary arterial hypertension. Am J Health Syst Pharm 2007;64:363-368.

Coons JC, Fera T. Multidisciplinary team for enhancing care for patients with acute myocardial infarction or heart failure. Am J Health Syst Pharm 2007;64:1274-1278.

Coons JC, Seidl E. Cardiovascular pharmacotherapy update for the intensive care unit. Crit Care Nurs Q. 2007 Jan-Mar;30(1):44-57.

Corman SL, Skledar SJ, Culley CM. Evaluation of conflicting literature and application to formulary decisions. Am J Health-Syst Pharm 2007;64:182-185.

Corman SL, Skledar SJ. Use of lipid emulsion to reverse local anesthetic-induced toxicity. Ann Pharmacother. 2007;41(11):1873-7.

Deremer CE, Ford H, Lee Y. Lifestyle characteristics of medical center employees. Am J Health-Syst Pharm. 2007;64(19):2000-1. Letter.

Gleason PP, Shaughnessy AF. Telithromycin (Ketek) for Community Acquired Pneumonia. American Family Physician 2007;76:1857-8.

Gleason PP, Walters C, Heaton AH, Schafer JA. Telithromycin: the perils of hasty adoption and persistence of off-label prescribing. J Manag Care Pharm. 2007 Jun;13(5):420-5.

Gleason PP. Assessing step-therapy programs: a step in the right direction. J Manag Care Pharm. 2007 Apr;13(3):273-5.

Gortney JS, Sanders RM. Impact of C-reactive protein on treatment of patients with cardiovascular disease. Am J Health-Syst Pharm. 2007;64(19):2009-16.

Joy MS, Candiani C, Vaillancourt BA, Chin H, Hogan SL, Falk RJ. Reengineering clinical operations in a medical practice to optimize the management of anemia of chronic kidney disease. Pharmacotherapy. 2007 May;27(5):734-44.

Joy MS, Hogan SL, Thompson BD, Finn WF, Nickeleit V. Cytochrome P450 3A5 expression in the kidneys of patients with calcineurin inhibitor nephrotoxicity. Nephrol Dial Transplant. 2007 Jul;22(7):1963-8. Epub 2007 Mar 29.

Joy MS, Karagiannis PC, Peyerl FW. Outcomes of secondary hyperparathyroidism in chronic kidney disease and the direct costs of treatment. J Manag Care Pharm. 2007 Jun;13(5):397-411.

Juang P, Fish DN, Jung R, Maclaren R. Enteral glutamine supplementation in critically ill patients with burn injuries: a retrospective case-control evaluation. Pharmacotherapy. 2007;27(1):11-9.

Juang P, Skledar SJ, Zgheib NK, Paterson DL, Vergis EN, Shannon WD, Ansani NT, Branch RA. Clinical outcomes of intravenous immune globulin in severe clostridium difficile-associated diarrhea. Am J Infect Control. 2007;35(2):131-7.

Juang P. Update on new antifungal therapy. AACN Adv Crit Care. 2007;18(3):253-60.

Kane-Gill SL, Olsen KM, Rebuck JA, Rea RS, Boatwright DW, Smythe MA et al. Aspiration Evaluation Group of the Clinical Pharmacy and Pharmacology Section. Multicenter treatment and outcome evaluation of aspiration syndromes in critically ill patients. Ann Pharmacother. 2007;41(4):549-55.

Kockler DR, McCarthy MW. Zoster vaccine live. Pharmacotherapy. 2007 Jul;27(7):1013-9.

Kunze AM, Gunderson BW, Gleason PP, Heaton AH, Johnson SV. Utilization, cost trends, and member cost-share for self-injectable multiple sclerosis drugs--pharmacy and medical benefit spending from 2004 through 2007. J Manag Care Pharm. 2007;13(9):799-806.

Lauderdale SA, Kendrach MG, Freeman MK. Preparing students for community pharmacy practice during a drug information advanced practice experience. Am J Pharm Educ. 2007;71(2):25.

Lauderdale SA, Kendrach MG, Freeman MK. Preparing students for community pharmacy practice during a drug information advanced practice experience. Am J Pharm Educ. 2007 Apr 15;71(2):25.

Lionaki S, Hogan SL, Falk RJ, Joy MS, Chin H, Jennette CE, Jennette JC, Nachman PH. Association of thyroid disease and its treatment with ANCA small-vessel vasculitis: a case control study. Nephrol Dial Transplant. 2007 Aug 8; [Epub ahead of print]

Mathias AA, Hinkle J, Menning M, Hui J, Kaul S, Kearney BP. Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen Development Team. Bioequivalence of efavirenz/emtricitabine/tenofovir disoproxil fumarate single-tablet regimen. J Acquir Immune Defic Syndr. 2007;46(2):167-73.

McGivney MS, Meyer SM, Duncan-Hewitt W et al. Medication therapy management: its relationship to patient counseling, disease management, and pharmaceutical care. J Am Pharm Assoc. 2007;47(5):620-8.

McMillen K, Weber RJ. Developing patient-centered pharmacy services through residency training. Hosp Pharm. 2007;42(8):756-759.

Mehta U, Durrheim D, Mabuza A et al. Malaria pharmacovigilance in Africa: lessons from a pilot project in Mpumalanga Province, South Africa. Drug Saf. 2007;30(10):899-910.

Mehta U, Maartens G. Is it safe to switch between efavirenz and nevirapine in the event of toxicity? Lancet Infect Dis. 2007;7(11):733-8.

Noronha G, Miller J, Brewer JM. Pharmacists as nonphysician practitioners. Fam Pract Manag. 2007 Jan;14(1):11.

Okusanya O, Forrest A, DiFrancesco R, Bilic S, Rosenkranz S, Para MF, Adams E, Yarasheski KE, Reichman RC, Morse GD; ACTG 5043 Protocol Team. Compartmental pharmacokinetic analysis of oral amprenavir with secondary peaks. Antimicrob Agents Chemother. 2007 May;51(5):1822-6. Epub 2007 Feb 5.

Pogue JM, Paterson DL, Pasculle AW, Potoski BA. Determination of risk factors associated with isolation of linezolid-resistant strains of vancomycin-resistant Enterococcus. Infect Control Hosp Epidemiol. 2007;28(12):1382-8.

Ramanathan S, Shen G, Cheng A, Kearney BP. Pharmacokinetics of emtricitabine, tenofovir, and GS-9137 following coadministration of emtricitabine/tenofovir disoproxil fumarate and ritonavir-boosted GS-9137. J Acquir Immune Defic Syndr. 2007;45(3):274-9.

Ramanathan S, Shen G, Hinkle J, Enejosa J, Kearney BP. Pharmacokinetics of coadministered ritonavir-boosted elvitegravir and zidovudine, didanosine, stavudine, or abacavir. J Acquir Immune Defic Syndr. 2007;46(2):160-6.

Rea RS, Battistone S, Fong JJ, Devlin JW. Atypical antipsychotics versus haloperidol for treatment of delirium in acutely ill patients. Pharmacotherapy. 2007 Apr;27(4):588-94.

Rea RS, Capitano B. Optimizing use of aminoglycosides in the critically ill. Semin Respir Crit Care Med. 2007;28(6):596-603.

Rea RS, Donihi AC, Bobeck M, Herout P, McKaveney TP, Kane-Gill SL, Korytkowski MT. Implementing an intravenous insulin infusion protocol in the intensive care unit. Am J Health Syst Pharm. 2007 Feb 15;64(4):385-95.

Shabsigh R, Duval S, Shah M, Regan TS, Juhasz M, Veltry LG. Efficacy of vardenafil for the treatment of erectile dysfunction in men with hypertension: a meta-analysis of clinical trial data. Curr Med Res Opin. 2007;23(10):2453-60.

Skledar SJ, McKaveney TP, Sokos DR, Ervin KA, Coldren M, Hynicka L, Lavsa S, Reynolds R, Beauchamp R. Role of student pharmacist interns in hospital-based standing orders pneumococcal vaccination program. J Am Pharm Assoc. 2007;47(3):404-9.

Somma MA, Meyer SM. “Community of Learning” in experiential education. Am J Pharm Educ 2007;71(1): Article 19.

Szczesiul JM, Shermock KM, Murtaza UI, Siberry GK. No decrease in clindamycin susceptibility despite increased use of clindamycin for pediatric community-associated methicillin-resistant Staphylococcus aureus skin infections. Pediatr Infect Dis J. 2007;26(9):852-4.

Taylor SE, Braitberg G, Lugt J. Multifaceted education initiative minimizes pethidine prescribing in the emergency department. Emerg Med Australas. 2007 Feb;19(1):25-30.

Watson K, Seybert AL, Saul MI, Lee JS, Kane-Gill SL. Comparison of patient outcomes with bivalirudin versus unfractionated heparin in percutaneous coronary intervention. Pharmacotherapy. 2007;27(5):647-656.

Zhang D, Carlson AM, Gleason PP et al. Relationship of the magnitude of member cost-share and medication persistence with newly initiated renin angiotensin system blockers. J Manag Care Pharm. 2007;13(8):664-76.

Zieve FJ, Kalin MF, Schwartz SL, Jones MR,